0001558370-23-018287.txt : 20231108 0001558370-23-018287.hdr.sgml : 20231108 20231108162501 ACCESSION NUMBER: 0001558370-23-018287 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231108 DATE AS OF CHANGE: 20231108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 231388261 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 10-Q 1 pahc-20230930x10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36410

Phibro Animal Health Corporation

(Exact name of registrant as specified in its charter)



Delaware	13-1840497
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21

Teaneck, New Jersey	07666-6712
(Address of Principal Executive Offices)	(Zip Code)

(201) 329-7300

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share		PAHC		Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 3, 2023, there were 20,337,574 shares of the registrant’s Class A common stock, par value $0.0001 per share, and 20,166,034 shares of the registrant’s Class B common stock, par value $0.0001 per share, outstanding.

Table of Contents

PHIBRO ANIMAL HEALTH CORPORATION

TABLE OF CONTENTS

		Page
PART I—FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)	3
	Consolidated Statements of Operations	3
	Consolidated Statements of Comprehensive (Loss) Income	4
	Consolidated Balance Sheets	5
	Consolidated Statements of Cash Flows	6
	Consolidated Statements of Changes in Stockholders’ Equity	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	33
PART II—OTHER INFORMATION
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3.	Defaults Upon Senior Securities	33
Item 4.	Mine Safety Disclosures	33
Item 5.	Other Information	34
Item 6.	Exhibits	34
SIGNATURES		35

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS


	Three Months
For the Periods Ended September 30	2023		2022

	(unaudited)
	(in thousands, except per share amounts)
Net sales	$	231,349	$	232,521
Cost of goods sold		163,623		163,875
Gross profit		67,726		68,646
Selling, general and administrative expenses		68,452		54,962
Operating (loss) income		(726)		13,684
Interest expense, net		4,564		3,067
Foreign currency losses, net		6,689		5,200
(Loss) income before income taxes		(11,979)		5,417
(Benefit) provision for income taxes		(3,964)		1,561
Net (loss) income	$	(8,015)	$	3,856

Net (loss) income per share
basic	$	(0.20)	$	0.10
diluted	$	(0.20)	$	0.10
Weighted average common shares outstanding
basic		40,504		40,504
diluted		40,504		40,504

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME


	Three Months
For the Periods Ended September 30	2023		2022

	(unaudited)
	(in thousands)
Net (loss) income	$	(8,015)	$	3,856
Change in fair value of derivative instruments		(1,891)		7,105
Foreign currency translation adjustment		(3,560)		(4,143)
Pension settlement recognition		10,425		—
Unrecognized net pension gains		644		176
Provision for income taxes		(2,264)		(1,820)
Other comprehensive income		3,354		1,318
Comprehensive (loss) income	$	(4,661)	$	5,174

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


	September 30,		June 30,
As of	2023		2023

	(unaudited)
	(in thousands, except share and per share amounts)
ASSETS
Cash and cash equivalents	$	43,153	$	41,281
Short-term investments		48,000		40,000
Accounts receivable, net		149,228		163,479
Inventories, net		279,154		277,570
Other current assets		64,889		63,393
Total current assets		584,424		585,723
Property, plant and equipment, net		193,359		195,568
Intangibles, net		52,184		54,987
Goodwill		53,251		53,274
Other assets		81,305		81,845
Total assets	$	964,523	$	971,397
LIABILITIES AND STOCKHOLDERS' EQUITY
Current portion of long-term debt	$	24,150	$	22,295
Accounts payable		77,216		73,853
Accrued expenses and other current liabilities		70,989		79,852
Total current liabilities		172,355		176,000
Revolving credit facility		154,000		141,000
Long-term debt		304,717		311,541
Other liabilities		60,382		60,347
Total liabilities		691,454		688,888
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2023, and June 30, 2023; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2023, and June 30, 2023		4		4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding		—		—
Paid-in capital		135,884		135,803
Retained earnings		248,037		260,912
Accumulated other comprehensive loss		(110,856)		(114,210)
Total stockholders’ equity		273,069		282,509
Total liabilities and stockholders’ equity	$	964,523	$	971,397

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS


	Three Months
For the Periods Ended September 30	2023		2022

	(unaudited)
	(in thousands)
OPERATING ACTIVITIES
Net (loss) income	$	(8,015)	$	3,856
Adjustments to reconcile net (loss) income to
net cash provided (used) by operating activities:
Depreciation and amortization		8,871		8,450
Amortization of debt issuance costs		260		147
Stock-based compensation		81		—
Deferred income taxes		(2,691)		(13)
Foreign currency losses, net		3,222		3,370
Pension settlement cost		10,425		—
Other		959		(309)
Changes in operating assets and liabilities:
Accounts receivable, net		12,781		22,347
Inventories, net		(5,005)		(24,977)
Other current assets		(3,297)		(7,682)
Other assets		(191)		(31)
Accounts payable		4,603		(5,595)
Accrued expenses and other liabilities		(5,804)		(10,261)
Net cash provided (used) by operating activities		16,199		(10,698)
INVESTING ACTIVITIES
Purchases of short-term investments		(17,000)		—
Maturities of short-term investments		9,000		7,000
Capital expenditures		(7,476)		(23,176)
Other, net		124		27
Net cash used by investing activities		(15,352)		(16,149)
FINANCING ACTIVITIES
Revolving credit facility borrowings		51,000		62,000
Revolving credit facility repayments		(38,000)		(36,000)
Proceeds from long-term debt		—		12,000
Payments of long-term debt		(5,105)		(3,750)
Debt issuance costs		—		(71)
Payments of insurance premium financing		(1,739)		—
Dividends paid		(4,860)		(4,860)
Net cash provided by financing activities		1,296		29,319
Effect of exchange rate changes on cash		(271)		(440)
Net increase in cash and cash equivalents		1,872		2,032
Cash and cash equivalents at beginning of period		41,281		74,248
Cash and cash equivalents at end of period	$	43,153	$	76,280

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY


										Accumulated
										Other
	Shares of									Comprehensive
	Common	Common		Preferred		Paid-in		Retained		Income
	Stock	Stock		Stock		Capital		Earnings		(Loss)		Total

	(unaudited)
	(in thousands, except share and per share amounts)
As of June 30, 2023	40,503,608	$	4	$	—	$	135,803	$	260,912	$	(114,210)	$	282,509
Comprehensive (loss) income	—		—		—		—		(8,015)		3,354		(4,661)
Dividends declared ($0.12 per share)	—		—		—		—		(4,860)		—		(4,860)
Stock-based compensation expense	—		—		—		81		—		—		81
As of September 30, 2023	40,503,608	$	4	$	—	$	135,884	$	248,037	$	(110,856)	$	273,069


										Accumulated
										Other
	Shares of									Comprehensive
	Common	Common		Preferred		Paid-in		Retained		Income
	Stock	Stock		Stock		Capital		Earnings		(Loss)		Total

	(unaudited)
	(in thousands, except share and per share amounts)
As of June 30, 2022	40,503,608	$	4	$	—	$	135,803	$	247,748	$	(121,113)	$	262,442
Comprehensive income	—		—		—		—		3,856		1,318		5,174
Dividends declared ($0.12 per share)	—		—		—		—		(4,860)		—		(4,860)
As of September 30, 2022	40,503,608	$	4	$	—	$	135,803	$	246,744	$	(119,795)	$	262,756

The accompanying notes are an integral part of these consolidated financial statements

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share amounts)

(unaudited)

1. Description of Business

Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.

The unaudited consolidated financial information for the three months ended September 30, 2023 and 2022, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Annual Report”), filed with the Securities and Exchange Commission on August 30, 2023 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2023, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.

The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

2. Summary of Significant Accounting Policies and New Accounting Standards

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2023, there have been no material changes to any of the significant accounting policies contained therein.

Net (Loss) Income per Share and Weighted Average Shares

Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period.

Diluted net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period after giving effect to dilutive common share equivalents, resulting from the assumed vesting of restricted stock units. The restricted stock units have been excluded from the computation of diluted earnings per share for the three months ended September 30, 2023, as the effect would have been antidilutive.


	Three Months
For the Periods Ended September 30	2023		2022
Net (loss) income	$	(8,015)	$	3,856

Weighted average number of shares – basic		40,504		40,504
Dilutive effect of restricted stock units		—		—
Weighted average number of shares - diluted		40,504		40,504

Net (loss) income per share
basic	$	(0.20)	$	0.10
diluted	$	(0.20)	$	0.10

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

New Accounting Standards

We do not expect the new accounting standards that are pending adoption by us to have a material effect on our consolidated financial statements.

3. Statements of Operations—Additional Information

Disaggregated revenue, deferred revenue and customer payment terms

We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. The products help prevent, control and treat diseases and enhance nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products directly to integrated poultry, cattle and swine customers and through commercial animal feed manufacturers, distributors and veterinarians. The animal health industry and demand for many of the animal health products in a particular region are affected by changing disease pressures and by weather conditions, as product usage follows varying weather patterns and seasons. Our operations are primarily focused on regions where the majority of livestock production is consolidated in large commercial farms.

We have a diversified portfolio of products that are classified within our three business segments—Animal Health, Mineral Nutrition and Performance Products. Each segment has its own dedicated management and sales team.

Animal Health

The Animal Health business develops, manufactures and markets products in three main categories:

●

MFAs and other: MFAs and other products primarily consist of concentrated medicated products administered through animal feeds, commonly referred to as Medicated Feed Additives (“MFAs”). Specific product classifications include antibacterials, which inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidia (parasites) that damage the intestinal tract of animals; and other related products. The MFAs and other category also includes antibacterials and other processing aids used in the ethanol fermentation industry.

●

Nutritional specialties: Nutritional specialty products enhance nutrition to help improve health and performance in areas such as immune system function and digestive health. We are also a developer, manufacturer and marketer of microbial products and bioproducts for a variety of applications serving animal health and nutrition, environmental, industrial and agricultural customers.

●

Vaccines: Vaccine products are primarily focused on preventing diseases in poultry, swine, beef and dairy cattle and aquaculture. They protect animals from either viral or bacterial disease challenges. We develop, manufacture and market conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. We have developed and market an innovative and proprietary delivery platform for vaccines.

Mineral Nutrition

The Mineral Nutrition business is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Our customers use these products to fortify the daily feed requirements of their livestock’s diets and maintain an optimal balance of trace elements in each animal. We manufacture and market a broad range of mineral nutrition products for food animals including poultry, swine, and beef and dairy cattle.

Performance Products

The Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following tables present our revenues disaggregated by major product category and geographic region:

Net Sales by Product Type


	Three Months
For the Periods Ended September 30	2023		2022
Animal Health
MFAs and other	$	94,104	$	92,790
Nutritional specialties		40,210		39,054
Vaccines		26,216		23,015
Total Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total	$	231,349	$	232,521

Net Sales by Region


	Three Months
For the Periods Ended September 30	2023		2022
United States	$	131,287	$	135,804
Latin America and Canada		58,703		52,246
Europe, Middle East and Africa		26,879		29,517
Asia Pacific		14,480		14,954
Total	$	231,349	$	232,521

Net sales by region are based on country of destination.

Our customer payment terms generally range from 30 to 120 days globally and do not include any significant financing components. Payment terms vary based on industry and business practices within the regions in which we operate. Our average worldwide collection period for accounts receivable is approximately 60 days after the revenue is recognized.

Interest Expense


	Three Months
For the Periods Ended September 30	2023		2022
Interest expense, net
2021 Credit Facilities	$	5,101	$	3,547
2022 Term Loan		216		—
Amortization of debt issuance costs		260		147
Other		68		1
Interest expense		5,645		3,695
Interest income		(1,081)		(628)
	$	4,564	$	3,067

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Depreciation and Amortization


	Three Months
For the Periods Ended September 30	2023		2022
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,431	$	6,051
Amortization of intangible assets		2,440		2,399
	$	8,871	$	8,450

Pension Settlement

In July 2023, we entered into an annuity purchase agreement to irrevocably transfer a portion of our pension benefit obligation to a third-party insurance company. The annuity purchase price was $26,381 and was approximately equal to the benefit obligation transferred. The annuity purchase was funded from pension assets. During the three months ended September 30, 2023, we recognized a partial settlement of the pension plan and recorded $10,425, in selling, general and administrative expenses in our consolidated statement of operations, resulting from the recognition of net pension losses previously included in Accumulated other comprehensive loss.

4. Balance Sheets—Additional Information


	September 30,		June 30,
As of	2023		2023
Inventories
Raw materials	$	84,369	$	84,328
Work-in-process		25,159		22,350
Finished goods		169,626		170,892
	$	279,154	$	277,570


	September 30,		June 30,
As of	2023		2023
Other assets
ROU operating lease assets	$	36,320	$	35,759
Deferred income taxes		8,981		8,711
Deposits		6,518		6,617
Insurance investments		6,096		6,067
Equity method investments		5,814		5,027
Derivative instruments		8,500		10,225
Debt issuance costs		1,284		1,408
Other		7,792		8,031
	$	81,305	$	81,845


	September 30,		June 30,
As of	2023		2023
Accrued expenses and other current liabilities
Employee related	$	26,647	$	29,359
Current operating lease liabilities		6,452		6,053
Commissions and rebates		3,442		5,833
Professional fees		4,643		5,032
Income and other taxes		5,951		8,663
Insurance-related		1,364		1,284
Insurance premium financing		2,898		4,769
Other		19,592		18,859
	$	70,989	$	79,852

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)


	September 30,		June 30,
As of	2023		2023
Other liabilities
Long-term operating lease liabilities	$	29,022	$	29,077
Long-term and deferred income taxes		12,823		12,146
Supplemental retirement benefits, deferred compensation and other		6,628		6,552
U.S. pension plan		1,687		2,286
International retirement plans		4,130		4,210
Other long-term liabilities		6,092		6,076
	$	60,382	$	60,347


	September 30,		June 30,
As of	2023		2023
Accumulated other comprehensive loss
Derivative instruments	$	22,698	$	24,589
Foreign currency translation adjustment		(118,622)		(115,062)
Unrecognized net pension losses		(12,927)		(23,996)
Income tax (provision) benefit		(2,005)		259
	$	(110,856)	$	(114,210)

5. Debt

Term Loans and Revolving Credit Facilities

In April 2021, we entered into an amended and restated credit agreement (the “2021 Credit Agreement”) under which we had a term A loan in an aggregate initial principal amount of $300,000 (the “2021 Term A Loan”) and a revolving credit facility under which we could borrow up to an aggregate amount of $250,000, subject to the terms of the 2021 Credit Agreement (the “2021 Revolver”). In November 2022, we amended the 2021 Credit Facilities to increase the revolving commitments under the 2021 Revolver to an aggregate amount of $310,000 and to adopt Secured Overnight Financing Rate (“SOFR”) as the reference for the fluctuating rate of interest on the 2021 Credit Facilities, replacing the London Interbank Offered Rate (“LIBOR”) reference rate. In June 2023, we obtained an additional incremental term loan (the “2023 Incremental Term Loan”) in the amount of $50,000 (the 2021 Revolver, the 2021 Term A Loan and the 2023 Incremental Term Loan are collectively referred to as the “2021 Credit Facilities”).

The 2021 Term A Loan and the 2023 Incremental Term Loan are repayable in quarterly installments, with the balances payable at maturity. The 2021 Revolver contains a letter of credit facility. The interest rate per annum applicable to the 2021 Revolver and the 2021 Term A Loan is based on a fluctuating rate of interest plus an applicable rate equal to 1.50%, 1.75%, 2.00% or 2.25% in the case of adjusted SOFR rate loans and 0.50%, 0.75%, 1.00% or 1.25%, in the case of base rate loans. The interest rate per annum applicable to the 2023 Incremental Term Loan is based on a fluctuating rate of interest plus an applicable rate equal to 2.00%, 2.25%, 2.50% or 2.75% in the case of adjusted SOFR rate loans and 1.00%, 1.25%, 1.50% or 1.75% in the case of base rate loans. The applicable rates are based on the First Lien Net Leverage Ratio (as defined in the 2021 Credit Agreement, as amended). The 2021 Credit Facilities mature in April 2026.

The 2021 Credit Agreement requires, among other things, compliance with financial covenants that permit: (i) a maximum First Lien Net Leverage Ratio of 4.00:1.00 (or, specifically with respect to the test periods ending September 30, 2023, December 31, 2023, March 31, 2024, and June 30, 2024, a maximum of 4.25:1.00); and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis. The 2021 Credit Agreement contains an acceleration clause should an event of default (as defined in the 2021 Credit Agreement) occur. As of September 30, 2023, we were in compliance with the financial covenants.

As of September 30, 2023, we had $154,000 in borrowings drawn under the 2021 Revolver and had outstanding letters of credit of $2,479, leaving $153,521 available for further borrowings and letters of credit under the 2021 Revolver, subject to restrictions in our 2021 Credit Facilities. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are all less than one year.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Interest Rates

Interest rates as of the balance sheet dates and the weighted-average rates for the periods presented were:


					Three Months
	September 30,		June 30,		Ended September 30,
	2023		2023		2023		2022
2021 Revolver	6.23	%	6.09	%	6.19	%	3.92	%
2021 Term A Loan	2.36	%	2.36	%	2.36	%	2.37	%
2023 Incremental Term Loan	7.66	%	7.44	%	7.57	%	—
2022 Term Loan	7.42	%	7.25	%	7.43	%	—

Interest rates as of the balance sheet dates are based on rates in effect as of those dates, including SOFR fluctuating rates of interest, applicable rates and the interest rate swap agreement.

In March 2020, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converted the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increased to a notional principal amount of $300,000. In November 2022, we amended this agreement to convert the floating portion of our interest obligation to SOFR. The agreement effectively converts the floating portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.61% through June 2025. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 9 — Derivatives.”

Other Long-Term Debt

In September 2022, we entered into a credit agreement (the “2022 Term Loan”) in the amount of $12,000, collateralized by certain facilities. The 2022 Term Loan matures in September 2027. The interest rate per annum applicable to the 2022 Term Loan is based on a fluctuating rate of interest, at the Company’s election from time to time, equal to either (i) one-month adjusted SOFR plus 2.0%, or (ii) a base rate determined by reference to the greater of (a) the prime rate and (b) the Federal Funds Effective Rate plus 0.5%. The 2022 Term Loan is repayable in monthly installments of $35, with the balance payable at maturity.

Maturities of Long-Term Debt


	September 30,		June 30,
As of	2023		2023
2021 Term A Loan due April 2026	$	270,000	$	273,750
2023 Incremental Term Loan due April 2026		48,750		50,000
2022 Term Loan due September 2027		11,580		11,685
		330,330		335,435
Unamortized debt issuance costs		(1,463)		(1,599)
		328,867		333,836
Less: current maturities		(24,150)		(22,295)
	$	304,717	$	311,541

6. Related Party Transactions

Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to the Company as employees or consultants and received aggregate compensation and benefits of approximately $438 and $780 during the three months ended September 30, 2023 and 2022, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

7. Stock Incentive Plan

Restricted Stock Units

In July 2023, our Board of Directors approved the grant of 300,000 restricted stock units (“RSUs”) to an officer of the Company, pursuant to the Company's 2008 Incentive Plan and the RSU award agreement. Each RSU represents the right to receive a share of our common stock upon vesting. The RSUs are subject to performance-based vesting. The RSUs will vest on June 30, 2027, subject to continuation of employment on such date, in increments of 10% (but no less than 20%) (with linear interpolation between increments) based upon the arithmetic average of the Company’s closing stock price per share for each trading day in the 90-calendar day period ending on the vesting date (the “90-Day Average”). None of the RSUs will vest if the 90-Day Average is below $20, and 100% of the RSUs will vest if the 90-Day Average is $60 or above. In the event of a change in control of the Company, following which either (i) 100% of the shares of stock cease to be traded on a nationally recognized stock exchange and the Company is no longer listed on any such exchange or (ii) a Qualifying Termination occurs within 12 months, all unvested RSUs will immediately vest in full.

We used a Monte Carlo simulation model to determine the grant date fair value of the RSUs. Assumptions used by the model were based on information as of the grant date and included a risk-free rate of return, expected volatility and an expected dividend yield. The risk-free rate of return is based on U.S. treasury yields for bonds with similar maturities. Expected volatility is based on the historical volatility of the Company’s common stock. The expected dividend yield considers estimated annual dividends and the closing share price of the underlying common stock.

The total grant date fair value of the RSUs was $1,284, equivalent to $4.28 per share. We will recognize the total grant date fair value of the RSUs as stock-based compensation expense on a straight-line basis over the vesting period. Stock-based compensation expense related to the RSUs was $81 for the three months ended September 30, 2023. We expect stock-based compensation expense related to the RSUs will be $321 in each of the years ending June 30, 2024, 2025, 2026 and 2027.

8. Commitments and Contingencies

Environmental

Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination, and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the period during which such costs are likely to be incurred are difficult to predict.

While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based on our experience, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of the Santa Fe Springs, California facility of our subsidiary, Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has entered into a settlement agreement with a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling (“OPOG”) to remediate the contaminated groundwater that has migrated from the Omega Chemical Site in accordance with a general remedy selected by the EPA. The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that any groundwater contamination at its site is localized and due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. PAHC and Phibro-Tech have vigorously contested this position and have asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. In 2014, several members of OPOG filed a complaint under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and the Resource Conservation and Recovery Act in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. In August 2022, the United States Department of Justice (the “DOJ”), on behalf of the EPA, sent Phibro-Tech and certain other PRPs a pre-litigation notice letter regarding potential CERCLA Sec. 107 cost recovery claims seeking unrecovered past costs related to the groundwater plume affected by the Omega Chemical Site, along with a declaration allocating liability for future costs.

In February 2023, the plaintiffs in the OPOG lawsuit and certain defendants in the OPOG lawsuit, including Phibro-Tech, signed a definitive settlement agreement that provides for a “cash-out” settlement, with contribution protection, for Phibro-Tech and its affiliates (as well as certain other defendants) releasing Phibro-Tech and its affiliates from liability for contamination of the groundwater plume affected by the Omega Chemical Site (with certain exceptions), including past and future EPA response costs that were the subject of the August 2022 pre-litigation notice letter sent by the DOJ on behalf of the EPA. As part of the settlement, Phibro-Tech also resolved all claims for indemnification and contribution between Phibro-Tech and the successor to the prior owner of the Phibro-Tech site. The definitive settlement agreement contemplates cash payments by Phibro-Tech and one of its affiliates over a period ending in February 2024. The definitive settlement agreement is subject to formal approval by the EPA, the DOJ and the district court.

Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, including the remaining liability for the OPOG lawsuit described in the preceding paragraph, to be approximately $8,531 and $8,505 at September 30, 2023 and June 30, 2023, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries are liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Claims and Litigation

PAHC and its subsidiaries are party to various claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

9. Derivatives

We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in Accumulated other comprehensive loss.

We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 10 — Fair Value Measurements.”

In March 2020, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converted the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increased to a notional principal amount of $300,000. In November 2022, we amended the March 2020 interest rate swap agreement to convert the floating portion of our interest obligation to SOFR. The agreement effectively converts the floating portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.61% through June 2025. We have designated the interest rate swap as a highly effective cash flow hedge.

The consolidated balance sheet includes the net fair values of our outstanding foreign currency option contracts within the respective line items, based on the net financial position and maturity date of the individual contracts. The consolidated balance sheet includes the net fair values of our outstanding interest rate swaps within the respective balance sheet line items, based on the expected timing of the cash flows. The consolidated balance sheet includes assets and liabilities for the fair values of outstanding derivatives that are designated and effective as cash flow hedges as follows:


	September 30,		June 30,
As of	2023		2023
Other current assets
Brazil Real options, net	$	—	$	333
Interest rate swap		14,198		14,031
Other assets
Interest rate swap		8,500		10,225
Total Fair Value
Brazil Real options, net		—		333
Interest rate swap		22,698		24,256

Notional amounts of the derivatives as of the balance sheet date were:


	September 30,
As of	2023
Interest rate swap	$	300,000

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The consolidated statements of operations and statements of comprehensive (loss) income for the periods ended September 30, 2023 and 2022 included the effects of derivatives as follows:


	Three Months
For the Periods Ended September 30	2023		2022
Brazil Real options, net
(Income) expense recorded in consolidated statements of operations	$	(181)	$	438
Consolidated statement of operations - total cost of goods sold	$	163,623	$	163,875
Expense recorded in comprehensive (loss) income	$	333	$	168
Interest rate swap
Income recorded in consolidated statements of operations	$	(3,570)	$	(1,211)
Consolidated statement of operations - total interest expense, net	$	4,564	$	3,067
Expense (income) recorded in comprehensive (loss) income	$	1,558	$	(7,273)

We recognize gains and losses related to foreign currency derivatives as a component of cost of goods sold at the time the hedged item is sold. Inventory as of September 30, 2023, included realized net gains of $1,182 related to matured contracts. We anticipate the net gains included in inventory will be recognized in cost of goods sold within the next twelve to eighteen months.

10. Fair Value Measurements

Short-term Investments

Our short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.

Current Assets and Liabilities

We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.

Debt

We record debt, including term loans and revolver balances, at amortized cost in our consolidated financial statements. We believe the carrying value of the debt is approximately equal to its fair value, due to the variable nature of the instruments and our evaluation of estimated market prices.

Derivatives

We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.

Non-financial Assets

Our non-financial assets, which primarily consist of goodwill, other intangible assets, property and equipment, and lease-related right-of-use (“ROU”) assets, are not required to be measured at fair value on a recurring basis, and instead are reported at carrying value in the consolidated balance sheet. Assets and liabilities may be required to be measured at fair value on a non-recurring basis, either upon initial recognition or for subsequent accounting or reporting, including the initial recognition of net assets acquired in a business combination. These fair value measurements involve unobservable inputs that reflect estimates and assumptions that represent Level 3 inputs.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Fair Value of Assets (Liabilities)


As of	September 30, 2023						June 30, 2023
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Short-term investments	$	48,000	$	—	$	—	$	40,000	$	—	$	—
Foreign currency derivatives	$	—	$	—	$	—	$	—	$	333	$	—
Interest rate swap	$	—	$	22,698	$	—	$	—	$	24,256	$	—

There were no transfers between levels during the periods presented.

11. Business Segments

We evaluate performance and allocate resources, based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and (e) certain items that we consider to be unusual, non-operational or non-recurring.

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)


	Three Months
For the Periods Ended September 30	2023		2022
Net sales
Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total segments	$	231,349	$	232,521

Depreciation and amortization
Animal Health	$	7,349	$	6,911
Mineral Nutrition		646		655
Performance Products		426		442
Total segments	$	8,421	$	8,008
Adjusted EBITDA
Animal Health	$	28,494	$	26,964
Mineral Nutrition		2,881		5,297
Performance Products		1,409		2,364
Total segments	$	32,784	$	34,625
Reconciliation of income before income taxes to Adjusted EBITDA
(Loss) income before income taxes	$	(11,979)	$	5,417
Interest expense, net		4,564		3,067
Depreciation and amortization – Total segments		8,421		8,008
Depreciation and amortization – Corporate		450		442
Corporate costs		14,133		12,491
Pension settlement cost		10,425		—
Stock-based compensation		81		—
Foreign currency losses, net		6,689		5,200
Adjusted EBITDA – Total segments	$	32,784	$	34,625


	September 30,		June 30,
As of	2023		2023
Identifiable assets
Animal Health	$	679,935	$	698,522
Mineral Nutrition		74,060		75,814
Performance Products		49,939		49,678
Total segments		803,934		824,014
Corporate		160,589		147,383
Total	$	964,523	$	971,397

The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax-related assets and certain other assets.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

Our management’s discussion and analysis of financial condition and results of operations (“MD&A”) is provided to assist readers in understanding our performance, as reflected in the results of our operations, our financial condition and our cash flows. The following discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. This MD&A should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Our future results could differ materially from our historical performance as a result of various factors such as those discussed in “Risk Factors” in Item 1A of our Annual Report and “Forward-Looking Statements.”

Overview of our business

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. Our products help prevent, control and treat diseases, and support nutrition to help improve animal health and well-being. In addition to animal health and mineral nutrition products, we manufacture and market specific ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Armed Conflicts

Hamas and Israel

On October 7, 2023, Hamas militants crossed into Israel from Gaza in a large-scale, surprise terrorist attack. Hamas terrorists invaded Israel, first firing rockets into the country and then carrying out attacks inflicting mass casualties with hundreds more taken hostage. In order to provide immediate assistance to the victims of the attacks and their families, we and our employees provided monetary donations that will be distributed to charities that offer relief services, welfare, equipment, food and other necessities.

We have three manufacturing sites in Israel. A manufacturing plant in Neot Hovav that produces active pharmaceutical ingredients for certain of our anticoccidial and antimicrobial products, a facility in Beit Shemesh that produces vaccines and a plant in Petah Tikvah that manufactures premix products and nutritionals. In addition, we have an office location near Tel Aviv in Airport City. As of September 30, 2023, we had approximately 550 employees located in Israel. While we have had some disruption to our operations, at the current time, we have confidence in our ability to meet our supply commitment to customers and maintain sufficient inventory to continue regional support. While the situation surrounding the ongoing conflict remains fluid, our operations in Israel have navigated numerous challenging situations over the years.

The prolonged continuation or escalation of this conflict may trigger bans, economic and other sanctions, as well as broader military conflict, which could include neighboring nations. The potential impacts of the current conflict, or escalation thereof, on our business is unclear but may include, without limitation, the possible disruption of our operations, particularly at our facilities in Israel, supply chain and logistics disruptions, personnel and raw material shortages, and other consequences, including as a result of the actions of, or disruption of the operations of, certain regulatory and governmental authorities and of certain of our suppliers, collaborative partners, licensees, manufacturing sites, distributors and customers. Our Israeli manufacturing facilities and local operations account for 27% of our consolidated assets as of September 30, 2023, and 19% of our consolidated net sales, for the three months ended September 30, 2023.

Russia and Ukraine

In response to the armed conflict between Russia and Ukraine that began in February 2022, we and our employees have provided support to Ukraine in the form of monetary donations, free products and humanitarian services. Our limited intent for the Russian market is to continue to provide medicines and vaccines, and related regulatory and technical support, to help existing customers combat disease challenges in the production of food animals on their farms. We have no production or direct distribution operations and no planned investments in Russia.

Table of Contents

Since the conflict began, the United States and other North Atlantic Treaty Organization (“NATO”) member states, as well as non-member states, announced targeted economic sanctions on Russia, including certain Russian citizens and enterprises. The continuation or escalation of the conflict may trigger additional economic and other sanctions, as well as broader military conflict. The potential impacts of any resulting bans, sanctions, boycotts or broader military conflicts on our business are uncertain. The potential impacts could include supply chain and logistics disruptions, macroeconomic impacts resulting from the exclusion of Russian financial institutions from the global banking system, volatility in foreign exchange rates and interest rates, inflationary pressures on raw materials and energy as well as heightened cybersecurity threats. Our annual sales to Russia and Ukraine represent approximately 1% of consolidated net sales.

We cannot know if the conflict could escalate and result in broader economic and security concerns that could adversely affect our business, financial condition, or results of operations.

Regulatory developments

In April 2016, the Food and Drug Administration (“FDA”) began initial steps to withdraw approval of carbadox (the active ingredient in our Mecadox product) via a regulatory process known as a Notice of Opportunity for Hearing (“NOOH”), due to concerns that certain residues from the product may persist in animal tissues for longer than previously determined. In the years following, Phibro has continued an ongoing process of responding collaboratively and transparently to the FDA’s Center for Veterinary Medicine (“CVM”) inquiries and has provided extensive and meticulous research and data that confirmed the safety of carbadox. In July 2020, the FDA announced it would not proceed to a hearing on the scientific concerns raised in the 2016 NOOH, consistent with the normal regulatory procedure, but instead announced that it was withdrawing the 2016 NOOH and issuing a proposed order to review the regulatory method for carbadox. Phibro reiterated the safety of carbadox and the appropriateness of the regulatory method and offered to work with the CVM to generate additional data to support the existing regulatory method or select a suitable alternative regulatory method.

In March 2022, the FDA held a Part 15 virtual public hearing seeking data and information related to the safety of carbadox in which Phibro participated and again detailed the extensive research and data that confirm the safety of carbadox. In November 2023, the FDA, through CVM, provided notice of a Federal Register publication issuing a final order to revoke the approved method for detecting residues of carbadox. The FDA has also provided notice of a second Federal Register publication proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of carbadox in medicated swine feed and announcing an opportunity for Phibro to request a hearing on this proposal. This second action is based on CVM’s determination that there is no approved regulatory method to detect carbadox residues in the edible tissues of the treated swine. Phibro intends to take appropriate action and next steps to continue to defend swine producers’ ability to use Mecadox, and we will argue that we are entitled to and expect to have a full evidentiary hearing on the merits before an administrative law judge. Should we be unable to successfully defend the safety of the product, the loss of carbadox sales will have an adverse effect on our financial condition and results of operations. Sales of Mecadox (carbadox) for the twelve months ended September 30, 2023, were approximately $20 million. As of the date of the filing of this Quarterly Report on Form 10-Q, Mecadox continues to be available for use by swine producers. For additional information, see also “Business – Compliance with Government Regulation – United States – Carbadox”; and “Business – Compliance with Government Regulation – Global Policy and Guidance” in Item 1 of our Annual Report.

Table of Contents

Analysis of the consolidated statements of operations

Summary Results of Operations


	Three Months
For the Periods Ended September 30	2023			2022			Change

	(in thousands, except per share amounts and percentages)
Net sales	$	231,349		$	232,521		$	(1,172)	(1)	%
Gross profit		67,726			68,646			(920)	(1)	%
Selling, general and administrative expenses		68,452			54,962			13,490	25	%
Operating (loss) income		(726)			13,684			(14,410)	*
Interest expense, net		4,564			3,067			1,497	49	%
Foreign currency losses, net		6,689			5,200			1,489	*
(Loss) income before income taxes		(11,979)			5,417			(17,396)	*
(Benefit) provision for income taxes		(3,964)			1,561			(5,525)	*
Net (loss) income	$	(8,015)		$	3,856		$	(11,871)	*

Net (loss) income per share
Basic	$	(0.20)		$	0.10		$	(0.30)	*
Diluted	$	(0.20)		$	0.10		$	(0.30)	*

Weighted average number of shares outstanding
Basic		40,504			40,504
Diluted		40,504			40,504

Ratio to net sales
Gross profit		29.3	%		29.5	%
Selling, general and administrative expenses		29.6	%		23.6	%
Operating (loss) income		(0.3)	%		5.9	%
(Loss) income before income taxes		(5.2)	%		2.3	%
Net (loss) income		(3.5)	%		1.7	%
Effective tax rate		33.1	%		28.8	%

Certain amounts and percentages may reflect rounding adjustments.

*	Calculation not meaningful

Net sales, Adjusted EBITDA and reconciliation of GAAP net (loss) income to Adjusted EBITDA

We report Net sales and Adjusted EBITDA by segment to understand the operating performance of each segment. This enables us to monitor changes in net sales, costs and other actionable operating metrics at the segment level. See “—General description of non-GAAP financial measures.”

Table of Contents

Segment net sales and Adjusted EBITDA:


	Three Months
For the Periods Ended September 30	2023			2022			Change

Net sales	(in thousands, except percentages)
MFAs and other	$	94,104		$	92,790		$	1,314	1	%
Nutritional specialties		40,210			39,054			1,156	3	%
Vaccines		26,216			23,015			3,201	14	%
Animal Health		160,530			154,859			5,671	4	%
Mineral Nutrition		56,026			59,646			(3,620)	(6)	%
Performance Products		14,793			18,016			(3,223)	(18)	%
Total	$	231,349		$	232,521		$	(1,172)	(1)	%

Adjusted EBITDA
Animal Health	$	28,494		$	26,964		$	1,530	6	%
Mineral Nutrition		2,881			5,297			(2,416)	(46)	%
Performance Products		1,409			2,364			(955)	(40)	%
Corporate		(14,133)			(12,491)			(1,642)	13	%
Total	$	18,651		$	22,134		$	(3,483)	(16)	%

Adjusted EBITDA as a percentage of segment net sales
Animal Health		17.7	%		17.4	%
Mineral Nutrition		5.1	%		8.9	%
Performance Products		9.5	%		13.1	%
Corporate ⁽¹⁾		(6.1)	%		(5.4)	%
Total ⁽¹⁾		8.1	%		9.5	%

(1)	Reflects ratio to total net sales

The table below sets forth a reconciliation of net (loss) income, as reported under GAAP, to Adjusted EBITDA:


	Three Months
For the Periods Ended September 30	2023		2022		Change

	(in thousands, except percentages)
Net (loss) income	$	(8,015)	$	3,856	$	(11,871)	*
Interest expense, net		4,564		3,067		1,497	49	%
(Benefit) provision for income taxes		(3,964)		1,561		(5,525)	*
Depreciation and amortization		8,871		8,450		421	5	%
EBITDA		1,456		16,934		(15,478)	(91)	%
Pension settlement cost		10,425		—		10,425	*
Stock-based compensation		81		—		81	*
Foreign currency losses, net		6,689		5,200		1,489	*
Adjusted EBITDA	$	18,651	$	22,134	$	(3,483)	(16)	%

Certain amounts may reflect rounding adjustments.

* Calculation not meaningful

Adjusted net (loss) income

We report adjusted net (loss) income to portray the results of our operations prior to considering certain income statement elements. See “—General description of non-GAAP financial measures.”

A reconciliation of net (loss) income, as reported under GAAP, to adjusted net income:

Table of Contents


	Three Months
For the Periods Ended September 30	2023			2022			Change

	(in thousands, except per share amounts and percentages)
Net (loss) income	$	(8,015)		$	3,856		$	(11,871)	*
Acquisition-related intangible amortization ⁽¹⁾		1,673			1,657			16	1	%
Acquisition-related intangible amortization⁽²⁾		766			739			27	4	%
Pension settlement cost ⁽²⁾		10,425			—			10,425	*
Stock-based compensation ⁽²⁾		81			—			81	*
Foreign currency losses, net ⁽³⁾		6,689			5,200			1,489	29	%
Adjustments to income taxes ⁽⁴⁾		(6,079)			(3,126)			(2,953)	*
Adjusted net income	$	5,540		$	8,326		$	(2,786)	(33)	%

Statement of Operations Line Items - adjusted
Adjusted cost of goods sold ⁽¹⁾	$	161,950		$	162,218		$	(268)	(0)	%
Adjusted gross profit		69,399			70,303			(904)	(1)	%
Adjusted selling, general and administrative ⁽²⁾		57,180			54,223			2,957	5	%
Adjusted interest expense, net		4,564			3,067			1,497	49	%
Adjusted income before income taxes		7,655			13,013			(5,358)	(41)	%
Adjusted provision for income taxes ⁽⁴⁾		2,115			4,687			(2,572)	(55)	%
Adjusted net income	$	5,540		$	8,326		$	(2,786)	(33)	%

Adjusted net income per share
diluted	$	0.14		$	0.21		$	(0.07)	(33)	%

Weighted average common shares outstanding
diluted		40,504			40,504

Ratio to net sales
Adjusted gross profit		30.0	%		30.2	%
Adjusted selling, general and administrative		24.7	%		23.3	%
Adjusted (loss) income before income taxes		3.3	%		5.6	%
Adjusted net (loss) income		2.4	%		3.6	%
Adjusted effective tax rate		27.6	%		36.0	%

Certain amounts and percentages may reflect rounding adjustments.

* Calculation not meaningful

⁽¹⁾ Adjusted cost of goods sold excludes acquisition-related intangible amortization

⁽²⁾Adjusted selling, general and administrative excludes acquisition-related intangible amortization, pension settlement cost and stock-based compensation

⁽³⁾ Foreign currency losses, net are excluded from adjusted net income

⁽⁴⁾ Adjusted provision for income taxes excludes the income tax effect of pre-tax income adjustments and certain income tax items

Comparison of three months ended September 30, 2023 and 2022

Net sales

Net sales of $231.3 million for the three months ended September 30, 2023, decreased $1.2 million, or 1%, as compared to the three months ended September 30, 2022. Animal Health increased $5.7 million, while Mineral Nutrition and Performance Products decreased $3.6 million and $3.2 million, respectively.

Table of Contents

Animal Health

Net sales of $160.5 million for the three months ended September 30, 2023, increased $5.7 million, or 4%. Net sales of MFAs and other increased $1.3 million, or 1%, primarily driven by increased sales of processing aids used in the ethanol fermentation industry. Net sales of nutritional specialty products increased $1.2 million, or 3%, with increased volumes in poultry customers, primarily domestic. Net sales of vaccines increased $3.2 million, or 14%, due to poultry product introductions in Latin America and growth in the U.S. swine sector, partially offset by timing of deliveries in other international regions.

Mineral Nutrition

Net sales of $56.0 million for the three months ended September 30, 2023, decreased $3.6 million, or 6%, due to declines in the average selling prices and reduced volumes due to reduced demand.

Performance Products

Net sales of $14.8 million for the three months ended September 30, 2023, decreased $3.2 million, or 18%, as a result of lower demand for the ingredients used in personal care products.

Gross profit

Gross profit of $67.7 million for the three months ended September 30, 2023, decreased $0.9 million, or 1%, as compared to the three months ended September 30, 2022. Gross margin decreased to 29.3% of net sales for the three months ended September 30, 2023, as compared to 29.5% for the three months ended September 30, 2022.

Animal Health gross profit increased $2.4 million, primarily driven by higher sales volume. Mineral Nutrition gross profit decreased $2.3 million, driven by lower sales and higher costs. Performance Products gross profit decreased $1.1 million as a result of lower sales volumes of ingredients for personal care products, along with increased costs for these products.

Selling, general and administrative expenses

Selling, general and administrative expenses (“SG&A”) of $68.5 million for the three months ended September 30, 2023, increased $13.5 million, or 25%, as compared to the three months ended September 30, 2022. SG&A for the three months ended September 30, 2023, included $10.4 million of pension settlement cost and $0.1 million of stock-based compensation. Excluding these items, SG&A increased $3.0 million.

Animal Health SG&A increased $1.3 million, primarily due to an increase in employee and employee-related costs. Mineral Nutrition increased $0.2 million, while Performance Products decreased $0.1 million. Corporate costs increased by $1.6 million, due to strategic investments and employee-related costs.

Interest expense, net

Interest expense, net of $4.6 million for the three months ended September 30, 2023, increased by $1.5 million, as compared to the three months ended September 30, 2022, as a result of the increased debt with the issuance of 2023 Incremental Term Loan and the higher variable interest rates.

Foreign currency losses, net

Foreign currency losses, net for the three months ended September 30, 2023, were $6.7 million, as compared to $5.2 million of net losses for the three months ended September 30, 2022. Current period losses were driven by fluctuations in certain currencies related to the U.S. dollar, primarily in Argentina and Brazil.

Table of Contents

(Benefit) provision for income taxes

The benefit for income taxes was $4.0 million for the three months ended September 30, 2023, compared to the provision for income taxes of $1.6 million for the three months ended September 30, 2022. The effective income tax rate was 33.1% and 28.8% for the three months ended September 30, 2023 and 2022, respectively. The benefit for income taxes during the three months ended September 30, 2023, included (i) a $1.2 million benefit related to the determination of whether a foreign tax is eligible for a U.S. foreign tax credit related to our fiscal year 2023, based on IRS guidance provided subsequent to our fiscal year-end and (ii) a $0.2 million expense from changes in uncertain tax positions related to prior years. The provision for income taxes for the three months ended September 30, 2022, included (i) a $0.9 million benefit related to exchange rate differences on intercompany dividends and (ii) a $0.2 million expense from changes in uncertain tax positions related to prior years. The effective income tax rate, without these items, would have been 24.8 % and 42.8% for the three months ended September 30, 2023 and 2022, respectively.

Net (loss) income

Net loss of $8.0 million for the three months ended September 30, 2023, represented a decrease of $11.9 million compared to net income of $3.9 million for the three months ended September 30, 2022. Operating loss resulted in a decrease of $14.4 million, driven mostly by higher SG&A, which included the $10.4 million pension settlement cost. Interest expense, net increased $1.5 million due to the issuance of new debt and higher variable interest rates. Foreign currency losses, net also increased by $1.5 million. Income tax expense decreased by $5.5 million.

Adjusted EBITDA

Adjusted EBITDA of $18.7 million for the three months ended September 30, 2023, decreased $3.5 million, as compared to the three months ended September 30, 2022. Animal Health Adjusted EBITDA increased $1.5 million due to higher gross profit, partially offset by increased SG&A. Mineral Nutrition Adjusted EBITDA decreased $2.4 million, due to lower sales. Performance Products Adjusted EBITDA decreased $1.0 million due to lower sales and gross profit. Corporate expenses increased $1.6 million, due to increased strategic investments and employee-related costs.

Adjusted provision for income taxes

The adjusted effective income tax rates for the three months ended September 30, 2023 and 2022, were 27.6% and 36.0%, respectively. The improvement in our adjusted effective income tax rate was driven by a favorable mix of international earnings and the benefit of recently implemented tax savings strategies.

Adjusted net income

Adjusted net income of $5.5 million for the three months ended September 30, 2023, decreased $2.8 million, or 33.0%, as compared to the prior year. The decrease was driven by lower gross profit, higher SG&A expenses and higher interest expense, partially offset by a lower tax provision. The lower gross profit results from lower sales. SG&A expenses increased due to strategic investments and increased employee-related costs.

Adjusted diluted earnings per share

Adjusted diluted earnings per share was $0.14 for the quarter, a decrease of $0.07, or 33.0% as compared to the adjusted diluted earnings per share of $0.21 in the prior year.

Table of Contents

Analysis of financial condition, liquidity and capital resources

Net increase in cash and cash equivalents was:


	Three Months
For the Periods Ended September 30	2023		2022		Change

	(in thousands)
Cash provided (used) by:
Operating activities	$	16,199	$	(10,698)	$	26,897
Investing activities		(15,352)		(16,149)		797
Financing activities		1,296		29,319		(28,023)
Effect of exchange-rate changes on cash and cash equivalents		(271)		(440)		169
Net increase in cash and cash equivalents	$	1,872	$	2,032	$	(160)

Certain amounts may reflect rounding adjustments.

Net cash provided by operating activities was comprised of:


	Three Months
For the Periods Ended September 30	2023		2022		Change

	(in thousands)
EBITDA	$	1,456	$	16,934	$	(15,478)
Adjustments:
Pension settlement cost		10,425		—		10,425
Stock-based compensation		81		—		81
Foreign currency losses, net		6,689		5,200		1,489
Interest paid, net		(4,304)		(2,906)		(1,398)
Income taxes paid		(4,658)		(3,802)		(856)
Changes in operating assets and liabilities and other items		6,510		(26,124)		32,634
Net cash provided (used) by operating activities	$	16,199	$	(10,698)	$	26,897

Certain amounts may reflect rounding adjustments.

Operating activities

Operating activities provided $16.2 million of net cash for the three months ended September 30, 2023. Cash provided by net (loss) income and non-cash items, including depreciation and amortization, was $13.1 million. Cash provided in the ordinary course of business for changes in operating assets and liabilities and other items was $3.1 million. Cash provided by receivables was $12.8 million as a result of quarterly variations in sales levels. Cash used for inventory was $5.0 million due to increased cost for raw material and production costs, forecasted future demand and internal production schedules. Other current assets used $3.3 million of cash, primarily due to prepayment of taxes. Accounts payable provided $4.6 million of cash due to timing of purchases and payments. Accrued expenses and other liabilities used cash of $5.8 million primarily due to employee-related liabilities and payments of commissions and rebates.

Investing activities

Investing activities used $15.4 million of net cash for the three months ended September 30, 2023. Capital expenditures totaled $7.5 million as we continue to invest in expanding production capacity and productivity improvements. Net purchases and maturities of our short-term investments used $8.0 million in cash.

Table of Contents

Financing activities

Financing activities provided $1.3 million of net cash for the three months ended September 30, 2023. Net borrowings on our 2021 Revolver provided $13.0 million in cash. We paid $6.8 million in scheduled debt maturities and insurance premium financing. We also paid $4.9 million in dividends to holders of our Class A common stock and Class B common stock.

Liquidity and capital resources

We believe our cash on hand, operating cash flows and financing arrangements, including the availability of borrowings under the 2021 Revolver and foreign credit lines, will be sufficient to support our ongoing cash needs. We are aware of the current and potential future effects of the macroeconomic market conditions in the financial markets. At this time, we expect adequate liquidity for at least the next twelve months. However, we can provide no assurance that our liquidity and capital resources will be adequate for future funding requirements. We believe we will comply with the terms of the covenants under the 2021 Credit Facilities and foreign credit lines based on our operating plan. In the event of adverse operating results and/or violation of covenants under the facilities, there can be no assurance we would be able to obtain waivers or amendments. Other risks to our meeting future funding requirements include global economic conditions and macroeconomic, business and financial disruptions that could arise. There can be no assurance that a challenging economic environment or an economic downturn would not affect our liquidity or ability to obtain future financing or fund operations or investment opportunities. In addition, our debt covenants may restrict our ability to invest.

Certain relevant measures of our liquidity and capital resources follow:


	September 30,		June 30,
As of	2023		2023

	(in thousands, except ratios)
Cash and cash equivalents and short-term investments	$	91,153	$	81,281
Working capital		345,066		350,737
Ratio of current assets to current liabilities		3.33:1		3.28:1

We define working capital as total current assets (excluding cash and cash equivalents and short-term investments) less total current liabilities (excluding current portion of long-term debt). We calculate the ratio of current assets to current liabilities based on this definition.

As of September 30, 2023, we had $154.0 million in outstanding borrowings under the 2021 Revolver and had outstanding letters of credit and other commitments of $2.5 million, leaving $153.5 million available for further borrowings and letters of credit, subject to restrictions in our 2021 Credit Facilities.

We currently intend to pay quarterly dividends on our Class A common stock and Class B common stock, subject to approval from the Board of Directors. Our Board of Directors declared a cash dividend of $0.12 per share on Class A common stock and Class B common stock, payable on December 20, 2023. Our future ability to pay dividends will depend upon our results of operations, financial condition, capital requirements, our ability to obtain funds from our subsidiaries and other factors that our Board of Directors deems relevant. Additionally, the terms of our current and any future agreements governing our indebtedness could limit our ability to pay dividends or make other distributions.

As of September 30, 2023, our cash and cash equivalents and short-term investments included $89.6 million held by our international subsidiaries. There are no restrictions on cash distributions to PAHC from our international subsidiaries. Distributions may be subject to taxation by U.S. or non-U.S. taxing authorities.

Contractual obligations

As of September 30, 2023, there were no material changes in payments due under contractual obligations from those disclosed in the Annual Report.

Table of Contents

Off-balance sheet arrangements

We do not currently use off-balance sheet arrangements for the purpose of credit enhancement, hedging transactions, investment or other financial purposes.

In the ordinary course of business, we may indemnify our counterparties against certain liabilities that may arise. These indemnifications typically pertain to environmental matters. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications generally are subject to certain restrictions and limitations.

General description of non-GAAP financial measures

Adjusted EBITDA

Adjusted EBITDA is an alternative view of performance used by management as our primary operating measure, and we believe that investors’ understanding of our performance is enhanced by disclosing this performance measure. We report Adjusted EBITDA to reflect the results of our operations prior to considering certain income statement elements. We have defined EBITDA as net (loss) income plus (i) interest expense, net, (ii) provision for income taxes or less benefit for income taxes, and (iii) depreciation and amortization. We calculate Adjusted EBITDA as EBITDA plus (a) (income) loss from, and disposal of, discontinued operations, (b) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and (c) certain items that we consider to be unusual, non-operational or non-recurring. The Adjusted EBITDA measure is not, and should not be viewed as, a substitute for GAAP reported net(loss) income.

The Adjusted EBITDA measure is an important internal measurement for us. We measure our overall performance on this basis in conjunction with other performance metrics. The following are examples of how our Adjusted EBITDA measure is utilized:

●

senior management receives a monthly analysis of our operating results that is prepared on an Adjusted EBITDA basis;

●

our annual budgets are prepared on an Adjusted EBITDA basis; and

●

other goal setting and performance measurements are prepared on an Adjusted EBITDA basis.

Despite the importance of this measure to management in goal setting and performance measurement, Adjusted EBITDA is a non-GAAP financial measure that has no standardized meaning prescribed by GAAP and, therefore, has limits in its usefulness to investors. Because of its non-standardized definition, Adjusted EBITDA, unlike GAAP net (loss) income, may not be comparable to the calculation of similar measures of other companies. Adjusted EBITDA is presented to permit investors to more fully understand how management assesses performance.

We also recognize that, as an internal measure of performance, the Adjusted EBITDA measure has limitations, and we do not restrict our performance management process solely to this metric. A limitation of the Adjusted EBITDA measure is that it provides a view of our operations without including all events during a period, such as the depreciation of property, plant and equipment or amortization of acquired intangibles, and does not provide a comparable view of our performance to other companies.

Adjusted net income and adjusted diluted earnings per share

Adjusted net income and adjusted diluted earnings per share represent alternative views of performance and we believe investors’ understanding of our performance is enhanced by disclosing these performance measures. We report adjusted net (loss) income and adjusted diluted earnings per share to portray the results of our operations prior to considering certain income statement elements. We have defined adjusted net income as net (loss) income plus (i) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, (ii) amortization of acquired intangibles and other acquisition-related costs, such as accrued compensation and accrued interest, (iii) stock-based compensation, (iv) certain items that we consider to be unusual or non-recurring and (v) the income tax effect of pre-tax (loss) income adjustments and certain income tax items. Adjusted diluted earnings per share is calculated using the adjusted net income

Table of Contents

divided by the diluted weighted average number of shares. The adjusted net income and adjusted diluted earnings per share measures are not, and should not be viewed as, a substitute for GAAP reported net (loss) income.

Adjusted net income and adjusted diluted earnings per share are non-GAAP financial measure that have no standardized meaning prescribed by GAAP and, therefore, have limits in their usefulness to investors. Because of its non-standardized definition, adjusted net income and adjusted diluted earnings per share, unlike GAAP net (loss) income, may not be comparable to the calculation of similar measures of other companies. Adjusted net (loss) income and adjusted diluted earnings per share are presented to permit investors to more fully understand how management assesses performance.

Certain significant items

Adjusted EBITDA, adjusted net income and adjusted diluted earnings per share are calculated prior to considering certain items. We evaluate such items on an individual basis. Such evaluation considers both the quantitative and the qualitative aspect of their unusual or non-operational nature. Unusual, in this context, may represent items that are not part of our ongoing business; items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis.

We consider acquisition-related activities and business restructuring costs related to productivity and cost saving initiatives, including employee separation costs, to be unusual items that we do not expect to occur as part of our normal business on a regular basis. We consider foreign currency gains and losses to be non-operational because they arise principally from intercompany transactions and are largely non-cash in nature.

New accounting standards

For discussion of new accounting standards, see “Notes to Consolidated Financial Statements—Summary of Significant Accounting Policies and New Accounting Standards.”

Critical Accounting Policies

Our significant accounting policies, which include management’s best estimates and judgments, are included in Note 2 to the consolidated financial statements for the year ended June 30, 2023 included in our Annual Report on Form 10-K filed with the Securities Exchange Commission on August 30, 2023. There have been no significant changes in our critical accounting estimates since June 30, 2023.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected earnings, revenues, costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth or initiatives, strategies, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Examples of such risks and uncertainties include:

●

outbreaks of animal diseases could significantly reduce demand for our products or availability of raw materials;

●

perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products;

●

restrictions on the use of antibacterials in food-producing animals may become more prevalent;

Table of Contents

●

the potential FDA withdrawal of approval of our Mecadox^® (carbadox) product;

●

a material portion of our sales and gross profits are generated by antibacterials and other related products;

●

competition in each of our markets from a number of large and small companies, some of which have greater financial, research and development (“R&D”), production and other resources than we have;

●

our business may be negatively affected by weather conditions and the availability of natural resources;

●

the negative effects of a pandemic, epidemic, or outbreak of an infectious disease in humans, such as COVID-19; on our business, financial results, manufacturing facilities and supply chain, as well as our customers, protein processors and markets;

●

climate change could have a material adverse impact on our operations and our customers’ businesses;

●

actions of regulatory bodies, including obtaining approvals related to the testing, manufacturing and marketing of certain of our products;

●

the continuing trend toward consolidation of certain customer groups as well as the emergence of large buying groups;

●

our ability to control costs and expenses;

●

any unforeseen material loss or casualty;

●

misuse or extra-label use of our products;

●

exposure relating to rising costs and reduced customer income;

●

heightened competition, including those from generics and those deriving from advances in veterinary medical practices and animal health technologies;

●

unanticipated safety or efficacy concerns;

●

our dependence on suppliers having current regulatory approvals;

●

our raw materials are subject to price fluctuations and their availability can be limited;

●

natural and man-made disasters, including but not limited to fire, snow and ice storms, flood, hail, hurricanes and earthquakes;

●

business interruption from political and social instability, including crime, civil disturbance, terrorist activities, outbreaks of disease and pandemics and armed conflicts, such as the ongoing armed conflicts between Russia and Ukraine and Israel and Hamas;

●

terrorist attacks, particularly attacks on or within markets in which we operate, including the recent terrorist attack on Israel by Hamas militants and the ongoing related conflict;

●

risks related to changes in tax rates and exposure;

●

our ability to successfully implement our strategic initiatives;

●

our reliance on the continued operation of our manufacturing facilities and application of our intellectual property;

Table of Contents

●

adverse U.S. and international economic market conditions, including currency fluctuations;

●

failure of our product approval, R&D, acquisition and licensing efforts to generate new products;

●

the risks of product liability claims, legal proceedings and general litigation expenses;

●

the impact of current and future laws and regulatory changes, including risks related to the protection of our customers’ privacy and risks related to environmental, health and safety laws and regulations;

●

modification of foreign trade policy may harm our food animal product customers;

●

our dependence on our Israeli and Brazilian operations;

●

impact of increased or decreased inventory levels at our direct customers or channel distributors;

●

our substantial level of indebtedness and related debt-service obligations;

●

restrictions imposed by covenants in our debt agreements;

●

the risk of work stoppages; and

●

other factors as described in “Risk Factors” in Item 1A of our Annual Report.

While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, are disclosed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

In the normal course of operations, we are exposed to market risks arising from adverse changes in interest rates, foreign currency exchange rates and commodity prices. As a result, future earnings, cash flows and fair values of assets and liabilities are subject to uncertainty. We use, from time to time, foreign currency contracts and interest rate swaps as a means of hedging exposure to foreign currency risks and fluctuating interest rates, respectively. We do not utilize derivative instruments for trading or speculative purposes. We do not hedge our exposure to market risks in a manner that eliminates the effects of changing market conditions on earnings, cash flows and fair values. We monitor the financial stability and credit standing of our major counterparties.

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures about Market Risk” section in the Annual Report and to the notes to the consolidated financial statements included therein. As of the date of this report, there were no material changes in the Company’s financial market risks from the risks disclosed in the Annual Report.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based upon that evaluation as of September 30, 2023, our Chief Executive Officer and Chief Financial Officer each concluded that, as of the end of such period, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended September 30, 2023.

PART II—OTHER INFORMATION

Item 1.Legal Proceedings

Information required by this Item is incorporated herein by reference to “Notes to Consolidated Financial Statements—Commitments and Contingencies” in Part I, Item 1, of this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in “Risk Factors” in Item 1A of our Annual Report, which could materially affect our business, financial condition or future results.

There were no material changes in the Company’s risk factors from the risks disclosed in the Annual Report.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not applicable.

Table of Contents

Item 5. Other Information

None.

Item 6.Exhibits


Exhibit 10.1		Executive Long-Term Incentive Agreement dated July 5, 2023 by and between Phibro Animal Health Corporation and Larry L. Miller (incorporated by reference to Exhibit 10.18 to Phibro Animal Health Corporation’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on August 30, 2023 (File No. 001-36410)).
Exhibit 31.1		Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
Exhibit 31.2		Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
Exhibit 32.1		Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
Exhibit 32.2		Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
Exhibit 101 .INS		Inline XBRL Instance Document
Exhibit 101.SCH		Inline XBRL Taxonomy Extension Schema Document
Exhibit 101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
Exhibit 101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
Exhibit 101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
Exhibit 101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
Exhibit 104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Phibro Animal Health Corporation

November 8, 2023	By:	/s/ Jack C. Bendheim
		Jack C. Bendheim
		Chairman, President and Chief Executive Officer

November 8, 2023	By:	/s/ Richard G. Johnson
		Richard G. Johnson
		Chief Financial Officer

EX-31.1 2 pahc-20230930xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Jack C. Bendheim, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Dated: November 8, 2023	/s/ Jack C. Bendheim
	Jack C. Bendheim
	Chairman, President and Chief Executive Officer

EX-31.2 3 pahc-20230930xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Richard G. Johnson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Dated: November 8, 2023	/s/ Richard G. Johnson
	Richard G. Johnson
	Chief Financial Officer

EX-32.1 4 pahc-20230930xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.


Dated: November 8, 2023	/s/ Jack C. Bendheim
	Jack C. Bendheim
	Chairman, President and Chief Executive Officer

EX-32.2 5 pahc-20230930xex32d2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


Dated: November 8, 2023	/s/ Richard G. Johnson
	Richard G. Johnson
	Chief Financial Officer

EX-101.SCH 6 pahc-20230930.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) link:presentationLink link:calculationLink link:definitionLink 40305 - Disclosure - Statements of Operations-Additional Information - Interest Expense, Net (Details) link:presentationLink link:calculationLink link:definitionLink 40306 - Disclosure - Statements of Operations-Additional Information - Depreciation and Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Balance Sheets-Additional Information - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Balance Sheets-Additional Information - Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40404 - Disclosure - Balance Sheets-Additional Information - Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40405 - Disclosure - Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 40505 - Disclosure - Debt - Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 40506 - Disclosure - Debt - Classification (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Derivatives - Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 41105 - Disclosure - Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Statements of Operations-Additional Information - Net Sales by Product Type (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Statements of Operations-Additional Information - Net Sales by Region (Details) link:presentationLink link:calculationLink link:definitionLink 40307 - Disclosure - Statements of Operations-Additional Information - Annuity Purchase Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Debt - General Information (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Debt - Interest Rates - Stated Rates (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - Debt - Interest Rates - Weighted Average Rates (Details) link:presentationLink link:calculationLink link:definitionLink 40504 - Disclosure - Debt - Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Stock Incentive Plan - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Stock Incentive Plan - Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Derivatives - General Information (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Derivatives - Notional Amounts (Details) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Derivatives - Effects of Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 40905 - Disclosure - Derivatives - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Fair Value Measurements - Fair Value of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Business Segments - Net Sales (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Business Segments - Depreciation and Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Business Segments - Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 41106 - Disclosure - Business Segments - Identifiable Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Statements of Operations-Additional Information link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Balance Sheets-Additional Information link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Stock Incentive Plan link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Statements of Operations-Additional Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Balance Sheets-Additional Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Statements of Operations-Additional Information - Segments (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - Statements of Operations-Additional Information - General Information (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Commitments and Contingencies - Environmental (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Business Segments - General Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pahc-20230930_cal.xml EX-101.CAL EX-101.DEF 8 pahc-20230930_def.xml EX-101.DEF EX-101.LAB 9 pahc-20230930_lab.xml EX-101.LAB Cover [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Common Class A Common Class B [Member] Common Class B Document Information [Line Items] Document Type Document Quarterly Report Document Transition Report Document Period End Date Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Entity Listing, Par Value Per Share Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Filer Category Entity Small Business Entity Interactive Data Current Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Central Index Key Amendment Flag Income Statement [Abstract] Revenue from Contract with Customer, Excluding Assessed Tax Net sales Cost of Goods and Services Sold Cost of goods sold Consolidated statement of operations - total cost of goods sold Gross Profit Gross profit Selling, General and Administrative Expense Selling, general and administrative expenses Operating Income (Loss) Operating (loss) income Interest Income (Expense), Net, Total Interest expense, net Foreign Currency Transaction Gain (Loss), before Tax Foreign currency losses, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest (Loss) income before income taxes (Loss) income before income taxes Income Tax Expense (Benefit) (Benefit) provision for income taxes Net Income (Loss) Attributable to Parent Net (loss) income Net (loss) income Earnings Per Share, Diluted [Abstract] Net (loss) income per share Earnings Per Share, Basic basic (in dollars per share) Earnings Per Share, Diluted diluted (in dollars per share) diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average number of shares Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic basic (in shares) Weighted average number of shares - basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares - diluted (in shares) diluted (in shares) Statement of Comprehensive Income [Abstract] Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax, Portion Attributable to Parent, Total Expense (income) recorded in comprehensive (loss) income Change in fair value of derivative instruments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent, Total Foreign currency translation adjustment Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax Pension settlement recognition Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Unrecognized net pension gains Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Provision for income taxes Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive (loss) income Comprehensive (loss) income Statement of Financial Position [Abstract] Assets [Abstract] Assets ASSETS Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Short-term Investments Short-term investments Accounts Receivable, Net, Current Accounts receivable, net Inventory, Net Inventories, net Inventory, net Other Assets, Current Other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property, plant and equipment, net Finite-Lived Intangible Assets, Net Intangibles, net Goodwill Goodwill Other Assets, Noncurrent Other assets Other assets, total Assets Total assets Assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Loans Payable, Current Current portion of long-term debt Accounts Payable, Current Accounts payable Accrued Liabilities and Other Liabilities, Current Accrued Liabilities and Other Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities, total Liabilities, Current Total current liabilities Long-term Line of Credit, Noncurrent Revolving credit facility Loans Payable, Noncurrent Long-term debt Other Liabilities, Noncurrent Other liabilities Other liabilities, total Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 8) Common Stock, Value, Outstanding Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2023, and June 30, 2023; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2023, and June 30, 2023 Preferred Stock, Value, Outstanding Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding Additional Paid in Capital, Common Stock Paid-in capital Accumulated deficit Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Accumulated other comprehensive loss Stockholders' Equity Attributable to Parent Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Statement [Table] Statement [Line Items] Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Common stock Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Balance (in shares) Balance (in shares) Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Preferred stock Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] OPERATING ACTIVITIES Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (loss) income Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net (loss) income to net cash provided (used) by operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Depreciation and amortization Amortization of Debt Issuance Costs Amortization of debt issuance costs Share-based Compensation Stock-based compensation Deferred Income Taxes and Tax Credits Deferred income taxes Foreign Currency Transaction Gain (Loss), Unrealized Foreign currency losses, net Pension Expense (Reversal of Expense), Noncash Pension settlement cost Other Noncash Income (Expense) Other Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities, net of business acquisition: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Inventories Inventories, net Increase (Decrease) in Prepaid Expense and Other Assets Other current assets Increase (Decrease) in Other Noncurrent Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Net Cash Provided by (Used in) Operating Activities Net cash provided (used) by operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] INVESTING ACTIVITIES Payments to Acquire Short-term Investments Purchases of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-term Investments Maturities of short-term investments Payments to Acquire Productive Assets Capital expenditures Payments for (Proceeds from) Other Investing Activities Other, net Net Cash Provided by (Used in) Investing Activities Net cash used by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] FINANCING ACTIVITIES Proceeds from Long-term Lines of Credit Revolving credit facility borrowings Repayments of Long-term Lines of Credit Revolving credit facility repayments Proceeds from Issuance of Other Long-Term Debt Proceeds from long-term debt Repayments of Other Long-Term Debt Payments of long-term debt Payments of Debt Issuance Costs Debt issuance costs Payments for Insurance Premium Financing, Financing Activities Payments for Insurance Premium Financing, Financing Activities Payments of insurance premium financing Payments of Ordinary Dividends, Common Stock Dividends paid Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of exchange rate changes on cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Component [Domain] Parent [Member] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Paid-in Capital Retained Earnings [Member] Retained Earnings (Accumulated Deficit) AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Dividends, Common Stock, Cash Dividends declared Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation expense Stock Transactions, Parenthetical Disclosures [Abstract] Dividends declared Common Stock, Dividends, Per Share, Declared Dividends declared (in dollars per share) Description of Business Nature of Operations [Text Block] Description of Business Summary of Significant Accounting Policies and New Accounting Standards Basis of Presentation and Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies and New Accounting Standards Statements of Operations-Additional Information Revenue from Contract with Customer [Text Block] Disaggregated Revenue, Deferred Revenue and Customer Payment Terms Additional Financial Information Disclosure [Text Block] Additional Information Balance Sheets-Additional Information Supplemental Balance Sheet Disclosures [Text Block] Balance Sheets-Additional Information Debt Debt Disclosure [Text Block] Debt Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Stock Incentive Plan Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Incentive Plan Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivatives Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Business Segments Segment Reporting Disclosure [Text Block] Business Segments Earnings Per Share, Policy [Policy Text Block] Net Income per Share and Weighted Average Shares New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Standards Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of net income per share and weighted average shares Disaggregation of Revenue [Table Text Block] Schedule of revenues disaggregated by major product category and geographic region Tabular disclosure of interest expense, net. Schedule of Interest Expense, Net [Table Text Block] Schedule of interest expense, net Tabular disclosure of depreciation and amortization. Schedule of Depreciation and Amortization [Table Text Block] Schedule of depreciation and amortization Schedule of Inventory, Current [Table Text Block] Schedule of inventories Schedule of Other Assets, Noncurrent [Table Text Block] Schedule of other assets Tabular disclosure of accrued expenses and other current liabilities. Accrued Expenses and Other Liabilities, Current [Table Text Block] Schedule of accrued expenses and other current liabilities Other Noncurrent Liabilities [Table Text Block] Schedule of other liabilities Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of accumulated other comprehensive loss EX-101.PRE 10 pahc-20230930_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - $ / shares	3 Months Ended
Document and Entity Information - $ / shares	Sep. 30, 2023	Nov. 03, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Entity File Number	001-36410
Entity Registrant Name	Phibro Animal Health Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-1840497
Entity Address, Address Line One	Glenpointe Centre East, 3rd Floor
Entity Address, Address Line Two	300 Frank W. Burr Boulevard
Entity Address, Address Line Three	Suite 21
Entity Address, City or Town	Teaneck
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07666-6712
City Area Code	201
Local Phone Number	329-7300
Title of 12(b) Security	Class A Common Stock, $0.0001 par value per share
Trading Symbol	PAHC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Interactive Data Current	Yes
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001069899
Amendment Flag	false
Common Class A [Member]
Document Information [Line Items]
Entity Listing, Par Value Per Share	$ 0.0001
Entity Common Stock, Shares Outstanding		20,337,574
Common Class B [Member]
Document Information [Line Items]
Entity Listing, Par Value Per Share	$ 0.0001
Entity Common Stock, Shares Outstanding		20,166,034

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 231,349	$ 232,521
Cost of goods sold	163,623	163,875
Gross profit	67,726	68,646
Selling, general and administrative expenses	68,452	54,962
Operating (loss) income	(726)	13,684
Interest expense, net	4,564	3,067
Foreign currency losses, net	6,689	5,200
(Loss) income before income taxes	(11,979)	5,417
(Benefit) provision for income taxes	(3,964)	1,561
Net (loss) income	$ (8,015)	$ 3,856
Net (loss) income per share
basic (in dollars per share)	$ (0.20)	$ 0.10
diluted (in dollars per share)	$ (0.20)	$ 0.10
Weighted average common shares outstanding
basic (in shares)	40,504	40,504
diluted (in shares)	40,504	40,504

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net (loss) income	$ (8,015)	$ 3,856
Change in fair value of derivative instruments	(1,891)	7,105
Foreign currency translation adjustment	(3,560)	(4,143)
Pension settlement recognition	10,425
Unrecognized net pension gains	644	176
Provision for income taxes	(2,264)	(1,820)
Other comprehensive income	3,354	1,318
Comprehensive (loss) income	$ (4,661)	$ 5,174

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-8

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-9

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-10

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483581/946-220-45-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-7

Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B

Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
ASSETS
Cash and cash equivalents	$ 43,153	$ 41,281
Short-term investments	48,000	40,000
Accounts receivable, net	149,228	163,479
Inventories, net	279,154	277,570
Other current assets	64,889	63,393
Total current assets	584,424	585,723
Property, plant and equipment, net	193,359	195,568
Intangibles, net	52,184	54,987
Goodwill	53,251	53,274
Other assets	81,305	81,845
Total assets	964,523	971,397
LIABILITIES AND STOCKHOLDERS' EQUITY
Current portion of long-term debt	24,150	22,295
Accounts payable	77,216	73,853
Accrued expenses and other current liabilities	70,989	79,852
Total current liabilities	172,355	176,000
Revolving credit facility	154,000	141,000
Long-term debt	304,717	311,541
Other liabilities	60,382	60,347
Total liabilities	691,454	688,888
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2023, and June 30, 2023; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2023, and June 30, 2023	4	4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding
Paid-in capital	135,884	135,803
Retained earnings	248,037	260,912
Accumulated other comprehensive loss	(110,856)	(114,210)
Total stockholders' equity	273,069	282,509
Total liabilities and stockholders' equity	$ 964,523	$ 971,397

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	Sep. 30, 2023	Jun. 30, 2023
Preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	16,000,000	16,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common Class A
Common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	20,337,574	20,337,574
Common stock, shares outstanding (in shares)	20,337,574	20,337,574
Common Class B
Common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	20,166,034	20,166,034
Common stock, shares outstanding (in shares)	20,166,034	20,166,034

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net (loss) income	$ (8,015)	$ 3,856
Adjustments to reconcile net (loss) income to net cash provided (used) by operating activities:
Depreciation and amortization	8,871	8,450
Amortization of debt issuance costs	260	147
Stock-based compensation	81
Deferred income taxes	(2,691)	(13)
Foreign currency losses, net	3,222	3,370
Pension settlement cost	10,425
Other	959	(309)
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable, net	12,781	22,347
Inventories, net	(5,005)	(24,977)
Other current assets	(3,297)	(7,682)
Other assets	(191)	(31)
Accounts payable	4,603	(5,595)
Accrued expenses and other liabilities	(5,804)	(10,261)
Net cash provided (used) by operating activities	16,199	(10,698)
INVESTING ACTIVITIES
Purchases of short-term investments	(17,000)
Maturities of short-term investments	9,000	7,000
Capital expenditures	(7,476)	(23,176)
Other, net	124	27
Net cash used by investing activities	(15,352)	(16,149)
FINANCING ACTIVITIES
Revolving credit facility borrowings	51,000	62,000
Revolving credit facility repayments	(38,000)	(36,000)
Proceeds from long-term debt		12,000
Payments of long-term debt	(5,105)	(3,750)
Debt issuance costs		(71)
Payments of insurance premium financing	(1,739)
Dividends paid	(4,860)	(4,860)
Net cash provided by financing activities	1,296	29,319
Effect of exchange rate changes on cash	(271)	(440)
Net increase in cash and cash equivalents	1,872	2,032
Cash and cash equivalents at beginning of period	41,281	74,248
Cash and cash equivalents at end of period	$ 43,153	$ 76,280

XML 17 R7.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Total
Balance at Jun. 30, 2022	$ 4	$ 135,803	$ 247,748	$ (121,113)	$ 262,442
Balance (in shares) at Jun. 30, 2022	40,503,608
Increase (Decrease) in Stockholders' Equity
Comprehensive (loss) income			3,856	1,318	5,174
Dividends declared			(4,860)		(4,860)
Balance at Sep. 30, 2022	$ 4	135,803	246,744	(119,795)	262,756
Balance (in shares) at Sep. 30, 2022	40,503,608
Balance at Jun. 30, 2023	$ 4	135,803	260,912	(114,210)	282,509
Balance (in shares) at Jun. 30, 2023	40,503,608
Increase (Decrease) in Stockholders' Equity
Comprehensive (loss) income			(8,015)	3,354	(4,661)
Dividends declared			(4,860)		(4,860)
Stock-based compensation expense		81			81
Balance at Sep. 30, 2023	$ 4	$ 135,884	$ 248,037	$ (110,856)	$ 273,069
Balance (in shares) at Sep. 30, 2023	40,503,608

- Definition

Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483421/250-10-45-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 23
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483421/250-10-45-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483421/250-10-45-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (a)(3)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483550/848-10-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479343/105-10-65-6

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479343/105-10-65-6

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-4

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 15
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480336/718-10-65-15

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 15
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480336/718-10-65-15

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 15
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480336/718-10-65-15

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-5

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481674/830-30-50-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481694/830-30-45-17

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481694/830-30-45-20

Reference 29: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-11

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 205
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480767/946-205-45-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-3

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2

Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481231/810-10-45-15

Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481231/810-10-45-16

Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I

+ Details

XML 18 R8.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) - $ / shares	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Dividends declared
Dividends declared (in dollars per share)	$ 0.12	$ 0.12

XML 19 R9.htm IDEA: XBRL DOCUMENT

Description of Business

3 Months Ended

Sep. 30, 2023

Description of Business

Description of Business

1. Description of Business

XML 20 R10.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards

3 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies and New Accounting Standards

Summary of Significant Accounting Policies and New Accounting Standards

2. Summary of Significant Accounting Policies and New Accounting Standards

Net (Loss) Income per Share and Weighted Average Shares

Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period.


	Three Months
For the Periods Ended September 30	2023		2022
Net (loss) income	$	(8,015)	$	3,856

Weighted average number of shares – basic		40,504		40,504
Dilutive effect of restricted stock units		—		—
Weighted average number of shares - diluted		40,504		40,504

Net (loss) income per share
basic	$	(0.20)	$	0.10
diluted	$	(0.20)	$	0.10

New Accounting Standards

We do not expect the new accounting standards that are pending adoption by us to have a material effect on our consolidated financial statements.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information

3 Months Ended

Sep. 30, 2023

Statements of Operations-Additional Information

Disaggregated Revenue, Deferred Revenue and Customer Payment Terms

Disaggregated revenue, deferred revenue and customer payment terms

Animal Health

The Animal Health business develops, manufactures and markets products in three main categories:

●

Mineral Nutrition

Performance Products

The Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

The following tables present our revenues disaggregated by major product category and geographic region:

Net Sales by Product Type


	Three Months
For the Periods Ended September 30	2023		2022
Animal Health
MFAs and other	$	94,104	$	92,790
Nutritional specialties		40,210		39,054
Vaccines		26,216		23,015
Total Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total	$	231,349	$	232,521

Net Sales by Region


	Three Months
For the Periods Ended September 30	2023		2022
United States	$	131,287	$	135,804
Latin America and Canada		58,703		52,246
Europe, Middle East and Africa		26,879		29,517
Asia Pacific		14,480		14,954
Total	$	231,349	$	232,521

Net sales by region are based on country of destination.

Additional Information

Interest Expense


	Three Months
For the Periods Ended September 30	2023		2022
Interest expense, net
2021 Credit Facilities	$	5,101	$	3,547
2022 Term Loan		216		—
Amortization of debt issuance costs		260		147
Other		68		1
Interest expense		5,645		3,695
Interest income		(1,081)		(628)
	$	4,564	$	3,067

Depreciation and Amortization


	Three Months
For the Periods Ended September 30	2023		2022
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,431	$	6,051
Amortization of intangible assets		2,440		2,399
	$	8,871	$	8,450

Pension Settlement

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

+ Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information

3 Months Ended

Sep. 30, 2023

Balance Sheets-Additional Information

Balance Sheets-Additional Information

4. Balance Sheets—Additional Information


	September 30,		June 30,
As of	2023		2023
Inventories
Raw materials	$	84,369	$	84,328
Work-in-process		25,159		22,350
Finished goods		169,626		170,892
	$	279,154	$	277,570


	September 30,		June 30,
As of	2023		2023
Other assets
ROU operating lease assets	$	36,320	$	35,759
Deferred income taxes		8,981		8,711
Deposits		6,518		6,617
Insurance investments		6,096		6,067
Equity method investments		5,814		5,027
Derivative instruments		8,500		10,225
Debt issuance costs		1,284		1,408
Other		7,792		8,031
	$	81,305	$	81,845


	September 30,		June 30,
As of	2023		2023
Accrued expenses and other current liabilities
Employee related	$	26,647	$	29,359
Current operating lease liabilities		6,452		6,053
Commissions and rebates		3,442		5,833
Professional fees		4,643		5,032
Income and other taxes		5,951		8,663
Insurance-related		1,364		1,284
Insurance premium financing		2,898		4,769
Other		19,592		18,859
	$	70,989	$	79,852


	September 30,		June 30,
As of	2023		2023
Other liabilities
Long-term operating lease liabilities	$	29,022	$	29,077
Long-term and deferred income taxes		12,823		12,146
Supplemental retirement benefits, deferred compensation and other		6,628		6,552
U.S. pension plan		1,687		2,286
International retirement plans		4,130		4,210
Other long-term liabilities		6,092		6,076
	$	60,382	$	60,347


	September 30,		June 30,
As of	2023		2023
Accumulated other comprehensive loss
Derivative instruments	$	22,698	$	24,589
Foreign currency translation adjustment		(118,622)		(115,062)
Unrecognized net pension losses		(12,927)		(23,996)
Income tax (provision) benefit		(2,005)		259
	$	(110,856)	$	(114,210)

XML 23 R13.htm IDEA: XBRL DOCUMENT

Debt

3 Months Ended

Sep. 30, 2023

Debt

Debt

5. Debt

Term Loans and Revolving Credit Facilities

Interest Rates

Interest rates as of the balance sheet dates and the weighted-average rates for the periods presented were:


					Three Months
	September 30,		June 30,		Ended September 30,
	2023		2023		2023		2022
2021 Revolver	6.23	%	6.09	%	6.19	%	3.92	%
2021 Term A Loan	2.36	%	2.36	%	2.36	%	2.37	%
2023 Incremental Term Loan	7.66	%	7.44	%	7.57	%	—
2022 Term Loan	7.42	%	7.25	%	7.43	%	—

Interest rates as of the balance sheet dates are based on rates in effect as of those dates, including SOFR fluctuating rates of interest, applicable rates and the interest rate swap agreement.

Other Long-Term Debt

Maturities of Long-Term Debt


	September 30,		June 30,
As of	2023		2023
2021 Term A Loan due April 2026	$	270,000	$	273,750
2023 Incremental Term Loan due April 2026		48,750		50,000
2022 Term Loan due September 2027		11,580		11,685
		330,330		335,435
Unamortized debt issuance costs		(1,463)		(1,599)
		328,867		333,836
Less: current maturities		(24,150)		(22,295)
	$	304,717	$	311,541

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

XML 24 R14.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Sep. 30, 2023

Related Party Transactions

Related Party Transactions

6. Related Party Transactions

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

+ Details

XML 25 R15.htm IDEA: XBRL DOCUMENT

Stock Incentive Plan

3 Months Ended

Sep. 30, 2023

Stock Incentive Plan

Stock Incentive Plan

7. Stock Incentive Plan

Restricted Stock Units

XML 26 R16.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Sep. 30, 2023

Commitments and Contingencies

Commitments and Contingencies

8. Commitments and Contingencies

Environmental

Claims and Litigation

XML 27 R17.htm IDEA: XBRL DOCUMENT

Derivatives

3 Months Ended

Sep. 30, 2023

Derivatives

Derivatives

9. Derivatives

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 10 — Fair Value Measurements.”

In March 2020, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converted the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increased to a notional principal amount of $300,000. In November 2022, we amended the March 2020 interest rate swap agreement to convert the floating portion of our interest obligation to SOFR. The agreement effectively converts the floating portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.61% through June 2025. We have designated the interest rate swap as a highly effective cash flow hedge.


	September 30,		June 30,
As of	2023		2023
Other current assets
Brazil Real options, net	$	—	$	333
Interest rate swap		14,198		14,031
Other assets
Interest rate swap		8,500		10,225
Total Fair Value
Brazil Real options, net		—		333
Interest rate swap		22,698		24,256

Notional amounts of the derivatives as of the balance sheet date were:


	September 30,
As of	2023
Interest rate swap	$	300,000

The consolidated statements of operations and statements of comprehensive (loss) income for the periods ended September 30, 2023 and 2022 included the effects of derivatives as follows:


	Three Months
For the Periods Ended September 30	2023		2022
Brazil Real options, net
(Income) expense recorded in consolidated statements of operations	$	(181)	$	438
Consolidated statement of operations - total cost of goods sold	$	163,623	$	163,875
Expense recorded in comprehensive (loss) income	$	333	$	168
Interest rate swap
Income recorded in consolidated statements of operations	$	(3,570)	$	(1,211)
Consolidated statement of operations - total interest expense, net	$	4,564	$	3,067
Expense (income) recorded in comprehensive (loss) income	$	1,558	$	(7,273)

XML 28 R18.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Sep. 30, 2023

Fair Value Measurements

Fair Value Measurements

10. Fair Value Measurements

Short-term Investments

Our short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.

Current Assets and Liabilities

We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.

Debt

Derivatives

Non-financial Assets

Fair Value of Assets (Liabilities)


As of	September 30, 2023						June 30, 2023
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Short-term investments	$	48,000	$	—	$	—	$	40,000	$	—	$	—
Foreign currency derivatives	$	—	$	—	$	—	$	—	$	333	$	—
Interest rate swap	$	—	$	22,698	$	—	$	—	$	24,256	$	—

There were no transfers between levels during the periods presented.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 29 R19.htm IDEA: XBRL DOCUMENT

Business Segments

3 Months Ended

Sep. 30, 2023

Business Segments

Business Segments

11. Business Segments


	Three Months
For the Periods Ended September 30	2023		2022
Net sales
Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total segments	$	231,349	$	232,521

Depreciation and amortization
Animal Health	$	7,349	$	6,911
Mineral Nutrition		646		655
Performance Products		426		442
Total segments	$	8,421	$	8,008
Adjusted EBITDA
Animal Health	$	28,494	$	26,964
Mineral Nutrition		2,881		5,297
Performance Products		1,409		2,364
Total segments	$	32,784	$	34,625
Reconciliation of income before income taxes to Adjusted EBITDA
(Loss) income before income taxes	$	(11,979)	$	5,417
Interest expense, net		4,564		3,067
Depreciation and amortization – Total segments		8,421		8,008
Depreciation and amortization – Corporate		450		442
Corporate costs		14,133		12,491
Pension settlement cost		10,425		—
Stock-based compensation		81		—
Foreign currency losses, net		6,689		5,200
Adjusted EBITDA – Total segments	$	32,784	$	34,625


	September 30,		June 30,
As of	2023		2023
Identifiable assets
Animal Health	$	679,935	$	698,522
Mineral Nutrition		74,060		75,814
Performance Products		49,939		49,678
Total segments		803,934		824,014
Corporate		160,589		147,383
Total	$	964,523	$	971,397

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//280/tableOfContent

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-26

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-34

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-21

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

+ Details

XML 30 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Policies)

3 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies and New Accounting Standards

Net Income per Share and Weighted Average Shares

Net (Loss) Income per Share and Weighted Average Shares

Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period.


	Three Months
For the Periods Ended September 30	2023		2022
Net (loss) income	$	(8,015)	$	3,856

Weighted average number of shares – basic		40,504		40,504
Dilutive effect of restricted stock units		—		—
Weighted average number of shares - diluted		40,504		40,504

Net (loss) income per share
basic	$	(0.20)	$	0.10
diluted	$	(0.20)	$	0.10

New Accounting Standards

New Accounting Standards

We do not expect the new accounting standards that are pending adoption by us to have a material effect on our consolidated financial statements.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Tables)

3 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies and New Accounting Standards

Schedule of net income per share and weighted average shares


	Three Months
For the Periods Ended September 30	2023		2022
Net (loss) income	$	(8,015)	$	3,856

Weighted average number of shares – basic		40,504		40,504
Dilutive effect of restricted stock units		—		—
Weighted average number of shares - diluted		40,504		40,504

Net (loss) income per share
basic	$	(0.20)	$	0.10
diluted	$	(0.20)	$	0.10

XML 32 R22.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information (Tables)

3 Months Ended

Sep. 30, 2023

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type


	Three Months
For the Periods Ended September 30	2023		2022
Animal Health
MFAs and other	$	94,104	$	92,790
Nutritional specialties		40,210		39,054
Vaccines		26,216		23,015
Total Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total	$	231,349	$	232,521

Net Sales by Region


	Three Months
For the Periods Ended September 30	2023		2022
United States	$	131,287	$	135,804
Latin America and Canada		58,703		52,246
Europe, Middle East and Africa		26,879		29,517
Asia Pacific		14,480		14,954
Total	$	231,349	$	232,521

Schedule of interest expense, net


	Three Months
For the Periods Ended September 30	2023		2022
Interest expense, net
2021 Credit Facilities	$	5,101	$	3,547
2022 Term Loan		216		—
Amortization of debt issuance costs		260		147
Other		68		1
Interest expense		5,645		3,695
Interest income		(1,081)		(628)
	$	4,564	$	3,067

Schedule of depreciation and amortization


	Three Months
For the Periods Ended September 30	2023		2022
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,431	$	6,051
Amortization of intangible assets		2,440		2,399
	$	8,871	$	8,450

XML 33 R23.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information (Tables)

3 Months Ended

Sep. 30, 2023

Balance Sheets-Additional Information

Schedule of inventories


	September 30,		June 30,
As of	2023		2023
Inventories
Raw materials	$	84,369	$	84,328
Work-in-process		25,159		22,350
Finished goods		169,626		170,892
	$	279,154	$	277,570

Schedule of other assets


	September 30,		June 30,
As of	2023		2023
Other assets
ROU operating lease assets	$	36,320	$	35,759
Deferred income taxes		8,981		8,711
Deposits		6,518		6,617
Insurance investments		6,096		6,067
Equity method investments		5,814		5,027
Derivative instruments		8,500		10,225
Debt issuance costs		1,284		1,408
Other		7,792		8,031
	$	81,305	$	81,845

Schedule of accrued expenses and other current liabilities


	September 30,		June 30,
As of	2023		2023
Accrued expenses and other current liabilities
Employee related	$	26,647	$	29,359
Current operating lease liabilities		6,452		6,053
Commissions and rebates		3,442		5,833
Professional fees		4,643		5,032
Income and other taxes		5,951		8,663
Insurance-related		1,364		1,284
Insurance premium financing		2,898		4,769
Other		19,592		18,859
	$	70,989	$	79,852

Schedule of other liabilities


	September 30,		June 30,
As of	2023		2023
Other liabilities
Long-term operating lease liabilities	$	29,022	$	29,077
Long-term and deferred income taxes		12,823		12,146
Supplemental retirement benefits, deferred compensation and other		6,628		6,552
U.S. pension plan		1,687		2,286
International retirement plans		4,130		4,210
Other long-term liabilities		6,092		6,076
	$	60,382	$	60,347

Schedule of accumulated other comprehensive loss


	September 30,		June 30,
As of	2023		2023
Accumulated other comprehensive loss
Derivative instruments	$	22,698	$	24,589
Foreign currency translation adjustment		(118,622)		(115,062)
Unrecognized net pension losses		(12,927)		(23,996)
Income tax (provision) benefit		(2,005)		259
	$	(110,856)	$	(114,210)

XML 34 R24.htm IDEA: XBRL DOCUMENT

Debt (Tables)

3 Months Ended

Sep. 30, 2023

Debt

Schedule of long term debt


					Three Months
	September 30,		June 30,		Ended September 30,
	2023		2023		2023		2022
2021 Revolver	6.23	%	6.09	%	6.19	%	3.92	%
2021 Term A Loan	2.36	%	2.36	%	2.36	%	2.37	%
2023 Incremental Term Loan	7.66	%	7.44	%	7.57	%	—
2022 Term Loan	7.42	%	7.25	%	7.43	%	—


	September 30,		June 30,
As of	2023		2023
2021 Term A Loan due April 2026	$	270,000	$	273,750
2023 Incremental Term Loan due April 2026		48,750		50,000
2022 Term Loan due September 2027		11,580		11,685
		330,330		335,435
Unamortized debt issuance costs		(1,463)		(1,599)
		328,867		333,836
Less: current maturities		(24,150)		(22,295)
	$	304,717	$	311,541

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482925/835-30-45-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482949/835-30-55-8

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480848/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-7

+ Details

XML 35 R25.htm IDEA: XBRL DOCUMENT

Derivatives (Tables)

3 Months Ended

Sep. 30, 2023

Derivatives

Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges


	September 30,		June 30,
As of	2023		2023
Other current assets
Brazil Real options, net	$	—	$	333
Interest rate swap		14,198		14,031
Other assets
Interest rate swap		8,500		10,225
Total Fair Value
Brazil Real options, net		—		333
Interest rate swap		22,698		24,256

Notional amounts of the derivatives as of the balance sheet date were:


	September 30,
As of	2023
Interest rate swap	$	300,000

Schedule of effects of derivatives


	Three Months
For the Periods Ended September 30	2023		2022
Brazil Real options, net
(Income) expense recorded in consolidated statements of operations	$	(181)	$	438
Consolidated statement of operations - total cost of goods sold	$	163,623	$	163,875
Expense recorded in comprehensive (loss) income	$	333	$	168
Interest rate swap
Income recorded in consolidated statements of operations	$	(3,570)	$	(1,211)
Consolidated statement of operations - total interest expense, net	$	4,564	$	3,067
Expense (income) recorded in comprehensive (loss) income	$	1,558	$	(7,273)

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References + Details

XML 36 R26.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2023

Fair Value Measurements

Schedule of fair value of assets and liabilities measured on a recurring basis


As of	September 30, 2023						June 30, 2023
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Short-term investments	$	48,000	$	—	$	—	$	40,000	$	—	$	—
Foreign currency derivatives	$	—	$	—	$	—	$	—	$	333	$	—
Interest rate swap	$	—	$	22,698	$	—	$	—	$	24,256	$	—

XML 37 R27.htm IDEA: XBRL DOCUMENT

Business Segments (Tables)

3 Months Ended

Sep. 30, 2023

Business Segments

Schedule of information regarding reportable segments


	Three Months
For the Periods Ended September 30	2023		2022
Net sales
Animal Health	$	160,530	$	154,859
Mineral Nutrition		56,026		59,646
Performance Products		14,793		18,016
Total segments	$	231,349	$	232,521

Depreciation and amortization
Animal Health	$	7,349	$	6,911
Mineral Nutrition		646		655
Performance Products		426		442
Total segments	$	8,421	$	8,008
Adjusted EBITDA
Animal Health	$	28,494	$	26,964
Mineral Nutrition		2,881		5,297
Performance Products		1,409		2,364
Total segments	$	32,784	$	34,625
Reconciliation of income before income taxes to Adjusted EBITDA
(Loss) income before income taxes	$	(11,979)	$	5,417
Interest expense, net		4,564		3,067
Depreciation and amortization – Total segments		8,421		8,008
Depreciation and amortization – Corporate		450		442
Corporate costs		14,133		12,491
Pension settlement cost		10,425		—
Stock-based compensation		81		—
Foreign currency losses, net		6,689		5,200
Adjusted EBITDA – Total segments	$	32,784	$	34,625

Schedule of identifiable assets


	September 30,		June 30,
As of	2023		2023
Identifiable assets
Animal Health	$	679,935	$	698,522
Mineral Nutrition		74,060		75,814
Performance Products		49,939		49,678
Total segments		803,934		824,014
Corporate		160,589		147,383
Total	$	964,523	$	971,397

XML 38 R28.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net Income per Share and Weighted Average Shares
Net (loss) income	$ (8,015)	$ 3,856
Net (loss) income - basic	(8,015)	3,856
Net (loss) income - diluted	$ (8,015)	$ 3,856
Weighted average number of shares
Weighted average number of shares - basic (in shares)	40,504	40,504
Weighted average number of shares - diluted (in shares)	40,504	40,504
Net (loss) income per share
basic (in dollars per share)	$ (0.20)	$ 0.10
diluted (in dollars per share)	$ (0.20)	$ 0.10

XML 39 R29.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Segments (Details) - segment	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Business Segments
Number of reportable segments	3	3

XML 40 R30.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Net Sales by Product Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net sales
Net sales	$ 231,349	$ 232,521
Animal Health
Net sales
Net sales	160,530	154,859
MFAs and other
Net sales
Net sales	94,104	92,790
Nutritional Specialties
Net sales
Net sales	40,210	39,054
Vaccines
Net sales
Net sales	26,216	23,015
Mineral Nutrition
Net sales
Net sales	56,026	59,646
Performance Products
Net sales
Net sales	$ 14,793	$ 18,016

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

+ Details

XML 41 R31.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Net Sales by Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net sales
Net sales	$ 231,349	$ 232,521
United States
Net sales
Net sales	131,287	135,804
Latin America and Canada
Net sales
Net sales	58,703	52,246
Europe, Middle East and Africa
Net sales
Net sales	26,879	29,517
Asia Pacific
Net sales
Net sales	$ 14,480	$ 14,954

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

+ References

+ Details

XML 42 R32.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - General Information (Details)	3 Months Ended
	Sep. 30, 2023
Statements of Operations-Additional Information
Payment term, minimum	30 days
Payment term, maximum	120 days
Average worldwide collection period for accounts receivable	60 days

XML 43 R33.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Interest Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Interest expense, net
Amortization of debt issuance costs	$ 260	$ 147
Other	68	1
Interest expense	5,645	3,695
Interest income	(1,081)	(628)
Interest expense, net	4,564	3,067
Credit Facilities
Interest expense, net
Interest expense, excluding amortization	5,101	$ 3,547
2022 Term Loan
Interest expense, net
Interest expense, excluding amortization	$ 216

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References + Details

XML 44 R34.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Depreciation and Amortization (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Depreciation and amortization
Depreciation of property, plant and equipment	$ 6,431	$ 6,051
Amortization of intangible assets	2,440	2,399
Depreciation and amortization	$ 8,871	$ 8,450

XML 45 R35.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information - Annuity Purchase Agreement (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Jul. 31, 2023	Sep. 30, 2023
Statements of Operations-Additional Information
Annuity purchase price	$ 26,381
Pension settlement cost		$ 10,425

XML 46 R36.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Inventories, net
Raw materials	$ 84,369	$ 84,328
Work-in-process	25,159	22,350
Finished goods	169,626	170,892
Inventory, net	$ 279,154	$ 277,570

XML 47 R37.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information - Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Other assets
ROU operating lease assets	$ 36,320	$ 35,759
Deferred income taxes	8,981	8,711
Deposits	6,518	6,617
Insurance investments	6,096	6,067
Equity method investments	5,814	5,027
Derivative instruments	8,500	10,225
Debt issuance costs	1,284	1,408
Other	7,792	8,031
Other assets, total	$ 81,305	$ 81,845
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Other assets, total	Other assets, total
Derivative Asset, Noncurrent, Statement of Financial Position	Other assets, total	Other assets, total

XML 48 R38.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Accrued expenses and other current liabilities
Employee related	$ 26,647	$ 29,359
Current operating lease liabilities	6,452	6,053
Commissions and rebates	3,442	5,833
Professional fees	4,643	5,032
Income and other taxes	5,951	8,663
Insurance-related	1,364	1,284
Insurance premium financing	2,898	4,769
Other	19,592	18,859
Accrued expenses and other current liabilities, total	$ 70,989	$ 79,852
Operating Lease, Liability, Current, Statement of Financial Position	Accrued expenses and other current liabilities, total	Accrued expenses and other current liabilities, total

XML 49 R39.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information - Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Other liabilities
Long-term operating lease liabilities	$ 29,022	$ 29,077
Long term and deferred income taxes	12,823	12,146
Supplemental retirement benefits, deferred compensation and other	6,628	6,552
U.S. pension plan	1,687	2,286
International retirement plans	4,130	4,210
Other long-term liabilities	6,092	6,076
Other liabilities, total	$ 60,382	$ 60,347
Operating Lease, Liability, Noncurrent, Statement of Financial Position	Other liabilities, total	Other liabilities, total

XML 50 R40.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Accumulated other comprehensive loss
Accumulated other comprehensive loss	$ (110,856)	$ (114,210)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated other comprehensive loss
Accumulated other comprehensive loss, before tax	22,698	24,589
Accumulated other comprehensive loss, tax	(2,005)	259
Accumulated Foreign Currency Adjustment Attributable to Parent
Accumulated other comprehensive loss
Accumulated other comprehensive loss, before tax	(118,622)	(115,062)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Accumulated other comprehensive loss
Accumulated other comprehensive loss, before tax	$ (12,927)	$ (23,996)

- Definition

Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.

+ References + Details

XML 51 R41.htm IDEA: XBRL DOCUMENT

Debt - General Information (Details) $ in Thousands	1 Months Ended	3 Months Ended
Debt - General Information (Details) $ in Thousands	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Nov. 30, 2022 USD ($)	Apr. 30, 2021 USD ($)
Line of Credit \| Credit Facilities
Debt
Line of credit facility, expiration date		Apr. 30, 2026
Maximum First Lien Net Leverage Ratio		4.00
Maximum First Lien Net Leverage Ratio, Test Period		4.25
Minimum interest coverage ratio		3.00
Line of Credit \| Credit Facilities \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario One
Debt
Basis spread on variable rate (as a percent)		1.50%
Line of Credit \| Credit Facilities \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Two
Debt
Basis spread on variable rate (as a percent)		1.75%
Line of Credit \| Credit Facilities \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Three
Debt
Basis spread on variable rate (as a percent)		2.00%
Line of Credit \| Credit Facilities \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Four
Debt
Basis spread on variable rate (as a percent)		2.25%
Line of Credit \| Credit Facilities \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario One
Debt
Basis spread on variable rate (as a percent)		0.50%
Line of Credit \| Credit Facilities \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Two
Debt
Basis spread on variable rate (as a percent)		0.75%
Line of Credit \| Credit Facilities \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Three
Debt
Basis spread on variable rate (as a percent)		1.00%
Line of Credit \| Credit Facilities \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Four
Debt
Basis spread on variable rate (as a percent)		1.25%
Loans Payable \| Term A Loan
Debt
Aggregate principal amount						$ 300,000
Loans Payable \| 2023 Incremental Term Loan due April 2026
Debt
Aggregate principal amount				$ 50,000
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario One
Debt
Basis spread on variable rate (as a percent)		2.00%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Two
Debt
Basis spread on variable rate (as a percent)		2.25%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Three
Debt
Basis spread on variable rate (as a percent)		2.50%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Four
Debt
Basis spread on variable rate (as a percent)		2.75%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario One
Debt
Basis spread on variable rate (as a percent)		1.00%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Two
Debt
Basis spread on variable rate (as a percent)		1.25%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Three
Debt
Basis spread on variable rate (as a percent)		1.50%
Loans Payable \| 2023 Incremental Term Loan due April 2026 \| Base Rate \| Debt Instrument, Basis Spread on Variable Rate, Scenario Four
Debt
Basis spread on variable rate (as a percent)		1.75%
Revolving Credit Facility \| Revolver
Debt
Maximum borrowing capacity					$ 310,000	$ 250,000
Aggregate available credit facilities		$ 153,521
Outstanding borrowings		154,000
Letter of Credit
Debt
Letters of credit outstanding		$ 2,479
Letter of Credit \| Maximum
Debt
Debt instrument, term		1 year
Secured Debt \| 2022 Term Loan
Debt
Aggregate principal amount	$ 12,000		$ 12,000
Debt instrument, periodic payment			$ 35
Debt instrument, frequency of periodic payment			monthly
Secured Debt \| 2022 Term Loan \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt
Basis spread on variable rate (as a percent)	2.00%
Secured Debt \| 2022 Term Loan \| Fed Funds Effective Rate Overnight Index Swap Rate
Debt
Basis spread on variable rate (as a percent)	0.50%

XML 52 R42.htm IDEA: XBRL DOCUMENT

Debt - Interest Rates - Stated Rates (Details)	Sep. 30, 2023	Jun. 30, 2023
Revolving Credit Facility \| Revolver
Debt
Interest rate (as a percent)	6.23%	6.09%
Loans Payable \| Term A Loan
Debt
Interest rate (as a percent)	2.36%	2.36%
Loans Payable \| 2023 Incremental Term Loan due April 2026
Debt
Interest rate (as a percent)	7.66%	7.44%
Secured Debt \| 2022 Term Loan
Debt
Interest rate (as a percent)	7.42%	7.25%

XML 53 R43.htm IDEA: XBRL DOCUMENT

Debt - Interest Rates - Weighted Average Rates (Details)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Revolving Credit Facility \| Revolver
Debt
Long-term debt, weighted average interest rate, over time	6.19%	3.92%
Loans Payable \| Term A Loan
Debt
Long-term debt, weighted average interest rate, over time	2.36%	2.37%
Loans Payable \| 2023 Incremental Term Loan due April 2026
Debt
Long-term debt, weighted average interest rate, over time	7.57%
Secured Debt \| 2022 Term Loan
Debt
Long-term debt, weighted average interest rate, over time	7.43%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482900/835-30-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

XML 54 R44.htm IDEA: XBRL DOCUMENT

Debt - Derivatives (Details) - Cash Flow Hedging - USD ($) $ in Thousands	1 Months Ended
	Jul. 31, 2022	Sep. 30, 2023	Mar. 31, 2020
Interest Rate Swap
Derivatives
Derivative, notional amount		$ 300,000
Interest Rate Swap, March 2020
Derivatives
Derivative, notional amount			$ 150,000
Derivative, fixed interest rate (as a percent)			0.62%
Interest Rate Swap, July 2022
Derivatives
Derivative, notional amount	$ 300,000
Derivative, fixed interest rate (as a percent)	0.61%
Derivative, maturity date	Jun. 30, 2025

- Definition

Date derivative contract ends, in YYYY-MM-DD format.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5C
-Subparagraph (SX 210.12-13C(Column D))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13(Column F))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5A
-Subparagraph (SX 210.12-13A(Column C))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5B
-Subparagraph (SX 210.12-13B(Column D))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B

+ Details

XML 55 R45.htm IDEA: XBRL DOCUMENT

Debt - Reconciliation (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Long-Term Debt
Long-term debt, gross	$ 330,330	$ 335,435
Unamortized debt issuance costs	(1,463)	(1,599)
Total	328,867	333,836
Loans Payable \| Term A Loan
Long-Term Debt
Long-term debt, gross	270,000	273,750
Loans Payable \| 2023 Incremental Term Loan due April 2026
Long-Term Debt
Long-term debt, gross	48,750	50,000
Secured Debt \| 2022 Term Loan
Long-Term Debt
Long-term debt, gross	$ 11,580	$ 11,685

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 56 R46.htm IDEA: XBRL DOCUMENT

Debt - Classification (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Long-term debt
Total	$ 328,867	$ 333,836
Less: current maturities	(24,150)	(22,295)
Long-term debt, non-current	$ 304,717	$ 311,541

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 57 R47.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Immediate Family Member of Management or Principal Owner \| Compensation and Benefit for Services
Related Party Transactions
Aggregate compensation and benefits	$ 438	$ 780

XML 58 R48.htm IDEA: XBRL DOCUMENT

Stock Incentive Plan - Restricted Stock Units (Details) - Restricted Stock Units (RSUs) - July 2023 $ / shares in Units, $ in Thousands	1 Months Ended
	Jul. 31, 2023 USD ($) $ / shares shares
Stock Incentive Plan
Granted (in shares) \| shares	300,000
Vesting percentage (as a percent)	10.00%
Vesting, achievement of arithmetic average of closing stock price per share for each trading day, vesting percentage, minimum (as a percent)	20.00%
Vesting, achievement of arithmetic average of closing stock price per share for each trading day, period	90 days
Vesting, achievement of arithmetic average of closing stock price per share for each trading day, share price, minimum (in dollars per share)	$ 20
Vesting, achievement of arithmetic average of closing stock price per share for each trading day, share price, maximum (in dollars per share)	$ 60
Vesting, immediately vest in full, change in control, shares of stock cease to trade on nationally recognized exchange, percentage (as a percent)	100.00%
Vesting, immediately vest in full, qualifying termination, period	12 months
Grant date fair value \| $	$ 1,284
Grant date fair value (in dollars per share)	$ 4.28

XML 59 R49.htm IDEA: XBRL DOCUMENT

Stock Incentive Plan - Stock-Based Compensation Expense (Details) - Restricted Stock Units (RSUs) $ in Thousands	3 Months Ended
	Sep. 30, 2023 USD ($)
Stock Incentive Plan
Stock-based compensation expense	$ 81
Share-based payment arrangement, expense, expected, year one	321
Share-based payment arrangement, expense, expected, year two	321
Share-based payment arrangement, expense, expected, year three	321
Share-based payment arrangement, expense, expected, year four	$ 321

XML 60 R50.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Environmental (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2023 USD ($) item	Jun. 30, 2023 USD ($)
Environmental
Number of potentially responsible parties \| item	140
Accrual for environmental loss contingencies \| $	$ 8,531	$ 8,505
Environmental Loss Contingency, Statement of Financial Position	Other liabilities, Accrued expenses and other current liabilities	Other liabilities, Accrued expenses and other current liabilities

XML 61 R51.htm IDEA: XBRL DOCUMENT

Derivatives - General Information (Details) - Cash Flow Hedging - USD ($) $ in Thousands	1 Months Ended
	Jul. 31, 2022	Sep. 30, 2023	Mar. 31, 2020
Interest Rate Swap
Derivatives
Derivative, notional amount		$ 300,000
Interest Rate Swap, March 2020
Derivatives
Derivative, notional amount			$ 150,000
Derivative, fixed interest rate (as a percent)			0.62%
Interest Rate Swap, July 2022
Derivatives
Derivative, notional amount	$ 300,000
Derivative, fixed interest rate (as a percent)	0.61%
Derivative, maturity date	Jun. 30, 2025

- Definition

Date derivative contract ends, in YYYY-MM-DD format.

+ References

+ Details

XML 62 R52.htm IDEA: XBRL DOCUMENT

Derivatives - Balance Sheet Location (Details) - Cash Flow Hedging - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Foreign Exchange Option
Other assets
Total Fair Value		$ 333
Foreign Exchange Option \| Other Current Assets
Other assets
Other assets		333
Interest Rate Swap
Other assets
Total Fair Value	$ 22,698	24,256
Interest Rate Swap \| Other Current Assets
Other assets
Other assets	14,198	14,031
Interest Rate Swap \| Other Noncurrent Assets
Other assets
Other assets	$ 8,500	$ 10,225

XML 63 R53.htm IDEA: XBRL DOCUMENT

Derivatives - Notional Amounts (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Interest Rate Swap \| Cash Flow Hedging
Derivatives
Derivative, notional amount	$ 300,000

XML 64 R54.htm IDEA: XBRL DOCUMENT

Derivatives - Effects of Derivatives (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Derivatives
Consolidated statement of operations - total cost of goods sold	$ 163,623	$ 163,875
Interest expense, net	4,564	3,067
Derivatives
Expense (income) recorded in comprehensive (loss) income	1,891	(7,105)
Foreign Exchange Option
Derivatives
Expense (income) recorded in comprehensive (loss) income	333	168
Foreign Exchange Option \| Cash Flow Hedging
Derivatives
(Income) expense recorded in consolidated statements of operations	$ (181)	$ 438
Derivative, Gain (Loss), Statement of Income or Comprehensive Income	Consolidated statement of operations - total cost of goods sold	Consolidated statement of operations - total cost of goods sold
Interest Rate Swap
Derivatives
Expense (income) recorded in comprehensive (loss) income	$ 1,558	$ (7,273)
Interest Rate Swap \| Cash Flow Hedging
Derivatives
(Income) expense recorded in consolidated statements of operations	$ (3,570)	$ (1,211)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income	Interest expense, net	Interest expense, net

XML 65 R55.htm IDEA: XBRL DOCUMENT

Derivatives - Additional Information (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Foreign Exchange Option \| Cash Flow Hedging
Derivatives
Realized gains (losses) related to matured contracts recorded as a component of inventory	$ (1,182)

XML 66 R56.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Fair Value of Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Fair Value of Assets
Short-term investments	$ 48,000	$ 40,000
Level 1
Fair Value of Assets
Short-term investments	48,000	40,000
Level 1 \| Foreign Exchange Option
Fair Value of Assets
Foreign currency derivatives and interest rate swap	0	0
Level 1 \| Interest Rate Swap
Fair Value of Assets
Foreign currency derivatives and interest rate swap	0	0
Level 2
Fair Value of Assets
Short-term investments	0	0
Level 2 \| Foreign Exchange Option
Fair Value of Assets
Foreign currency derivatives and interest rate swap	0	333
Level 2 \| Interest Rate Swap
Fair Value of Assets
Foreign currency derivatives and interest rate swap	22,698	24,256
Level 3
Fair Value of Assets
Short-term investments	0	0
Level 3 \| Foreign Exchange Option
Fair Value of Assets
Foreign currency derivatives and interest rate swap	0	0
Level 3 \| Interest Rate Swap
Fair Value of Assets
Foreign currency derivatives and interest rate swap	$ 0	$ 0

XML 67 R57.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023
Changes in the fair value of the Level 3 assets
Transfers between levels, assets	$ 0	$ 0

XML 68 R58.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023
Changes in the fair value of the Level 3 liabilities
Transfers between levels, liabilities	$ 0	$ 0

XML 69 R59.htm IDEA: XBRL DOCUMENT

Business Segments - General Information (Details) - segment	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Business Segments
Number of reportable segments	3	3

XML 70 R60.htm IDEA: XBRL DOCUMENT

Business Segments - Net Sales (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net sales
Net sales	$ 231,349	$ 232,521
Animal Health
Net sales
Net sales	160,530	154,859
Mineral Nutrition
Net sales
Net sales	56,026	59,646
Performance Products
Net sales
Net sales	$ 14,793	$ 18,016

- Definition

+ References

+ Details

XML 71 R61.htm IDEA: XBRL DOCUMENT

Business Segments - Depreciation and Amortization (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Depreciation and amortization
Depreciation and amortization	$ 8,871	$ 8,450
Operating Segments
Depreciation and amortization
Depreciation and amortization	8,421	8,008
Operating Segments \| Animal Health
Depreciation and amortization
Depreciation and amortization	7,349	6,911
Operating Segments \| Mineral Nutrition
Depreciation and amortization
Depreciation and amortization	646	655
Operating Segments \| Performance Products
Depreciation and amortization
Depreciation and amortization	$ 426	$ 442

XML 72 R62.htm IDEA: XBRL DOCUMENT

Business Segments - Adjusted EBITDA (Details) - Operating Segments - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Adjusted EBITDA
Adjusted EBITDA	$ 32,784	$ 34,625
Animal Health
Adjusted EBITDA
Adjusted EBITDA	28,494	26,964
Mineral Nutrition
Adjusted EBITDA
Adjusted EBITDA	2,881	5,297
Performance Products
Adjusted EBITDA
Adjusted EBITDA	$ 1,409	$ 2,364

XML 73 R63.htm IDEA: XBRL DOCUMENT

Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Reconciliation of income before income taxes to Adjusted EBITDA
(Loss) income before income taxes	$ (11,979)	$ 5,417
Interest expense, net	4,564	3,067
Depreciation and amortization	8,871	8,450
Corporate costs	14,133	12,491
Pension settlement cost	10,425
Stock-based compensation	81
Foreign currency losses, net	6,689	5,200
Operating Segments
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	8,421	8,008
Foreign currency losses, net	6,689	5,200
Adjusted EBITDA - Total segments	32,784	34,625
Operating Segments \| Animal Health
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	7,349	6,911
Adjusted EBITDA - Total segments	28,494	26,964
Operating Segments \| Mineral Nutrition
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	646	655
Adjusted EBITDA - Total segments	2,881	5,297
Operating Segments \| Performance Products
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	426	442
Adjusted EBITDA - Total segments	1,409	2,364
Corporate
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	$ 450	$ 442

XML 74 R64.htm IDEA: XBRL DOCUMENT

Business Segments - Identifiable Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023
Assets
Assets	$ 964,523	$ 971,397
Operating Segments
Assets
Assets	803,934	824,014
Operating Segments \| Animal Health
Assets
Assets	679,935	698,522
Operating Segments \| Mineral Nutrition
Assets
Assets	74,060	75,814
Operating Segments \| Performance Products
Assets
Assets	49,939	49,678
Corporate
Assets
Assets	$ 160,589	$ 147,383

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481203/810-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481231/810-10-45-25

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481372/852-10-55-10

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481404/852-10-50-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

XML 75 pahc-20230930x10q_htm.xml IDEA: XBRL DOCUMENT 0001069899 us-gaap:RetainedEarningsMember 2023-09-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001069899 us-gaap:RetainedEarningsMember 2023-06-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001069899 us-gaap:RetainedEarningsMember 2022-09-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001069899 us-gaap:RetainedEarningsMember 2022-06-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001069899 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001069899 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001069899 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001069899 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001069899 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001069899 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001069899 us-gaap:EMEAMember 2023-07-01 2023-09-30 0001069899 srt:AsiaPacificMember 2023-07-01 2023-09-30 0001069899 pahc:VaccinesMember 2023-07-01 2023-09-30 0001069899 pahc:PerformanceProductsMember 2023-07-01 2023-09-30 0001069899 pahc:PerformanceProductsMember 2023-07-01 2023-09-30 0001069899 pahc:NutritionalSpecialtiesMember 2023-07-01 2023-09-30 0001069899 pahc:MineralNutritionMember 2023-07-01 2023-09-30 0001069899 pahc:MineralNutritionMember 2023-07-01 2023-09-30 0001069899 pahc:MedicatedFeedAdditivesAndOthersMember 2023-07-01 2023-09-30 0001069899 pahc:LatinAmericaAndCanadaMember 2023-07-01 2023-09-30 0001069899 pahc:AnimalHealthMember 2023-07-01 2023-09-30 0001069899 pahc:AnimalHealthMember 2023-07-01 2023-09-30 0001069899 country:US 2023-07-01 2023-09-30 0001069899 us-gaap:EMEAMember 2022-07-01 2022-09-30 0001069899 srt:AsiaPacificMember 2022-07-01 2022-09-30 0001069899 pahc:VaccinesMember 2022-07-01 2022-09-30 0001069899 pahc:PerformanceProductsMember 2022-07-01 2022-09-30 0001069899 pahc:PerformanceProductsMember 2022-07-01 2022-09-30 0001069899 pahc:NutritionalSpecialtiesMember 2022-07-01 2022-09-30 0001069899 pahc:MineralNutritionMember 2022-07-01 2022-09-30 0001069899 pahc:MineralNutritionMember 2022-07-01 2022-09-30 0001069899 pahc:MedicatedFeedAdditivesAndOthersMember 2022-07-01 2022-09-30 0001069899 pahc:LatinAmericaAndCanadaMember 2022-07-01 2022-09-30 0001069899 pahc:AnimalHealthMember 2022-07-01 2022-09-30 0001069899 pahc:AnimalHealthMember 2022-07-01 2022-09-30 0001069899 country:US 2022-07-01 2022-09-30 0001069899 pahc:CompensationAndBenefitForServicesMember us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember 2023-07-01 2023-09-30 0001069899 pahc:CompensationAndBenefitForServicesMember us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember 2022-07-01 2022-09-30 0001069899 us-gaap:InterestRateSwapMember 2023-07-01 2023-09-30 0001069899 us-gaap:ForeignExchangeOptionMember 2023-07-01 2023-09-30 0001069899 us-gaap:InterestRateSwapMember 2022-07-01 2022-09-30 0001069899 us-gaap:ForeignExchangeOptionMember 2022-07-01 2022-09-30 0001069899 pahc:TermALoanMember us-gaap:LoansPayableMember 2023-07-01 2023-09-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2023-07-01 2023-09-30 0001069899 pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember 2023-07-01 2023-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember 2023-07-01 2023-09-30 0001069899 pahc:TermALoanMember us-gaap:LoansPayableMember 2022-07-01 2022-09-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2022-07-01 2022-09-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2022-11-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2021-04-30 0001069899 pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0001069899 us-gaap:LetterOfCreditMember 2023-09-30 0001069899 pahc:CreditFacilitiesMember 2023-07-01 2023-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember 2023-07-01 2023-09-30 0001069899 pahc:CreditFacilitiesMember 2022-07-01 2022-09-30 0001069899 2022-07-01 2023-06-30 0001069899 pahc:InterestRateSwapJuly2022Member us-gaap:CashFlowHedgingMember 2022-07-01 2022-07-31 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-07-01 2023-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2023-07-01 2023-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-07-01 2022-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2022-07-01 2022-09-30 0001069899 pahc:InterestRateSwapJuly2022Member us-gaap:CashFlowHedgingMember 2022-07-31 0001069899 pahc:InterestRateSwapMarch2020Member us-gaap:CashFlowHedgingMember 2020-03-31 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-06-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2023-06-30 0001069899 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-09-30 0001069899 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-09-30 0001069899 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-06-30 0001069899 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-06-30 0001069899 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2023-06-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2023-06-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:FairValueInputsLevel1Member 2023-06-30 0001069899 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0001069899 srt:MaximumMember us-gaap:LetterOfCreditMember 2023-07-01 2023-09-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2023-09-30 0001069899 pahc:RevolverMember us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember 2022-07-01 2022-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember 2022-09-30 0001069899 pahc:TermALoanMember us-gaap:LoansPayableMember 2021-04-30 0001069899 pahc:TermALoanMember us-gaap:LoansPayableMember 2023-09-30 0001069899 pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember 2023-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember 2023-09-30 0001069899 pahc:TermALoanMember us-gaap:LoansPayableMember 2023-06-30 0001069899 pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember 2023-06-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember 2023-06-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember pahc:IncrementalTermLoan2023DueApril2026Member us-gaap:LoansPayableMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-07-01 2023-09-30 0001069899 pahc:DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-07-01 2023-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-09-01 2022-09-30 0001069899 pahc:CreditAgreement2022TermLoanMember us-gaap:SecuredDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2022-09-01 2022-09-30 0001069899 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001069899 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001069899 us-gaap:CommonStockMember 2023-09-30 0001069899 us-gaap:CommonStockMember 2023-06-30 0001069899 us-gaap:CommonStockMember 2022-09-30 0001069899 us-gaap:CommonStockMember 2022-06-30 0001069899 us-gaap:CommonClassBMember 2023-09-30 0001069899 us-gaap:CommonClassAMember 2023-09-30 0001069899 us-gaap:CommonClassBMember 2023-06-30 0001069899 us-gaap:CommonClassAMember 2023-06-30 0001069899 2022-09-30 0001069899 2022-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember 2023-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2023-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2023-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2023-06-30 0001069899 us-gaap:OperatingSegmentsMember 2023-06-30 0001069899 us-gaap:CorporateNonSegmentMember 2023-06-30 0001069899 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001069899 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0001069899 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0001069899 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001069899 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001069899 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001069899 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001069899 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001069899 pahc:July2023Member us-gaap:RestrictedStockUnitsRSUMember 2023-07-31 0001069899 pahc:July2023Member us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-07-31 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2023-09-30 0001069899 2023-07-01 2023-07-31 0001069899 pahc:CreditFacilitiesMember us-gaap:LineOfCreditMember 2023-09-30 0001069899 2022-07-01 2022-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2023-07-01 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2023-07-01 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2023-07-01 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2022-07-01 2022-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2022-07-01 2022-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2022-07-01 2022-09-30 0001069899 us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001069899 2023-09-30 0001069899 2023-06-30 0001069899 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001069899 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001069899 us-gaap:CommonClassBMember 2023-11-03 0001069899 us-gaap:CommonClassAMember 2023-11-03 0001069899 2023-07-01 2023-09-30 shares iso4217:USD shares iso4217:USD pure pahc:item pahc:segment

http://www.pahc.com/20230930#AccruedLiabilitiesAndOtherLiabilitiesCurrent

0001069899 2024 Q1 false

http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent

http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent

0.0001

http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold

http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet

http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.pahc.com/20230930#AccruedLiabilitiesAndOtherLiabilitiesCurrent

http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent

http://www.pahc.com/20230930#AccruedLiabilitiesAndOtherLiabilitiesCurrent

http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent

2026-04-30

2025-06-30

321000 321000 321000

2025-06-30

http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold

http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet

10-Q true 2023-09-30 false 001-36410 Phibro Animal Health Corporation DE 13-1840497 Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard Suite 21 Teaneck NJ 07666-6712 201 329-7300 Class A Common Stock, $0.0001 par value per share 0.0001 PAHC NASDAQ Yes Yes Accelerated Filer false false false 20337574 0.0001 20166034 0.0001

231349000

232521000

163623000

163875000

67726000

68646000

68452000

54962000

-726000

13684000

-4564000

-3067000

-6689000

-5200000

-11979000

5417000

-3964000

1561000

-8015000

3856000

-0.20

0.10

-0.20

0.10

40504000

-8015000

3856000

-1891000

7105000

-3560000

-4143000

10425000

644000

176000

2264000

1820000

3354000

1318000

-4661000

5174000

43153000

41281000

48000000

40000000

149228000

163479000

279154000

277570000

64889000

63393000

584424000

585723000

193359000

195568000

52184000

54987000

53251000

53274000

81305000

81845000

964523000

971397000

24150000

22295000

77216000

73853000

70989000 79852000

172355000

176000000

154000000

141000000

304717000

311541000

60382000

60347000

691454000

688888000

0.0001

300000000

20337574

30000000

20166034

--06-30

4000

0.0001

16000000

135884000

135803000

248037000

260912000

-110856000

-114210000

273069000

282509000

964523000

971397000

-8015000

3856000

8871000

8450000

260000

147000

81000

-2691000

-13000

-3222000

-3370000

10425000

-959000

309000

-12781000

-22347000

5005000

24977000

3297000

7682000

191000

31000

4603000

-5595000

-5804000

-10261000

16199000

-10698000

17000000

9000000

7000000

7476000

23176000

-124000

-27000

-15352000

-16149000

51000000

62000000

38000000

36000000

12000000

5105000

3750000

71000

1739000

4860000

1296000

29319000

-271000

-440000

1872000

2032000

41281000

74248000

43153000

76280000

40503608

4000

135803000

260912000

-114210000

282509000

-8015000

3354000

-4661000

0.12

4860000

81000

40503608

4000

135884000

248037000

-110856000

273069000

40503608

4000

135803000

247748000

-121113000

262442000

3856000

1318000

5174000

0.12

4860000

40503608

4000

135803000

246744000

-119795000

262756000

1. Description of BusinessPhibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.The unaudited consolidated financial information for the three months ended September 30, 2023 and 2022, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the “Annual Report”), filed with the Securities and Exchange Commission on August 30, 2023 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2023, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

2. Summary of Significant Accounting Policies and New Accounting StandardsOur significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2023, there have been no material changes to any of the significant accounting policies contained therein.Net (Loss) Income per Share and Weighted Average SharesBasic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period.Diluted net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period after giving effect to dilutive common share equivalents, resulting from the assumed vesting of restricted stock units. The restricted stock units have been excluded from the computation of diluted earnings per share for the three months ended September 30, 2023, as the effect would have been antidilutive.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,015)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,856</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares – basic </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;">Dilutive effect of restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares - diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income per share </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;margin:0pt;padding:0pt;"> basic</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;"> diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr></table> New Accounting StandardsWe do not expect the new accounting standards that are pending adoption by us to have a material effect on our consolidated financial statements.

Net (Loss) Income per Share and Weighted Average SharesBasic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period.Diluted net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the reporting period after giving effect to dilutive common share equivalents, resulting from the assumed vesting of restricted stock units. The restricted stock units have been excluded from the computation of diluted earnings per share for the three months ended September 30, 2023, as the effect would have been antidilutive.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,015)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,856</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares – basic </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;">Dilutive effect of restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares - diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income per share </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;margin:0pt;padding:0pt;"> basic</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;"> diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr></table>

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,015)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,856</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares – basic </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;">Dilutive effect of restricted stock units</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares - diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 40,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;">Net (loss) income per share </td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;margin:0pt;padding:0pt;"> basic</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.64%;background:#cceeff;margin:0pt;padding:0pt;"> diluted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> (0.20)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.29%;background:#cceeff;margin:0pt;padding:0pt;"> 0.10</td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr></table>

-8015000

3856000

40504000

-0.20

0.10

-0.20

0.10

New Accounting StandardsWe do not expect the new accounting standards that are pending adoption by us to have a material effect on our consolidated financial statements.

Disaggregated revenue, deferred revenue and customer payment termsWe develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. The products help prevent, control and treat diseases and enhance nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products directly to integrated poultry, cattle and swine customers and through commercial animal feed manufacturers, distributors and veterinarians. The animal health industry and demand for many of the animal health products in a particular region are affected by changing disease pressures and by weather conditions, as product usage follows varying weather patterns and seasons. Our operations are primarily focused on regions where the majority of livestock production is consolidated in large commercial farms.We have a diversified portfolio of products that are classified within our three business segments—Animal Health, Mineral Nutrition and Performance Products. Each segment has its own dedicated management and sales team.Animal HealthThe Animal Health business develops, manufactures and markets products in three main categories:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">MFAs and other: MFAs and other products primarily consist of concentrated medicated products administered through animal feeds, commonly referred to as Medicated Feed Additives (“MFAs”). Specific product classifications include antibacterials, which inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidia (parasites) that damage the intestinal tract of animals; and other related products. The MFAs and other category also includes antibacterials and other processing aids used in the ethanol fermentation industry.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Nutritional specialties: Nutritional specialty products enhance nutrition to help improve health and performance in areas such as immune system function and digestive health. We are also a developer, manufacturer and marketer of microbial products and bioproducts for a variety of applications serving animal health and nutrition, environmental, industrial and agricultural customers.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Vaccines: Vaccine products are primarily focused on preventing diseases in poultry, swine, beef and dairy cattle and aquaculture. They protect animals from either viral or bacterial disease challenges. We develop, manufacture and market conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. We have developed and market an innovative and proprietary delivery platform for vaccines.</td></tr></table><div style="margin-top:12pt;"></div>Mineral NutritionThe Mineral Nutrition business is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Our customers use these products to fortify the daily feed requirements of their livestock’s diets and maintain an optimal balance of trace elements in each animal. We manufacture and market a broad range of mineral nutrition products for food animals including poultry, swine, and beef and dairy cattle.Performance ProductsThe Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.The following tables present our revenues disaggregated by major product category and geographic region:Net Sales by Product Type<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Animal Health</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">MFAs and other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 94,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 92,790</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Nutritional specialties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 40,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 39,054</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Vaccines</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 26,216</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 23,015</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total Animal Health</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 160,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 154,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Mineral Nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 56,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 59,646</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Performance Products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,793</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,016</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr></table>Net Sales by Region<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">United States</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 131,287</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 135,804</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Latin America and Canada</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 58,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 52,246</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Europe, Middle East and Africa</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 26,879</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 29,517</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Asia Pacific</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,954</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr></table> Net sales by region are based on country of destination.Our customer payment terms generally range from 30 to 120 days globally and do not include any significant financing components. Payment terms vary based on industry and business practices within the regions in which we operate. Our average worldwide collection period for accounts receivable is approximately 60 days after the revenue is recognized.

Net Sales by Product Type<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Animal Health</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">MFAs and other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 94,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 92,790</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Nutritional specialties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 40,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 39,054</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Vaccines</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 26,216</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 23,015</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total Animal Health</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 160,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 154,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Mineral Nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 56,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 59,646</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Performance Products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,793</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,016</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr></table>Net Sales by Region<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">United States</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 131,287</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 135,804</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Latin America and Canada</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 58,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 52,246</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Europe, Middle East and Africa</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 26,879</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 29,517</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Asia Pacific</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,954</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr></table>

94104000

92790000

40210000

39054000

26216000

23015000

160530000

154859000

56026000

59646000

14793000

18016000

231349000

232521000

131287000

135804000

58703000

52246000

26879000

29517000

14480000

14954000

231349000

232521000

P30D P120D P60D

Interest Expense <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:normal;width:24.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:normal;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;">Interest expense, net </td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;">2021 Credit Facilities</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 5,101</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 3,547</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;">2022 Term Loan</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> 216</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;">Amortization of debt issuance costs</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 260</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 147</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 68</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;">Interest expense</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 5,645</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;margin:0pt;padding:0pt;"> 3,695</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;">Interest income</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,081)</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (628)</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:normal;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,564</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:normal;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,067</td><td style="vertical-align:bottom;white-space:normal;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.13%;margin:0pt;padding:0pt;"></td></tr></table> Depreciation and Amortization<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months</td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation and amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 6,431</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 6,051</td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,440</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,399</td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,871</td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,450</td></tr></table> Pension SettlementIn July 2023, we entered into an annuity purchase agreement to irrevocably transfer a portion of our pension benefit obligation to a third-party insurance company. The annuity purchase price was $26,381 and was approximately equal to the benefit obligation transferred. The annuity purchase was funded from pension assets. During the three months ended September 30, 2023, we recognized a partial settlement of the pension plan and recorded $10,425, in selling, general and administrative expenses in our consolidated statement of operations, resulting from the recognition of net pension losses previously included in Accumulated other comprehensive loss.

5101000

3547000

216000

260000

147000

68000

1000

5645000

3695000

1081000

628000

-4564000

-3067000

6431000

6051000

2440000

2399000

8871000

8450000

26381000

10425000

4. Balance Sheets—Additional Information<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Inventories</td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Raw materials </td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 84,369</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 84,328</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Work-in-process</td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 25,159</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 22,350</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Finished goods </td><td style="vertical-align:bottom;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 169,626</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 170,892</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 279,154</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 277,570</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">ROU operating lease assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 36,320</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 35,759</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Deferred income taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,981</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,711</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,617</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Insurance investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,096</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,067</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Equity method investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,814</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,027</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Derivative instruments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Debt issuance costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 1,284</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 1,408</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,031</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 81,305</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 81,845</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Accrued expenses and other current liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Employee related</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 26,647</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 29,359</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Current operating lease liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,053</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Commissions and rebates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 3,442</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,833</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 4,643</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 5,032</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Income and other taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,663</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Insurance-related</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 1,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 1,284</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Insurance premium financing</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 2,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 4,769</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 70,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 79,852</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.95%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Other liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">Long-term operating lease liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 29,022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 29,077</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Long-term and deferred income taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"> 12,823</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"> 12,146</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">Supplemental retirement benefits, deferred compensation and other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 6,628</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 6,552</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">U.S. pension plan</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,687</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"> 2,286</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">International retirement plans</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 4,130</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 4,210</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Other long-term liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,092</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,076</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,347</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Accumulated other comprehensive loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Derivative instruments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 22,698</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 24,589</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency translation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> (118,622)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> (115,062)</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Unrecognized net pension losses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> (12,927)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> (23,996)</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Income tax (provision) benefit</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,005)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 259</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (110,856)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (114,210)</td></tr></table>

84369000

84328000

25159000

22350000

169626000

170892000

279154000

277570000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">ROU operating lease assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 36,320</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 35,759</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Deferred income taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,981</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,711</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,617</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Insurance investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,096</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,067</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Equity method investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,814</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,027</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Derivative instruments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 8,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Debt issuance costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 1,284</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 1,408</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,031</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 81,305</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 81,845</td></tr></table>

36320000

35759000

8981000

8711000

6518000

6617000

6096000

6067000

5814000

5027000

8500000

10225000

1284000

1408000

7792000

8031000

81305000

81845000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Accrued expenses and other current liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Employee related</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 26,647</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 29,359</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Current operating lease liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 6,053</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Commissions and rebates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 3,442</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,833</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 4,643</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 5,032</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Income and other taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,663</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Insurance-related</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 1,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 1,284</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Insurance premium financing</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 2,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 4,769</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 70,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 79,852</td></tr></table>

26647000

29359000

6452000

6053000

3442000

5833000

4643000

5032000

5951000

8663000

1364000

1284000

2898000 4769000

19592000

18859000

70989000 79852000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.95%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Other liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">Long-term operating lease liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 29,022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 29,077</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Long-term and deferred income taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"> 12,823</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"> 12,146</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">Supplemental retirement benefits, deferred compensation and other</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 6,628</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 6,552</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">U.S. pension plan</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,687</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;margin:0pt;padding:0pt;"> 2,286</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;">International retirement plans</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 4,130</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;margin:0pt;padding:0pt;"> 4,210</td></tr><tr><td style="vertical-align:bottom;width:71.65%;background:#cceeff;margin:0pt;padding:0pt;">Other long-term liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,092</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,076</td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,347</td></tr></table>

29022000

29077000

12823000 12146000

6628000

6552000

1687000

2286000

4130000

4210000

6092000

6076000

60382000

60347000

22698000

24589000

-118622000

-115062000

-12927000

-23996000

2005000

-259000

-110856000

-114210000

5. DebtTerm Loans and Revolving Credit FacilitiesIn April 2021, we entered into an amended and restated credit agreement (the “2021 Credit Agreement”) under which we had a term A loan in an aggregate initial principal amount of $300,000 (the “2021 Term A Loan”) and a revolving credit facility under which we could borrow up to an aggregate amount of $250,000, subject to the terms of the 2021 Credit Agreement (the “2021 Revolver”). In November 2022, we amended the 2021 Credit Facilities to increase the revolving commitments under the 2021 Revolver to an aggregate amount of $310,000 and to adopt Secured Overnight Financing Rate (“SOFR”) as the reference for the fluctuating rate of interest on the 2021 Credit Facilities, replacing the London Interbank Offered Rate (“LIBOR”) reference rate. In June 2023, we obtained an additional incremental term loan (the “2023 Incremental Term Loan”) in the amount of $50,000 (the 2021 Revolver, the 2021 Term A Loan and the 2023 Incremental Term Loan are collectively referred to as the “2021 Credit Facilities”).The 2021 Term A Loan and the 2023 Incremental Term Loan are repayable in quarterly installments, with the balances payable at maturity. The 2021 Revolver contains a letter of credit facility. The interest rate per annum applicable to the 2021 Revolver and the 2021 Term A Loan is based on a fluctuating rate of interest plus an applicable rate equal to 1.50%, 1.75%, 2.00% or 2.25% in the case of adjusted SOFR rate loans and 0.50%, 0.75%, 1.00% or 1.25%, in the case of base rate loans. The interest rate per annum applicable to the 2023 Incremental Term Loan is based on a fluctuating rate of interest plus an applicable rate equal to 2.00%, 2.25%, 2.50% or 2.75% in the case of adjusted SOFR rate loans and 1.00%, 1.25%, 1.50% or 1.75% in the case of base rate loans. The applicable rates are based on the First Lien Net Leverage Ratio (as defined in the 2021 Credit Agreement, as amended). The 2021 Credit Facilities mature in April 2026.The 2021 Credit Agreement requires, among other things, compliance with financial covenants that permit: (i) a maximum First Lien Net Leverage Ratio of 4.00:1.00 (or, specifically with respect to the test periods ending September 30, 2023, December 31, 2023, March 31, 2024, and June 30, 2024, a maximum of 4.25:1.00); and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis. The 2021 Credit Agreement contains an acceleration clause should an event of default (as defined in the 2021 Credit Agreement) occur. As of September 30, 2023, we were in compliance with the financial covenants.As of September 30, 2023, we had $154,000 in borrowings drawn under the 2021 Revolver and had outstanding letters of credit of $2,479, leaving $153,521 available for further borrowings and letters of credit under the 2021 Revolver, subject to restrictions in our 2021 Credit Facilities. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are all less than one year.Interest RatesInterest rates as of the balance sheet dates and the weighted-average rates for the periods presented were:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.13%;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;">September 30,</td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.13%;margin:0pt;padding:0pt;">Ended September 30,</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">2021 Revolver</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;">6.23</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;background:#cceeff;margin:0pt;padding:0pt;">6.09</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;background:#cceeff;margin:0pt;padding:0pt;">6.19</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;background:#cceeff;margin:0pt;padding:0pt;">3.92</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;">2021 Term A Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;">2.37</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">2023 Incremental Term Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;">7.66</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;background:#cceeff;margin:0pt;padding:0pt;">7.44</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;background:#cceeff;margin:0pt;padding:0pt;">7.57</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;">2022 Term Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;">7.42</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;">7.25</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;">7.43</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td></tr></table> Interest rates as of the balance sheet dates are based on rates in effect as of those dates, including SOFR fluctuating rates of interest, applicable rates and the interest rate swap agreement.In March 2020, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converted the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increased to a notional principal amount of $300,000. In November 2022, we amended this agreement to convert the floating portion of our interest obligation to SOFR. The agreement effectively converts the floating portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.61% through June 2025. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 9 — Derivatives.”Other Long-Term DebtIn September 2022, we entered into a credit agreement (the “2022 Term Loan”) in the amount of $12,000, collateralized by certain facilities. The 2022 Term Loan matures in September 2027. The interest rate per annum applicable to the 2022 Term Loan is based on a fluctuating rate of interest, at the Company’s election from time to time, equal to either (i) one-month adjusted SOFR plus 2.0%, or (ii) a base rate determined by reference to the greater of (a) the prime rate and (b) the Federal Funds Effective Rate plus 0.5%. The 2022 Term Loan is repayable in monthly installments of $35, with the balance payable at maturity. Maturities of Long-Term Debt<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">2021 Term A Loan due April 2026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;margin:0pt;padding:0pt;"> 270,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 273,750</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;">2023 Incremental Term Loan due April 2026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 48,750</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 50,000</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">2022 Term Loan due September 2027</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,580</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,685</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 330,330</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 335,435</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">Unamortized debt issuance costs </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> (1,463)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> (1,599)</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 328,867</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 333,836</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">Less: current maturities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (24,150)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (22,295)</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 304,717</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 311,541</td></tr></table>

300000000

250000000

310000000

50000000

0.0150

0.0175

0.0200

0.0225

0.0050

0.0075

0.0100

0.0125

0.0200

0.0225

0.0250

0.0275

0.0100

0.0125

0.0150

0.0175

4.00 4.25 3.00

154000000

2479000

153521000

P1Y

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.13%;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;">September 30,</td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.13%;margin:0pt;padding:0pt;">Ended September 30,</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">2021 Revolver</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;">6.23</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;background:#cceeff;margin:0pt;padding:0pt;">6.09</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;background:#cceeff;margin:0pt;padding:0pt;">6.19</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;background:#cceeff;margin:0pt;padding:0pt;">3.92</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;">2021 Term A Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;">2.36</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;">2.37</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">2023 Incremental Term Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;">7.66</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;background:#cceeff;margin:0pt;padding:0pt;">7.44</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;background:#cceeff;margin:0pt;padding:0pt;">7.57</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.5%;margin:0pt;padding:0pt;">2022 Term Loan</td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;">7.42</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;">7.25</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.36%;margin:0pt;padding:0pt;">7.43</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:6.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.03%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">2021 Term A Loan due April 2026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;margin:0pt;padding:0pt;"> 270,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 273,750</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;">2023 Incremental Term Loan due April 2026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 48,750</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 50,000</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">2022 Term Loan due September 2027</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,580</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,685</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 330,330</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 335,435</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">Unamortized debt issuance costs </td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> (1,463)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> (1,599)</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;margin:0pt;padding:0pt;"> 328,867</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 333,836</td></tr><tr><td style="vertical-align:bottom;width:71.92%;background:#cceeff;margin:0pt;padding:0pt;">Less: current maturities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (24,150)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (22,295)</td></tr><tr><td style="vertical-align:bottom;width:71.92%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 304,717</td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 311,541</td></tr></table>

0.0623

0.0609

0.0619

0.0392

0.0236

0.0237

0.0766

0.0744

0.0757

0.0742

0.0725

0.0743

150000000

0.0062

300000000

0.0061

12000000

0.020

0.005

monthly

35000

270000000

273750000

48750000

50000000

11580000

11685000

330330000

335435000

1463000

1599000

328867000

333836000

24150000

22295000

304717000

311541000

6. Related Party TransactionsCertain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to the Company as employees or consultants and received aggregate compensation and benefits of approximately $438 and $780 during the three months ended September 30, 2023 and 2022, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

438000

780000

7. Stock Incentive PlanRestricted Stock UnitsIn July 2023, our Board of Directors approved the grant of 300,000 restricted stock units (“RSUs”) to an officer of the Company, pursuant to the Company's 2008 Incentive Plan and the RSU award agreement. Each RSU represents the right to receive a share of our common stock upon vesting. The RSUs are subject to performance-based vesting. The RSUs will vest on June 30, 2027, subject to continuation of employment on such date, in increments of 10% (but no less than 20%) (with linear interpolation between increments) based upon the arithmetic average of the Company’s closing stock price per share for each trading day in the 90-calendar day period ending on the vesting date (the “90-Day Average”). None of the RSUs will vest if the 90-Day Average is below $20, and 100% of the RSUs will vest if the 90-Day Average is $60 or above. In the event of a change in control of the Company, following which either (i) 100% of the shares of stock cease to be traded on a nationally recognized stock exchange and the Company is no longer listed on any such exchange or (ii) a Qualifying Termination occurs within 12 months, all unvested RSUs will immediately vest in full.We used a Monte Carlo simulation model to determine the grant date fair value of the RSUs. Assumptions used by the model were based on information as of the grant date and included a risk-free rate of return, expected volatility and an expected dividend yield. The risk-free rate of return is based on U.S. treasury yields for bonds with similar maturities. Expected volatility is based on the historical volatility of the Company’s common stock. The expected dividend yield considers estimated annual dividends and the closing share price of the underlying common stock. The total grant date fair value of the RSUs was $1,284, equivalent to $4.28 per share. We will recognize the total grant date fair value of the RSUs as stock-based compensation expense on a straight-line basis over the vesting period. Stock-based compensation expense related to the RSUs was $81 for the three months ended September 30, 2023. We expect stock-based compensation expense related to the RSUs will be $321 in each of the years ending June 30, 2024, 2025, 2026 and 2027.

300000

0.10

0.20 P90D 20 60 1 P12M 1284000

4.28

81000

321000

8. Commitments and ContingenciesEnvironmentalOur operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination, and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the period during which such costs are likely to be incurred are difficult to predict.While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based on our experience, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of the Santa Fe Springs, California facility of our subsidiary, Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has entered into a settlement agreement with a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling (“OPOG”) to remediate the contaminated groundwater that has migrated from the Omega Chemical Site in accordance with a general remedy selected by the EPA. The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that any groundwater contamination at its site is localized and due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. PAHC and Phibro-Tech have vigorously contested this position and have asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. In 2014, several members of OPOG filed a complaint under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and the Resource Conservation and Recovery Act in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. In August 2022, the United States Department of Justice (the “DOJ”), on behalf of the EPA, sent Phibro-Tech and certain other PRPs a pre-litigation notice letter regarding potential CERCLA Sec. 107 cost recovery claims seeking unrecovered past costs related to the groundwater plume affected by the Omega Chemical Site, along with a declaration allocating liability for future costs. In February 2023, the plaintiffs in the OPOG lawsuit and certain defendants in the OPOG lawsuit, including Phibro-Tech, signed a definitive settlement agreement that provides for a “cash-out” settlement, with contribution protection, for Phibro-Tech and its affiliates (as well as certain other defendants) releasing Phibro-Tech and its affiliates from liability for contamination of the groundwater plume affected by the Omega Chemical Site (with certain exceptions), including past and future EPA response costs that were the subject of the August 2022 pre-litigation notice letter sent by the DOJ on behalf of the EPA. As part of the settlement, Phibro-Tech also resolved all claims for indemnification and contribution between Phibro-Tech and the successor to the prior owner of the Phibro-Tech site. The definitive settlement agreement contemplates cash payments by Phibro-Tech and one of its affiliates over a period ending in February 2024. The definitive settlement agreement is subject to formal approval by the EPA, the DOJ and the district court.Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, including the remaining liability for the OPOG lawsuit described in the preceding paragraph, to be approximately $8,531 and $8,505 at September 30, 2023 and June 30, 2023, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries are liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.Claims and LitigationPAHC and its subsidiaries are party to various claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

140

8531000

8505000

9. DerivativesWe monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in Accumulated other comprehensive loss.We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 10 — Fair Value Measurements.”In March 2020, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converted the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increased to a notional principal amount of $300,000. In November 2022, we amended the March 2020 interest rate swap agreement to convert the floating portion of our interest obligation to SOFR. The agreement effectively converts the floating portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.61% through June 2025. We have designated the interest rate swap as a highly effective cash flow hedge.The consolidated balance sheet includes the net fair values of our outstanding foreign currency option contracts within the respective line items, based on the net financial position and maturity date of the individual contracts. The consolidated balance sheet includes the net fair values of our outstanding interest rate swaps within the respective balance sheet line items, based on the expected timing of the cash flows. The consolidated balance sheet includes assets and liabilities for the fair values of outstanding derivatives that are designated and effective as cash flow hedges as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Other current assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 333</td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 14,198</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 14,031</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 8,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Total Fair Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 333</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 22,698</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 24,256</td></tr></table>Notional amounts of the derivatives as of the balance sheet date were:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.97%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.4%;margin:0pt;padding:0pt;">September 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:83.97%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.94%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"> 300,000</td></tr></table> The consolidated statements of operations and statements of comprehensive (loss) income for the periods ended September 30, 2023 and 2022 included the effects of derivatives as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">(Income) expense recorded in consolidated statements of operations</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (181)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 438</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Consolidated statement of operations - total cost of goods sold</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 163,623</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 163,875</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Expense recorded in comprehensive (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 168</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Income recorded in consolidated statements of operations</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (3,570)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (1,211)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Consolidated statement of operations - total interest expense, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 4,564</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 3,067</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Expense (income) recorded in comprehensive (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 1,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (7,273)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr></table> We recognize gains and losses related to foreign currency derivatives as a component of cost of goods sold at the time the hedged item is sold. Inventory as of September 30, 2023, included realized net gains of $1,182 related to matured contracts. We anticipate the net gains included in inventory will be recognized in cost of goods sold within the next twelve to eighteen months.

150000000

0.0062

300000000

0.0061

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Other current assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 333</td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 14,198</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 14,031</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 8,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Total Fair Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.07%;background:#cceeff;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"> 333</td></tr><tr><td style="vertical-align:bottom;width:74.07%;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 22,698</td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"> 24,256</td></tr></table>Notional amounts of the derivatives as of the balance sheet date were:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.97%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.4%;margin:0pt;padding:0pt;">September 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:83.97%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.94%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;background:#cceeff;margin:0pt;padding:0pt;"> 300,000</td></tr></table>

333000

14198000

14031000

8500000

10225000

333000

22698000

24256000

300000000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Brazil Real options, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">(Income) expense recorded in consolidated statements of operations</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (181)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 438</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Consolidated statement of operations - total cost of goods sold</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 163,623</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 163,875</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Expense recorded in comprehensive (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 168</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Income recorded in consolidated statements of operations</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (3,570)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (1,211)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;background:#cceeff;margin:0pt;padding:0pt;">Consolidated statement of operations - total interest expense, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 4,564</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;background:#cceeff;margin:0pt;padding:0pt;"> 3,067</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:74.9%;margin:0pt;padding:0pt;">Expense (income) recorded in comprehensive (loss) income</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> 1,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"> (7,273)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td></tr></table>

181000

-438000

163623000

163875000

-333000

-168000

3570000

1211000

-4564000

-3067000

-1558000

7273000

-1182000

10. Fair Value MeasurementsShort-term InvestmentsOur short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.Current Assets and Liabilities We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items. Debt We record debt, including term loans and revolver balances, at amortized cost in our consolidated financial statements. We believe the carrying value of the debt is approximately equal to its fair value, due to the variable nature of the instruments and our evaluation of estimated market prices. DerivativesWe determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.Non-financial AssetsOur non-financial assets, which primarily consist of goodwill, other intangible assets, property and equipment, and lease-related right-of-use (“ROU”) assets, are not required to be measured at fair value on a recurring basis, and instead are reported at carrying value in the consolidated balance sheet. Assets and liabilities may be required to be measured at fair value on a non-recurring basis, either upon initial recognition or for subsequent accounting or reporting, including the initial recognition of net assets acquired in a business combination. These fair value measurements involve unobservable inputs that reflect estimates and assumptions that represent Level 3 inputs.Fair Value of Assets (Liabilities)<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:38.21%;background:#cceeff;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 48,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 40,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:38.21%;margin:0pt;padding:0pt;">Foreign currency derivatives</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:38.21%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 22,698</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 24,256</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr></table> There were no transfers between levels during the periods presented.

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:38.21%;background:#cceeff;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 48,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 40,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:38.21%;margin:0pt;padding:0pt;">Foreign currency derivatives</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:1.13%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:38.21%;background:#cceeff;margin:0pt;padding:0pt;">Interest rate swap</td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:top;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 22,698</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;background:#cceeff;margin:0pt;padding:0pt;"> 24,256</td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.13%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr></table>

48000000

40000000

333000

22698000

24256000

11. Business SegmentsWe evaluate performance and allocate resources, based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and (e) certain items that we consider to be unusual, non-operational or non-recurring.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Net sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 160,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 154,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 56,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 59,646</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,793</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,016</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation and amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 7,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,911</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 646</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 655</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 426</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 442</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,421</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;">Adjusted EBITDA</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 28,494</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 26,964</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 2,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,297</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,409</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,364</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 34,625</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Reconciliation of income before income taxes to Adjusted EBITDA</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">(Loss) income before income taxes </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> (11,979)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,417</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Interest expense, net </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 4,564</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 3,067</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Depreciation and amortization – Total segments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,421</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,008</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation and amortization – Corporate </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 442</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Corporate costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 14,133</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 12,491</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Pension settlement cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 10,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Stock-based compensation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 81</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency losses, net </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,200</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Adjusted EBITDA – Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 34,625</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Identifiable assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"> 679,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"> 698,522</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> 74,060</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> 75,814</td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> 49,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> 49,678</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> 803,934</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> 824,014</td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Corporate </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 160,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 147,383</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 964,523</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 971,397</td></tr></table> The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax-related assets and certain other assets.

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three Months </td></tr><tr><td style="vertical-align:bottom;width:71.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">For the Periods Ended September 30</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Net sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 160,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 154,859</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 56,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 59,646</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,793</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,016</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 231,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 232,521</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation and amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 7,349</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 6,911</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 646</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 655</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 426</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 442</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,421</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.59%;margin:0pt;padding:0pt;">Adjusted EBITDA</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 28,494</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 26,964</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 2,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,297</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,409</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,364</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 34,625</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Reconciliation of income before income taxes to Adjusted EBITDA</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">(Loss) income before income taxes </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> (11,979)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 5,417</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Interest expense, net </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 4,564</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 3,067</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Depreciation and amortization – Total segments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,421</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 8,008</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation and amortization – Corporate </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 442</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Corporate costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 14,133</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 12,491</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Pension settlement cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> 10,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Stock-based compensation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> 81</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:71.59%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency losses, net </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,200</td></tr><tr><td style="vertical-align:bottom;width:71.59%;margin:0pt;padding:0pt;">Adjusted EBITDA – Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 34,625</td></tr></table>

160530000

154859000

56026000

59646000

14793000

18016000

231349000

232521000

7349000

6911000

646000

655000

426000

442000

8421000

8008000

28494000 26964000 2881000 5297000 1409000 2364000 32784000 34625000

-11979000

5417000

-4564000

-3067000

8421000

8008000

450000

442000

14133000 12491000

10425000

81000

-6689000

-5200000

32784000 34625000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Identifiable assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Animal Health </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"> 679,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"> 698,522</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Mineral Nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> 74,060</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> 75,814</td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Performance Products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> 49,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"> 49,678</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Total segments </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;margin:0pt;padding:0pt;"> 803,934</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;margin:0pt;padding:0pt;"> 824,014</td></tr><tr><td style="vertical-align:bottom;width:73.85%;margin:0pt;padding:0pt;">Corporate </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 160,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 147,383</td></tr><tr><td style="vertical-align:bottom;width:73.85%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 964,523</td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 971,397</td></tr></table>

679935000

698522000

74060000

75814000

49939000

49678000

803934000

824014000

160589000

147383000

964523000

971397000

EXCEL 76 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
_2"MOKXU>"4.W@8U^ ML*@,#>:RDHSRR1J<9H"SM[^HF;T^M)B]A/\C3BU#[>8K'@K")S\H4XD'+LA:R M3,6C>M+Y4U8NQ%NCTLR*>YED>68S58MWI;BK3):3A@-/K)10I56X)K+2:H + MB5B#-1D3*%EIL4@<(KDP2N',[D8-G$&:R"T N0 QKL"IS 3;+)*OP2Q:Z 4T]%Z\BW_=\ MW]^E_]EA)"WTI$D$"2$Z=;12S)TZGK=92W23IV*F#5FTJ42KCYZQ 1MAS&QX MR&*S/Y!9Z"YQ1'+5=(,6>_6RR[DSES(=VV,RTK_TDRIFX Y70K939Y=MS /C M@@FH#$FY5GQM(+DNBLP2_;J5ND?3D7])W"AP6B>%TK545U9\4DE#CO,!P"5E M/7&?E1(F [U'0G#<2OGIP_WCVB9UR]H<7E.X@/Q@ ,4$KLGZ)KWB-SLUN_26C2.@6U_KH[4GGCGI!@J/ M!UZ^825OK8>!QSO#N(,#Q(0TY.$YU\$GE3\[D4DM9%%GE3T!O5;SVC\__PT6 M8"KY+&,;"9S>!1(1CWS\2")-P',9'G;#AG^?ZD;UH;G M=$&/N-/-]#MU$SA$K2Z"#E&P#]%>U6RQ6+-_]W(2^'UF(-)#II#0T5D_*'@0 M>EQ*1)D6QX@Z=(Z<5;+=!->7#(_"LTW_P^C;+0 <&AQ9?9$_V[F_+D4&2LT, M)5"D'AA#@P5*QC ,]E S(!^%GXO'N)R*8XSI'?J M2K,"#O*R[-#I!/J_)".(8XV\5E;09XYTP 3!6;516VNFE>FT1M>2DON@ M8;2N3G9=HX>6*&FW@F[KO30H\>UZXK'Y.;VW4+35,\ZLA3&S=G+%=X\S)QI: M$[K1.RLI@H4RG5!1)Y0GE 1-B),T.?=0[/O62!@+G,]U8UZW^8^<)JMW+;NV MU#JOT0238)IABJ5(LE]RXXA9I=#6EGDF_VLA.A$Q3TL;CC!F:?9E$& M5\KYU[9S< 7?=9"O8*-F\%403[C8 :OKOJ&\P67 M\.M!QN=.S9M,+SP<2FZ$0"WR8J"23S $QRXU(//&L.\/&" 2NR@/,+31"))K MF(S'S9JD@J4/!.Q8_-YU%GMHL9K+LAU<6I%7Z6JY##,== MM]CE 1Z&2@HO\LQ+[F#\Z.K_YOEYB?#JQN3MP\VHZ!-2=\Q3]=:E;11<=/G? MQLY@$0X7@Q Z&^/>$1[^!3\">D3CBQ"/G>:F1S&.SNCG#E%IPS$- M7)0KG7RQV?A43NQ@+ ;&%'$ZX$ W5CH MFOU] NS.V%^=0S;=;?C9LLU[TSV*/#3:L[ M909'H&)TLUCV(V L/G#*Q&2Y>,VNR.]=!MZUCM)>49L>]M57*.$W#89!Z-X[ MT"0'EHW,L_^ QNRY+PWS075I&XIA^+@6D>O2!L_3'VCWPQ]J\3T:X@C#6_00 MLGSF6)U>H:?KWM'.C2Z$S0I'"T]OW?ZKC"U!O28*SNN",NM6G\\C!,8$=/7: M=+W;NH-/%14W[H=FSX/!OY4+]I'MX'@L3URQ,<0+ W,W.'/;]RHE XA[- 6U M^+5S5_>:@9G ^'6TUPK0UL8@S&)LC<$N%N/=:7C_,-PYXWNW0^, $!SPV+_[ MW%^4^@KFFKY#%2G:K2]IHX8C2W?YE0BG+G:'.Y$WC?V7RLP!;-US1-=VW6S--@.MPA+4P"L>_-^.G@@T2AS((_N]3TGK6T M[MM$O]M_V;ES'S36U]UG(53O!GEXNQ]P\./R5N[<$9O)*U,4_^#=)0HL/PLG MYE,R6R#OS6C^$*2&:"8GM?]3'AWQ6\EQ;OZ M7"8PTJ0V\%W$MJ*4"\[C1WC M>Z\XVV,M.JST':P1W!OM*@O7.L?\[_B8>?7DTA=RB_0HX",V0Q@E TB3='0$ M;]2+'06\T7\1VV&-W\;RPW)I&Y'A+.)IL$@;C.8?/YR>)Y^.,!WW3,?'T/^1 MZ7&L\R&\#P=+),>SRP/&+CP@%DP!7T7V!,LA+%#G%4HU -,2+"LA>1#T %:L M6.:H'0B=LUUB =?/F+4> ;X5A@90K9'Z?@N1?$@'3,,V M&-9'O1O"/;T6!BJ68$V-(%I7&9)<7M:X,3N%8 M\>< R3OP^\*P^OW%)^@_,/,_4$L#!!0 ( !J#:%<>]]0MO 4 (,- 9 M >&PO=V]R:W-H965TUE>>WH8=2JDKM$$["QYGI[WST;N+ UXO"_[4N I;S\">3)V[XY>/Y6DO M8T)HL(B,H.C?$M^C,0Q$-+ZVF+UN2S;GO4D/ M2IRIQL1KM_H56W_>,E[A3)!?6*6U.>U8-"&ZJC6F]TK;]%]]:W78,IADSQCD MK4$NO--&PO)2175VXMT*/*\F-'X05\6:R&G+0;F)GF8UV<6SF^B*._AH"[0L M#UP994^&D9!Y?EBT*!<))7\&90R?G(V+ !]LB>5#^R$QZFCE&UH7^8N -U@/ M8)SU(<_R\0MXX\[-L>"-_Z>;">7@:10ND'>A5@6>]J@" OHE]L[>O!H=9LW=DBSC F'NE8T\/\ZR?I9E5)H=-#P^BT;&OBIT#TLLECCY1-A&@# M4"LFK>8>D3I&', '52QDQJ.$RA(C7NRY2AF??$.&4A 6RB-S8>\+5U74+%I' M:GIU%O]V!WI>,".$^4)ZN(OG8F;3'%N$+:1.,K"_)Z#RQVZ3: 'YWMN/Z* AZMMEWRQ)T M($'HE(*=G(+#Z37*2-;_"+%SF 'YJJ94,0.N+UZ&2TQ%HZ"@P/!**]'VU/$? ME\',&6+!OJX6FA1#B@#IN*OW'A 2727X2?$"*7*<15,4D2F*?.R!E5@K0U5. M2>_F5O_=E2I^:^ELBJDEP8YP)CF:\Y0[(;9H-"5IV!DZ)D;,%/S1**-G:^;] M&3V=56T:%P65-7 2DL^C'"HY*DA@DK*Q+"9AWZNKJPI+34$FODEI"[/&F %\ M06@X-Y6<-L15>>,@Z*IIT[ER)1I6H,0H#'"K8TG>S)3VL%2F>9 9 S@/="NI M&22D/:9KF4V(*Z0$3G7AN%C274@N%6&#L[4):TD599I2R'H=[O9GU)G \RRM M]Q@;;_LD8HW2-Y=2D$;'M1A3Y793I5[JDBH!UAI-F5K*4! M)47CU\DZ2!5.G2U3/%@[;:CHR)N&ZEPC2?'A"5+;N.SL@A+"48$KL[WJN;ZP MU5(3_V>C0B<'O6 MWOL\&4F:B L+3K)4L-R.^?* =<1J2KMNKF?B?PKI]QUYF.W(UV7QCG MZ6)]OSQ]GGQ2?JZI.QB)S4MTM5RSIR[2I5T>%_25A)X7T/S, MN;AYX0VZ[ZZS?P!02P,$% @ &H-H5R:3+3;Y#0 +2< !D !X;"]W M;W)K&ULO5IM;QLW$OXKA'LH$F CRR]I@SHQX*C- MI;T6,>SV^IG:I21>N.26W)6B_OI[9DCNBRP[U_;N@""6=LGAO,\S0[W>.?\Q M;)1JQ:?:V/#F9-.VS3>GIZ'W)]6M^=NNO7[NN-=JJ6R]"5]?2[]\JXW9O3LY.\H,[O=ZT].#T^G4C MU^I>M;\TMQ[?3GLJE:Z5#=I9X=7JSK%LH8(@0V?DLT3_HC:>/X)7E>$KW2F<#_BUU<>S$_$6476E>GS>"@UC;^E9^2 M'D8;7CVVX3QM.&>^XT',Y;>RE=>OO=L)3ZM!C3ZPJ+P;S&E+1KEO/=YJ[&NO M%ZZN=0LMMT%(6XF%LZVV:V5+K<+KTQ9'T,+3,I%[&\F=/T+N0OP$ IL@OK.5 MJJ;[3\%:S]]YYN_M^9,$[U4S$Q?S0IS/SR^>H'?1RWO!]"[^6_)&1G%?KSD3RA="V-%T%9D2[<4&)M=LJ;^E[XXSI:-45 M,="F>'8K+%1"#3Q?\8,NX-!:6J04>EBDDXQ"[-*FC?Q=^LIU 8M:Y;4T.!R2 M@%U;JLC83H96A2LAM1>JUH%2$+ZNO5)V@ZW@3H;QFQV1BD>'KFG,GLE4&DE4 M^C61(M:TW:K0ZK6,"8GYJE6E91:HA#DDHEQ&:6D/).E6R%V=!VT0;+U>LC*B M8$$:EBJI4E5CJ0:5-G1NJ:N>D[IQGBQ?P'+I(]-KO;2!'O0\0>555[:D#7J/ MS1LE3;M)QZ]4NZ=EKB-5-<;M%93X#'F)$^]6F7TAOOSBU?GY_&KJ7S_"#?C% MV=7SF;@)T%RY*?@$* #R9K)EYSVV9!^JU<0OB?^ (V%0^"'M]CI\9&T:J>N MA IF$9Q-3+0TJA:Z)"85=5,_,.Z'H3PHR%]\("5R23Q*SYJ/ZP& 2&$%?T)'N/ M0A++4N QQ3/+,PKWZ&XK[VK1 O:P,]-?. 8#>F&A,H#J(C$PV*.X[] MIQ,,JV\FOK>45/98W#L@YTTX/>6.I.5'Y6^UBA8H;8E%* M%$'[W9DDXDW%!-7 +>G.+UV5B-7T6*U M CLM!X&L*OA9F+JGD"&X4K.;L78W"!)L+<>V2369684Y86>U=>Q2P 8$"Y"H MR(IN#ETUC_.!*M1J,8K2#,:SZ'4YM> M[8\$Q.I;3PE^S$<4_*\ZB,#%%6*RH]4 YBP!,. MJ>*1CC!4ZQF M2,T).C?Q.OAKQV7Q%(VFOC@! A/H6=CD0K.0Z/T/(@S$S__ MKTOKT40?$56O*/@1,; C]1I#L193PSB.LUZ0Y4@^B M U(7#_()R9&U^4!)D7!? 8ZED$/&*(P_6 M@RYD!3\+@P]%\0!5P"R]AX%T#F^NEVS9D=^4$F5CA=Z;*Y31_&,-)>AW.U-QFX$/$:I)@%)5"3+Z'V5'/( ZKK5 MBM+$*,F D;5W",D(IME6&\!L0"//;V/*!JD/M5I+L=@ @%-OL7 >B#52ON\@ M^PI$Q#U1?Y;8/=A![S+[1:I=D"+" DT!D3+9/0PGQ3M\:"A,H<^%-!HB62TS M=.CA;Y^6D;AO-WKIW8N?%4':[VTYZUD9O1G0+QD#*F5Y<;R**(9RL0BJ;0T' MMY#4@/ G]E+)^FJR TO+((;4%FA-F:3M@_>($M@Z#-O0R23+H0SN2T/?>NW= M?OA[;VT0&U!-S#1_V8+,BJ893>E\-<0A)%26NLEXY%[$<4Z$VFW4V51Y5F+= M6/LL4L;=#GL.RB>4=WOS?H&T-$ TL^>D1D6+"A9C;6IJL@7O;OO&!?B'$<18 M[FG=9)D/C'[V]55XX%N#/_6* RL*=1W\E-2XV[7)U?=1I3^E8L9^]ZH!8%QB MZ?G\[+S(:F30L])4FAHXQ"?&@CCX['(N2. Q_#]4+Y%XJ-JB3[?[,3**A9@/ M>ESEJP$[3^ 2G326MC$=$)SDY#AXQ3'O2A6.1240%[CABO[.YZJ,C\?2,;JV M50HK0LV/&QH+=!MQ&B43GGOHWU.M3VZ209.<-'5,' #B144Q=:!=PFE_-,1& MB6P8V;#U98*7!666KJ2XCXT+6DK@3)3_G240$-/?F!66BYTRH >AH_CP&#SV M(.8(8<1F.7:RX&(+R\.'*E5;F+^4O4U):4-WE"MKFJ"HE>I-,^DI_[0GS(ZS MS!ZZU6L'FH$##I8/44P=^CH[X/RI&ACVCO7)+=)(H]R=#ZU]5L1^PL0?4@?; M$S%\62 M;CE+UAS8G-0H9P,G4,*0$=\0($UM'3&WP#.O-FEJ-ZW]=RDD"EZ% M):,.]<>>HQL DIP3%]_=+7X<($'."G<)Z].@D3K7H3&]4R6%8:2"U-P^@"/? M\K +;Q<@T?;AOP"+)&O_&L*.BK)<2VIL8XN;W1CY:Y1+#SN9/Y]4GAW-B<^9 M5W*@/*N#Q7?2 Q3)D+#V@#_#47X^.RK\"_X/M[GIUAU8.9^?IPIPH'I%-:]. M0.B'CH:':H+_OOWPPP"@P-%2;:199<:09(L(0IZNQ-$PG/I&8Z38?@NCJ'V@ MM@BJBW/@'!71VU#*@*O.YE]''.^S1R7@'93Z2-LZF]ZH9(!1,HG!^*=UB8@P M+O>N$N&)HQ,0A;NY,F:K(8;)+\:F9UN\4TO? 33R%4>T1@Q6#8B<0X/#F0;G MG6XGBN24 ,C4'EWZ2-6&+T'7L=F7V 6HL7KFN3 M(XSV%P-(Z4-@&-T73.;0,RCO0>50%+O@,U2:G4)7A+]3IQDD?I[F^LRR!L:BR/Y_,X ^"GY#(%'M$9>_@J:F>Q.N5Q-HH M9I^.& Z\Q"WB]&AX\L"=@KR?V8R,-]$E#5=I9,/C+'AU#B^N50?EG!US;/2E M:G>$^HXAQB?+Y2, )(+]S_GL:"8:8@/5;[5FI#L[4BJY*OX]KQ/+:49 T:)3.RK_+L1@9G>2S7SZR*-').Z_IA4DQ> MGF/PL^5I!/.#T_'^;Q);\=(B$&H>9OYIQED:OD[A;TD7VE0V[&M8- M991C>K3S\,("'$*^APGY07I%HBOAP7&>&AU3E2K%L(==9;,ITE1[VBS][57Q M\N*,>:./\Y<%%%E/ M1E'.YHX<\:HKMM]2&FZH^3<"J#CO\^PRI2%\X;DA^PIUT&HW=BY88R/M.@[@ MGIB+I;FC)M\ 7U!9.P*-/.K,Z!K1!/)E#(X&C):I$1]?GJ4[Z8)O>-846UX' ME<;3:4(^GH*F\=:@"\ZEB!M3D9WR0&TFWE$)0QIK.A^GFRG5T&5MQ_>Y/4C6 M%#9-[^+*!+7;*+ZUBF^]HJM2.!I";9./0C+.70$"J94?U= TT+?D4[FAX(56 MZ0B(J#6QQ*%].%;*TWZ2,O7(TXDC94\FDU)T37=<&1!SFO/1$HGRL7&(9[K1 M_Q(3[!E'UI)E\JV1V/Z&R^RQTY2Y,) UF^ZG&XFMSS#6!XB M92#"I^*D.)J(6%-4LI8I4#+[LD;*&U^ZH1JI'&Q9-LY@$9\N^5JN\W%>_^O! MY-JF4L4Q'C?3^"X5IZR?0B1G0G76@&T=3U>X6O-.N5X3IB;TRF/G_]_(F8#B M_.+H+V-.1S]AJI5?\P^UZ H*ZHN_9NJ?]K\%NXD_@1J6QQ^2_23]&DH$&EIA MZWSV]D+'=#_0N[ZWU!+ M P04 " :@VA7[CA2@"L' ;%0 &0 'AL+W=OB#=UL^T1-M$)=(C M*3O9K]_SDI(L'TG:K4 0233?ZWE/\F*CS1>[%,*Q^[)0]K*W=&[U:C"PV5*4 MW/;U2BC\,M>FY Z?9C&P*R-X[HG*8I#&\610!KT'+)92F4E5HQ(^:7 MO>ODU_+[&H4,PC1\A2&N"U.L=!'DM?^&.7UT8O6&& M=H,;O7A3/364DXJ<\LD9_"I!YZY^$4:N.2%C+P8.#&EYD-7$-X$X?81XR-YI MY9:6O5&YR'?I!U"DU29MM+E)GV3X2:SZ;!A'+(W3X1/\AJUU0\]O^-^L"\2C MX\24#J_LBF?BLH=XM\*L1>_JIQ^227S^A&JC5K714]R?4^UIXI_[K$///@M6 M:B6=-DQ7AHG[E;:5$.0_4S/F5L")V:D_6+[I%4N+(2# MZPXIQQ];BARTH.%>QXQ;)W+F#%>6AX0E:SQ+MN9&\IDLI'MHEK!_R>8H*5Z3 M&82*3(![3F0K+LDJOW%>.8+"B()[ 1H"L5Z MM X@&M13^!W-2UEJV60J_G]3HX@H7>0.#O Z4U@MO5>NS MVSG;$"W\CIH"W3I\X$]4N096KCHF><:1)Y4V0^I+58G&O"S3%:TL&H168*GS MQF%!=Y1S1_[&$G<=H5$(Q+(4N00BL+7U$7YY8)5"QRF\QQ:(->L]IHEEU[.' M?MD3TZ@&W:TN9.X)K<.#%+-$@7:'-"#0 OC>8[OAZ[I"CG&<\8*K3#!?EL$' M_8/Q/)?$EA>$.Y<%:;[@)B?$MOPB9H5@/_TP3=/X_+U&YB2Q_TS2<_:6MOWE MQ;Z#DQ#77NV^WYZV3W%-OMQ)=68W?,7XP@C/AR'G M7B3C.(KCF)!0NM9W9:3*Y IO'LXV'N EF+U&^A/\A'VAN8^ WV]O/MRQE38A MD>>^++6R]:R0"QY^4H$G+REX:&@Z]7%.MQ?Y+^V"<3?ZL@&!:F M$6BE[1@ -0T%;YWF1PS8RGDQC+VEGN5[O1;E#"D5V (X#H9Y;=86TZ?Q@] : MCUTTO@('D'[Z\/:NS_Z@5&DY'H':?C-O7ZHI!W4*=D_!O2"\H MN*J+$/5")I&Q-O+S6!Z"J)8I%522Y'-M99C[4%@PO56&:GM>VTC[)?18R[S" MYE9F_WM;>1@PC]FU*^=1*]'<04"1*4L2<- /O]X$W_M"OV^ZG\1R*,_BT+*M M53N#@,]?TVGVN6>Y;1OH]WO-T,\ 8N'Y]_MB2G2A72F4;)9]8%, M"]?>')HPP[\/H?GZ,'0-*/L\;PS_1Q;L#EVH#E0XAOS?;'C15NGMRG X1'4Y MJ!C-AF04)3]/NY_Q,*G5>42-YYY/2&N>TV@K21REE./:P3]O-]4]%#';=-].]-E_7J;MC[U-] [G\/N-W ZL31 M$P8A"NK:^[W#O'G^L42[:$YBS>+;.HD_^B&L/J'M&-!F0/IMSCSV/+E5&%[% MJ:].RNX.NE\U;'7P.DFFR6GG>S3W.^JEO_TT(3 J#+.UR3 MR3": (#=E>G9N%UY<]26[HA^0B/H*154&+^7]UV^6_V_(C\?3VTOY7\A.XS& M9_'I#M91FG30_B9\V]Y6>WV_((ZB\634A26*)V<'\)[(.G:^'>'H 73W'A^-$.#_XIG=P@#B820Z.K:285C4F1P*,A]G/'YGIQ;>[W'=R M)L,>FCC7X*#-0UVL=NL*Y674=&D,P,W!A\"M#S\87Y,HF:9=W?V,@]?.+/.9 M#D].TNCK1#NQ!!XM?TFG@D:?C<1)=R:Z)V3OC0,[.S.,$O
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
>]I%P5Q\XU#-*R? MB5LC$2W044VBFJ(T.QZF0._M617D1QV)NVZ0=#_?QGE%.WY4$Z@F44U1FIUJ MU -4$JDE44Y1F_STRIE+O/^UB(6Z^:8CZ.Q8+V?H]-72W M M4DJBE*L_-A6O7^GL5"'C$2GW(-$?=A-\X=>GM M(=)'RW%4"U!-H)I$-45I=CA,.=Y_VC5$W'SC$'5KKP=N_O(:NE.!:A+5%*79 MZ3#M>-_=CG_WN;;CNI[[L!NGCM0"5!.H)E%-49H=SK6_W?&XE47Z[-_=B!;< MJ"903:*:HC0['*;@[C_MRB)NOG&(ZE<6V?Z5-G2W M4DJBE*L_-A.N[^GI5% MOOMDVW5]SGW@C9.'WJ2.:@+5)*HI2K/C:3KV_G$+CO31JAK5 E03J"9135&: M'0Y35?>?=L$1-]\X1"_J9]O6:$/+:E23J*8HS?Z+K$U9/=BSXLCW'FV[KK.Y MC[MI[E M0#6!:A+5%*79Z315^>"XA4@&:%6-:@&J"523J*8HS0Z'J:H'3[L0 MB9MO'*(="Y%L76=#=RM03:*:HC0['Z:M'KC;ZD_Z-IG+V*MHW1?C:OD] M73]YT)8:U0)4$Z@F44U1FAT>4V8/>L=-'K1,1K4 U02J2513E&:'PY3) _=] MWN_#K]%T/O6^)&FQ;7F&&8?%[HI32VUDT(H9U0)4$Z@F!S5KB'2V?\E*]Q7@Y2JY6"S+6ON)H'UQIZ\^OT^_V_A>!:I)5%.49N?"U,$#=QW\89YG>1A?EO_AKTX!]4% Z]E*&UA!Z&W]!Q&@ M>Q6H)E%-49H=!%.\#O;$8F@IVN*>"79Q%LO(T4KV[2,R J4N-VVN:FDJS MWC[UAB\V9@JZ3X%J$M44I=EI,)7G<,_=P1LSQ?OF51\W:J. %J&H%J":0#6) M:HK2[,B8(G1XW#V[0[3@1+4 U02J2513E&:'P[2@0W<+NK@P%ZU=F"O.+O6G M$K3VW'-4'>]>AW7M:X >AD UB6J*TNQ@F(9SZ"S)SAY^NW(1D,6%7]]<[*T- M"%I]HEJ :@+5)*HI2K-38ZK/X7'WT0[1DA/5 E03J"9135&:'0Y3F X/+4P/ M62UU6--K^EMMUKE[GXVS<-!.!;I3B6J*TNP7V;2?0W?[N?6&8J;3*+F,QMXL MO"\?J7VMT2(4U8)*LZXS]#?S@):@J*8HSAT0U16EV9$P=.G3?D^I\ZTDL_%&;,K1K M1;4 U02J2513E&8E;V2ZUM%QRQV/T$H5U0)4$Z@F44U1FAT.4[V.GG:YX]%! M"Q2?NX^B<3K0EA75)*HI2K/385K6D?MVTWU#2Q;?D_/X,O/$U94>Y]%M=7-\ MHRGE/HC&)R*TLT4U@6H2U12EV5$SG>WHN$6(1VA%BVH!J@E4DZBF*,T.A^EM M1^[>]M%3:LEOWJC>[F^.*;2@136!:A+5%*4MXW&2W6B=!V$>GIU.=7JMS_5D MDGGCLE1[U2J'U^I1+]5717PZ+U_[K9.MQ\\[+X-.^?B)8S(B\M[TN2Y\ET\<>;(GPZ+7^@^/Y5DN0/7Y0[ MN$O2/Q:'??9_4$L#!!0 ( !J#:%=/5 <5%0, ,(- 9 >&PO=V]R M:W-H965T;/=T#986:YULO DFQW4@_8X33#6UB!_)$MN.K9%4M,$D@% M82GBL)E9M^[-W/4UP$3\)' 0)VVDI:P9>]2=AWAF.3HCH!!)38'590]SH%0S MJ3Q^EZ16]4P-/&V_L'\RXI68-18P9_07B>5N9EU;*(8-SJER N(Y6;+IAYL:@E1J2ZF5<2:[N$H63X3VL)?J 'E()'(1$2RQ!J(&5 M5(VX[%[=@\2$BG=36ZIG:J0=E?QW!;_7PK^";(!\YSWR',]O@,^[X5_RM UN M*Z657*^2ZQF^80O?$O:,[DFZ17,.,9'H$XX()?(9_4'%/>!-(CM9]:MV(S(< MPZ7QE.!5K@9[RFH$SX'7B";I$>;LJVD^S29>J)K*8[J'0'K_)AT*? GLAJ M L>5P'&O/APW^LOS@S,?_CNNENYUE>[U13[4WUNU*T0RVJQ,JEF9O,JEDSX%]D16$^@ZQ_W?Z=6G)=VY GF&^9;HKZ7 M%#8*Z S&:BOEQ8&AZ$B6F9I[S:2JX$USIPY9P'6 NK]A3+YT=!E?'=O"OU!+ M P04 " :@VA7T$PX-U\# E#P &0 'AL+W=O^S'SMU@+>2S6@!H\I+P5 V=A=;9I>NJ: $) M56P< @MT3PS2^N::CH:2+$F MTE@CFGFP:V.]D0U+S38^:HEO&?KIT35,-3DEMZD&"4J3!ZI!X<23Y0\Q&:] MXGX6+SY=@Z:,J\\#5V-T@^%&1:2K/%)P(%)([D2J%XI\36.(J_XN9EVF'FQ2 MOPH: 1\A.R.A=T("+PAK\IG\OWO0D$Y8KF1H\3H'\!Y@)?B*I7,RD1 S36YH MQ#C3K^0/R=^!K%NU1E1SBB]51B,8.GA,%<@5.*./'_R>]Z6.AA@Y3J"';:)-@26(5@MR38;=SA[R*=G^(Y2?">F.H3LMZ<$5J<$;8Y11(/ MRPD1.$TT7GIUJY*'\CT;RURVJY%WYO7\BX&[VB5<;Q=>!*5=A4NOY-+[!Q>: M*G)/7^F4 RKTAZ$U)F:Z+MM&L&/WL"6P"N]^R;O_)I'VVR38$EB%X'E)\/S] M1'I>*[X@[.V)])!=OUZD%R67BZ-$:BYZ_%1%$K"0T)3GJC56)%X"&6>2<6/4 MJ^/2&.K8'6X)K+(JOK?]9GMO$G'AUA+'MM"J)'<*$__]A%S$VE=HO]O?4W)S M4F\E'6Q)!XVD'R%:8O5 ;%EF!1]L15Y+K!'OZ"UO":W*?EM!^>';=-UJC=06 M6I7DMDKR&VN4EG7=J==U)]S7=:N%D[O3<"0@Y[8/4R02RU3G!7PY6_9Z8]OA M[,U?F1[0-C);F+R!O*-RSO#VYS!#2.^LCX60S'NR?*!%9MN:J=#8)-G'!?:Q M((T!OI\)H3<#$Z#LC$=_ 5!+ P04 " :@VA72J' 78P# #O$@ &0 M 'AL+W=O,/XD$ M0*+G+*5BXB12YN>N*Z($,BQ.6 Y4W5DPGF&IBGSIBIP#CHTH2]W \X9NA@EU MIF-3=\>G8U;(E%"XXT@468;YRP6D;#UQ?.>UXIXL$ZDKW.DXQTN8@WS([[@J MN;5+3#*@@C"*."PFS@__//3[6F!:_":P%EO72 _ED;$G7;B.)XZG>P0I1%); M8/6S@AFDJ792_?A;F3IU3"WA5@MY'!?U*8%"[Y5 ,AQ!+/!USMD9H>YB$Z/#A"!XA0 M]"MAA< T%F-7JNYH4S>J0E^4H8,=H7UTRZA,!/I)8XB;>E<-HQY+\#J6BZ#3 M\*9(3U#//T:!%P0M_9EUR^>0*[EGY+T6>=@MO\6\CNYUC*97/YF>\>OO\+NF M$C@(B>ZQ!#1?X[P-<:>'GC3.18XCF#AJ5A# 5^!,OW[QA][W-CXVS4)+9@UV M_9I=W[CW=K[5]>OODMT?]!( M] :>LQK/V8?Q+,@SQ&II4F4KU]EZB 7"* <> 95';<0Z_?25;?0EEN3Y=8JVO_,I%:I;9&S MZ1;:):$"I;!04N]DI!;E MO#Q=*0N2Y>:\X9%)R3)SF0".@>L&ZOZ",?E:T 'J,Z[I/U!+ P04 " : M@VA7L8'KB%D# &#@ &0 'AL+W=O0QU*EXL]%U_E#D"A;V7!Y-+;*56=^[[,=E 2>VUDI*PY_VHZG_.E%QA&4$"F# 31?P]P"45AD#2/?UM0KYO3)/;;C^A_ M6/%:S)I(N.3%%YJKW=)+/93#AM2%NN'[3] *B@U>Q@MI?]&^B8UU<%9+Q*N$ODIUGEI=P5JA$W0#&6<9+2BQB_OV"A2AA7RG+]W?7J&W;]ZA M-X@R=+?CM20LEPM?Z=D-AI^U,WUL9HJ>F>D6JE.$@_YW+BF2P]/3^D2 >P%O] M_EN8!!]C+.\9*;E0] ?DEB>B4M:$98 R+I63;P.8](BZG#)P(;Z)YWNN>OW,SS*:5.!#:0FG92TVDV MZ,\3([K"\#P.W$8\ZUB>OO6Z.!0)]])BX.IT(;J#^5!B%]K MRM$"X\5R)T(;RCW4&>%XH?'KIIP=%3IA&*='IG2%)>G3GFA/0W$5NJ M'Y(%;'1><#K7)8%H#AU-1_'*UNUKKO0IP#9W^J &P@3HZQO.U6/'' 6ZH]_J M/U!+ P04 " :@VA7Z;H@MV8" [!@ &0 'AL+W=OY,=I'K2)0"2YXH+/?5*Q'KB^[HHH:+Z M1M8@S,Y&JHJBF:JMKVL%=.U %?>C(!CZ%67"RS.WME!Y)G?(F8"%(GI7553] MO@4N#U,O]%X6[MFV1+O@YUE-M[ $?*P7RLS\CF7-*A":24$4;*;>IW R2VV\ M"_C!X*"/QL0Z64GY9"=?UU,OL(* 0X&6@9K7'F; N24R,GZUG%YWI 4>CU_8 M/SOOQLN*:IA)_I.ML9QZ8X^L84-W'._EX0NT?IS 0G+MGN30Q*8CCQ0[C;)J MP49!Q43SIL]M'HX 87("$+6 Z%\!<0N(G=%&F;,UITCS3,D#43;:L-F!RXU# M&S=,V*^X1&5VF<%A/H<5D@&9<:HUV[""NN1>S@$IX_K*;#TNY^3RXHI<$";( M0REWFHJUSGPTIUL.OVA/NFU.BDZ]SV,!&#F;+?9_'T7@\'&7^_EA[3U@EYH:]NRC414@Q:V7U:T[^S%22C\&U2>\+",$W"-UK]H]*V;?4[55LF-.&P M,<#@9F1X5-.JF@G*VE7[2J+I'6Y8FNX.R@:8_8V4^#*Q#:3[7^1_ %!+ P04 M " :@VA7-E!4Y)P" #P!@ &0 'AL+W=OW:3V\0BMC/;;4#: MC]^UDV:%E6J3>&G\<<_Q.;>^U\-&Z0=3(EIX%)4THZ"TMKX(0Y.5*)@Y4C5* MVEDJ+9BEJ2Y"4VMDN0>)*HRCZ#04C,L@'?JUF4Z':F4K+G&FP:R$8/IIC)5J M1L%QL%FXY45IW4*8#FM6X!SM?3W3- M[EIP+E(8K"1J7H^#R^&)RXN)]P'>. MC=D:@W.R4.K!36[R41 Y05AA9AT#H\\:)UA5CHAD_.PX@_Y(!]P>;]BOO7?R MLF &)ZKZP7-;CH+S ')EBHP"RE;%*=&!2(+AL MO^RQR\,6@'AV ^(.$+\$#%X!)!T@\49;9=[6%;,L'6K5@';1Q.8&/C<>36ZX M=/_BW&K:Y82SZ2U6S&(.,Z;M$]QI)@WS"39P>(66\;/\2%)[_7'&_WC>"_A M'.LC2**/$$=QLD//Y-_A\1XY29_.Q/,-7N&[$0)S3AF%:R9X]013% O4H)8P M99+*@@K @M(PTUQFO&85?&LD!?R"B1)4FH:UMUOF,$:)2VZ!2A7FJ-<\PYT9 MWZO(=8$+4[,,1P&5N2$>#-+W[XY/H\^[TO5&9,^2-^B3-_#LR7_?Q5VV!V]I M^XW(GMD^Z6V?[+TSET6AL7!W)GMY!1;M%=CIOR4]\Z2N5Z_307(^#-?;MOZ. M.3N/^IA6;;C5/ 3JPO=40UI6TK9UV*_V;?O2=ZL7ZV-JYVWW_4/3O@53I@M. M':7")5%&1V>D2[?]M9U85?L6M5"6&IX?EO0DH78!M+]4RFXF[H#^D4M_ U!+ M P04 " :@VA7+151#[H# S# &0 'AL+W=ODG*3HI^?(>D+7L;69N@#]L\1+S,#,\9;)1^-"6BA:=*2#.-2FM75W%L M\A(K9OIJA9)V%DI7S-)4+V.STL@*KU2).$N245PQ+J/9Q*_=ZME$U59PB;<: M3%U53#]?HU";:91&NX4[OBRM6XAGDQ5;XASM_>I6TRQNK!2\0FFXDJ!Q,8W> MI5?7Z(G/'#?F8 R.RH-2CV[RL9A&B4.$ G/K3##ZK/$]"N$L$8XO6Z-1 M6'+:32.H, %JX6]4YO?<$OHW-G+E3#^/VRV MLDD$>6VLJK;*A*#B,GS9T]81!PK#8PK95B'SN,-!'N4-LVPVT6H#VDF3-3?P M5+TV@>/2W[__>RV>(4NR 9Q #*9D&@UP&<1ZM$CC/TI5&R8+,XDMD7&0 MXGP+_#H SXX 3^&3DK8T\(LLL/A:/R8G-)[(=IZXSCH-$MX^#-)>P'P_OX'3 MD[-#[.'3<=*@\?G GS1X@\_;'!"L#-NMN'"],BN6XS2B>#2HUQC-?OPA'24_ M=V <-AB'7=9GOVHFW=6>TBT%XF?P=ZL+ M9@;>2MN4RPG@T2]S>)URTHSAL4 MYYTH/M,;XW()*]3.690FX)098+N%LS8HP62:'F!)^FD[D%$#9/0:(#W*(B7' M-5)>LJ 6P#2W9866Y\#6J!U 6LV%,@ZV\1>]HBA!ASBX#RB5 I(=L)H53JQ@ MSSU8OZ#:<_'.J[IZ!>=1&^>LG?-%P_GB.W.F?:Z*-C[=R"X3I]\5BN.&X_@[ M1YE6%!6<6J3BYD'-5:%$+T8.\9)(XTSRGPJ*5Z.T2/[DAT,^1ZC]8 MY>F2>R1(YGH+)LB:QEPM)?^+DB8^!6.]MR6N+8>OHOA(WDH/ZGOZ7YE_J9G@ MBV=W?Q8UO5%/JBL\OW%FFD'EBW-'A*;9GD'V[5)$+\O2>V-P3#Z]_TUOSX -:PGXW_!2L^Z.,JU$O?K1IZC[6T MH:5K5IN.^%WH _?BH9W^Q/222P,"%Z2:]"^H*NK0H8:)52O?%3XH2SVF'Y;4 MU:-V K2_4,KN)NZ YG?"[!]02P,$% @ &H-H5V*EW8>B @ >@< !D M !X;"]W;W)K&ULM95M3]LP$,>_RBE#$TA T@3: MBJ61*##!"Z2J7;?7;G)M+!([LYVF?/OY(GPD[@B&UR@6E8SH5M^ MIY+1$IFDG(' ]<2['=Q,Q\;?.ORDV,@#&TPF*\Y?3.,IFWB! <("4V44B/YM M\0Z+P@AIC-^MIM=-:0(/[;WZ=YN[SF5%)-[QXA?-5#[QQAYDN"9UH>:\><0V MGVNCE_)"VB\TK6_@05I+QI9*%X^@)/+$5FE@=F!6%P ;;[8JK3 MS>".E_H(2&)7\6%G;(33>U2$%O),.\]1*D%3I7V=W))1)>%TOECJ\1.@#'[D MO):$93+VE:8V<_MI2SAUA.$[A!$\%]GVZ4<[E.>AD<%%UA= M0A2<0QB$$2P7]W!Z3KE\$P^':$\:ICO#JF[A@O5G9?T\-]1;>O?;Q.<605S1W?)N-![&][**X[ MBNOC%#D1V%)4Y%7?<05$",(V:.SS/8TSS,$ZAU+HDQ!S@;WK./HXY+B#''\.Y)K7HH]Q_.8TOF7T#^IA MB6)CJ[[4![YFRI7&KK=[6&Y=/?WK[EZE9R(VE$DH<*U#@\N1/FO"57K74+RR MU77%E:[5ULSUXXC"..CQ->=JWS 3=,]M\@=02P,$% @ &H-H5R/Y/Z/E M @ !P@ !D !X;"]W;W)K&ULO55M;],P$/XK M5IC0)HTE3=IL&FVDK6,"Q*!:&7QVDVMCS;&#[;2;M!_/V/+W+*4JJ,&M6OFZ5$ S M!RJX'P9![!>4"2\9N[.92L:R,IP)F"FBJZ*@ZO$2N-Q,O('W?'#+5KFQ!WXR M+ND*YF#NRIG"G=^R9*P H9D41,%RXET,SJ>QM7<&WQAL]-::6"4+*>_MYD,V M\0(;$'!(C66@^+>&*7!NB3",'PVGU[JTP.WU,_NUTXY:%E3#5/+O+#/YQ#OS M2 9+6G%S*S?OH=$SLGRIY-K]DDUM>XH>TTH;631@W!=,U/_TH7F'+4 <[P&$ M#2#\4T#4 "(GM([,R;JBAB9C)3=$66MDLPOW-@Z-:IBP69P;A;<,<2:9RJ)@ M!M-B-*$B(U,I#!,K$"D#3=Z0=V+-E!36@')R> 6&,JZ/R %A@GS-9:41I<>^ MP5@LHY\V?B]KO^$>OQ&Y04^Y1@<99+MX'S6T0L)G(9=A+^$DE ;E,LKY(U:] M+B4V@ 4'4E)E["?VM"]'E[6'V'FPS6B=#(;!V%]O:^R-XB\UCEJ-HUZ-%VFJ M*BP*;*4$=LJ$2ZU)NE-)3^2@2V/MX71+X]DH&OPBLLLH&+5&.\'';?!Q;_"[ M=?W)!OQ2^H_'9&XHI@5O;0ZOF: H PUG4C/;?KNT]#O\8G+\(#BC"\:9S?PQ M<0\(&8$'G$D:Z@8DG5U:*66=;]EW?>+_U67]SOY6KRU K=P(LMFNA*G;;GO: M3KD+U]S]%_-Z1-Y0M6)"$PY+A 8GIYAH58^=>F-DZ3KW0AJ< VZ9XZ0&90WP M?BFQN)J-==#._N0G4$L#!!0 ( !J#:%=?9#+PDP, /X2 9 >&PO M=V]R:W-H965TVT\.]G.VG:0 A4N!=M[/A];3_).;4]6C'^*!( B9ZR ME(JQDTB9G[FNB!+(L#AB.5!U9\YXAJ4J\H4K<@XX-J(L=0//.W8S3*@S&9FZ M6SX9L4*FA,(M1Z+(,LR?SR%EJ['C.^N*.[)(I*YP)Z,<+V &\CZ_Y:KDUBXQ MR8 *PBCB,!\[/_RST.]K@6GQA\!*;%TC/94'QAYUX2H>.YX>$:0026V!U<\2 MII"FVDF-XU]EZM1]:N'V]=K]PDQ>3>8!"YBR]"^)93)V3AP4PQP7J;QCJTNH M)C30?A%+A?E&JZJMYZ"H$))EE5B-(".T_,5/%8@M@?)I%P25('@IZ+\AZ%6" MWD<%_4I@4+OE5 R'$$L\&7&V0ERW5F[ZPL T:C5]0O5SGTFN[A*EDY,0.%EB MS5Z@;^@74. X15>T?*/TD]D/06*2B@-U?XI%@B[4NX(N(5X0NE!U][,0[>\= MH#U$*/J=L$)@&HN1*]7H=!]N5(WDO!Q)\,9(?'3#J$P$^DECB)MZ5\VJGEJP MGMIYT&EX7:1'J.1OB3@^=0\Y$CB,8.RI)".!+<"9?O_C'WO?\G;H/5M0K-I%EHR:T ;U- &G2_17H M_J 1Z T\IS6>TP_CF9,GB-72I(I6KJ-U'PN$40X\ BH/VHAU^N]*S*996)KY MWA8R[T@M\H-V9+ZW60AZ.RYU9T:6W)J,-CL!OWLK\/GT5G7P.HOX M+[E9W0/87DRI-:\"T(%2F&NI-[1 M4"W*>7G84A8DR\WQPP.3DF7F,@$< ]<-U/TY8W)=T!W41UZ3_U!+ P04 M" :@VA7<:@*"UH# "'$ &0 'AL+W=O_-/><7DEB*@9&*&5Z9IK"#R$AXI2E0-63 M">,)D6K(IZ9(.9 @"TIBT[8LUTQ(1 VOG]V[Y5Z?S60<4;CE2,R2A/ _%Q"S MQ<# QNN-NV@:2GW#]/HIF<(8Y$-ZR]7(+%2"* $J(D81A\G .,=G0^SJ@&S& M8P0+L7:--,H38\]Z*=.G#]^E7] M,H-7,$]$P)#%OZ) A@.C:Z )F06RSNVN((Y=%[!T"X8VO]C4/07+9=Q..,S5G]?PH;$2J5PBU*X M!_G6;1*T(;$2:*< [=2N^2[0VNA]09=B[GL\VRWR[];F?TTEJ#=+=$>D^J%9 MD+2*HE9C7XJ&Q$JXO0*W=Y O>TV"-B16 L76JI.P#MY1YIOC[VR7GO?M6I*K5R)56N#[8-\B1OM:)I2*\.N M>AI-.55=,L!V]QY:H3P?6M2(TK?S+J[S9FHWU*4VKE8JQ: M&MP^S)B-MBQ-J95A5TT+KFT5=L.Z&]MEMVU9;WVY.0M;MMU^XTMS[92HC^@_ M"%?G-X%BF*@XZ[2C:L&7I][E0+(T.S@^,:F.H=EE""0 KB>HYQ/&Y.M GT6+ M_SUX_P!02P,$% @ &H-H5V8HH&DB @ T@0 !D !X;"]W;W)K&ULM511;]HP$/XK)Z^:6JEK0@)T8DFD JK:ATT(UNW9 M) >QZMB9;4@G[!"%X3BH*!,D2_S>0F6)W!G.!"X4 MZ%U54?5SBEPV*1F0P\:2;4OC-H(LJ>D65VA>ZH6R5M"S%*Q"H9D4H'"3DH?! M9#IT_M[A&\-&'ZW!9;*6\M49ST5*0B<(.>;&,5#[V>,,.7=$5L:/CI/T(1WP M>'U@?_2YVUS65.-,\N^L,&5*/A(H<$-WW"QE\X1=/B/'ETNN_1N:UG: MBD(G@;'!'460=X&F;:#H3* 5UG<0A[<0A5$,+ZLY7%_=_$T36.U] E&?0.1Y MAV=XGX5!A=K DAJ$54-K^ 4SJDMXM T'3UALF=B>TGN1UPW#1-H M]DBR]^\&X_#3!=5QKSKV[/&_RWY*6OP?I U[:<.+!?TC[1;$H1^H[X=34ENR M>T_F;H!]%H?N28+]L8C@J$7=M'^FROX7#1PW%AC>W8\(J':"6L/(VG?M6AH[ M WY9VDL'E7.PYQLIS<%P@]!?8]EO4$L#!!0 ( !J#:%>[*0211@0 (45 M 9 >&PO=V]R:W-H965TM-,W&L_*R ;YD"BDFRG,_WQE8" L3'GU%R^F+?=9_6L M5MK'FFX8_R9B0B2\9"D5,R.6,K\Q31'&),/BBN6$JB\+QC,LU2-?FB+G!$>% M4Y::MF6Y9H83:OC3XMTC]Z=L)=.$DD<.8I5EF/]S2U*VF1G(>'WQE"QCJ5^8 M_C3'2S(G\FO^R-636:-$24:H2!@%3A8SXR.Z">S"H;#X,R$;L74/FLHS8]_T MPT,T,RP](I*24&H(K"YK$I TU4AJ'']7H$8=4SMNW[^B?RK(*S+/6)" I7\E MD8QGQL2 B"SP*I5/;/.95(3&&B]DJ2A^85/:>K8!X4I(EE7.:@190LLK?JD2 ML>7@C@XXV)6#?:R#4SDX!=%R9 6M.RRQ/^5L UQ;*S1]4^2F\%9L$JJG<2ZY M^IHH/^G?$9ZLL4ZE@$NX7RQ4>@6P!6Q_.+LC$B>I.%U*3ND\ZG;6:_=&Y#@D,T,M3D'X MFAC^SS\AU_JEB]E 8"V>HYKGJ _=#Q@5+$TB+$D$0JJ+6N125Y#::CC6:U57 MEF02IQ R47Q:,A8)4'Y15V[*@%X14&]#:Q^YCJLG=;W-NM-LXHUKLQ:?<,^T:.Y7K=(W3K$;JG5)8[ M9&4-!-;BZ=4\O=Z9N"\G ,X2&K*,G*NN$3*N-@N]\Z@W*F2L^\E:F:1,J-VI M-.Q*BKZ[71-<@ M>X'>.G,#@;4X7]>0X$UN*)K*9[6N]6HU6HUF;A[&YZ'4;(G727 M*-H2 >C_%"G\"P$6,7Q28@\^DVB9T&7GR'O1WSJC0Z&URBN M Z&UN38:!?5* __LH2K;JMGME&]79Q?MUMZ9(F>O,U^BR>YNVV$U<@Y5]["Y@OBU-2MK . 2M-?IP>'&^MPH*WC-B.]F-5$)' M:J4G%1[F&YQWIJX7Y,TK9B"T-N5&>Z&3Q!<:5'T-A=;FVN@O]'X"K K54NOC M\61W3]BWNO1LSSFP*S0:#/6+L/U"/;JU#2K*AD)KIZ&19>@D788&%69#H;4/ M QIE9O6IOL++,[_R0;*\.#9[9E*RK+B-"8X(UP;J^X(Q^?J@ ]0GK_Y_ M4$L#!!0 ( !J#:%?^1C$U5@( !H% 9 >&PO=V]R:W-H965T*ZELE-6.==,HLCF%=;< M#G2#BDY6VM31&":ADE<7P>U5PHEJ7!=F^R5*^=% KO#=AU77/S M1Z[/V# MPP^!6[LG@Z]DJ?635^Z**8L](928.X_ Z;?!&4KI@8C&KPZ3]2E]X+Z\0[\) MM5,M2VYQIN5/4;AJRBX9%+CB:^D>]/86NWK./%ZNI0U?V':^,8-\;9VNNV!B M4 O5_OESUX>]@"0Y$)!T 4G@W28*+.?<\2PU>@O&>Q.:%T*I(9K(">4O9>$, MG0J*<]DT)'(%0\+W2:\M58=/( M$04/%.5=NNLV77(@W0*; 8SB3Y#$R0@>%W,X/CKY&R:B"OHRDKZ,).".#^#2 M#5'_%7QYSBNN2H1O36#^&V;<5G!#LP>W6)1"E6^1?A?<[\7$-CS'*:/!MV@V MR+*/'X;G\>=WJ(]ZZJ. /OKW#;Q%;?0?J(U[:N-WN_J 7(I7+*"D[;9P++6U M2%-@4')'9J=I%-W:D)AKY0RMF*7#7)N"3-P")WO=:(7*@5[1[&Q(TN;EK4); M*A>!BG]*-MGI<'B9I-%FOX)H;]3]J_&5F])SD[BBN'AP<<; M)O8*DXW8?J7 MVM$N!;&BQPN-=Z#SE=9NI_B%ZI_#[ ]02P,$% @ &H-H5VPRC@1$! MN!P !D !X;"]W;W)K&ULM5EK;]LV%/TKA%8, M+=!&$N5G9AMHDA7KT&)!O':?&9FVA4JB1E)V"NS'CY1D46QEQ@)NOMAZW'MT M#^^Q>$PNCHQ_$WM*)7K*TEPLO;V4Q;7OBWA/,R*N6$%S=6?+>$:D.N4[7Q2< MDDV5E*4^#H*)GY$D]U:+ZMH]7RU8*=,DI_<63LFS[YN%EZ@:Z(IC26&H*HKP.]I6FJD50=_S:@7OM,G=@]/J%_J,@K,H]$ MT%N6_I-LY'[IS3RTH5M2IO*!'?^@#:&QQHM9*JI/=&QB P_%I9 L:Y)5!5F2 MU]_DJ1F(3D(X.I. FP1\:4+4)$05T;JRBM8=D62UX.R(N(Y6:/J@&ILJ6[%) M3J;J+RY.H#23CZ2M*2HL^4B))3U2,IT#O4N<.VZ+T05%U^?4H%U8*DF_$PI>J+ WNQTT)-W4)^$P):UI>J* ;914Y:HL<.8O\1 \T16%?5<[$H8T K,XCEN.8Q#E MC2$) X%9A"XI*K,\2NWAB/ MT.T\:KWBWHJ)1S!2!/4RD"AV:2-F0F=UF' Y-X .=7G"K$+ M-.8C=+N/1GW#)G8WYN 6 :'9(V"<33B%T26HG8%"LTD;0Q,Z[0/8*W/VO&A_ M#HFBZ(QLC3\)W0;%R/;"2=X)-[AY0&CV7W/C<' \^<QV(XWZADWV;LS!+7J)I19L M[ Z>P.@2U.% H=FDC+U-5I](5E0[38],2I95AWM*% 4=H.YO&9.G$[UYU6Y6KOX' M4$L#!!0 ( !J#:%?U UZHA@( "$& 9 >&PO=V]R:W-H965TSG30K4]M/^]+8EWO/[]W5ETFK] N5B 9>*R%I&I3&U)=A2%F)%:,S M5:.T;PJE*V;L5J]"JC6RW(,J$<91=!Y6C,L@G?C8O4XGJC&"2[S70$U5,?U[ MAD*UTV 4; (/?%4:%PC32.;8TM8:G).E4B]N,:WAFHD&X0T:-1MLB0_ !KHC0+OIH#C\D/:,WE M"F:,.)W"DU1+0KUF2X%P*^O& HZOT3 NZ,1R/"VNX?CH!(Z 2W@L54-,YC0) MC57NS@^S7N6L4QGO49G G9*F)/@B<\QWX.>'\:/X $%H2S;4+=[4;18?9%Q@ M?09)= IQ%">[!!V&?VOD/O@;.C\^CS+O?_B>Q-+<9# M+<:'V--'S205J F6:%I$"<*9MW_7_>8[Q@O/Z ;?.HTFX7K;T:&,3F:X=0LK MU"L_G @RU4C37<@A.LR_*W_MP[_IW?"\8WK%)5GAA85&9Q=V>NAN('4;HVI_ MIY?*V GAEZ6=X:A=@GU?*&4V&W? \%5(_P!02P,$% @ &H-H5S+.0)N+ M @ , 8 !D !X;"]W;W)K&ULK55=;YLP%/TK M5ZR:6JDK!+)VZ@A2DZY:IT:JFK9[-G !J\9FM@G=OY]M"$VG)'O9"_CCGN-S MS\67N!/R156(&EYKQM7,J[1N+GU?91761)V)!KG9*82LB3936?JJD4AR!ZJ9 M'P;!N5\3RKTD=FOW,HE%JQGE>"]!M75-Y.\Y,M'-O(FW67B@9:7M@I_$#2EQ MA?JIN9=FYH\L.:V1*RHX2"QFWM7D+&3VWSF!580 M,LRT92#FM<8%,F:)C(Q? Z22$H4+P7[27%SY)"U2HMZ !L%->7]F[P./FP!#,]N0#@ PK\! MYWL T0"(7**],I?6-=$DB:7H0-IHPV8'SAN'-ME0;JNXTM+L4H/3R0VA$IX) M:Q&62%0KT91(*_@$=Y2DE%%-46VVEI=P_'1"1P!Y?!8B581GJO8UT:^%>%G@]1Y+S7<(S6" MI>"Z4O"-YYCOP"\.XR?A 0+?^#::%V[,FX<'&5?8G$$4G$(8A-$N08?A/UJ^ M#_Y.3C36,G)\T1Z^145X::IE;-850F%+NW:E%85;N<,U,HB O95V5QGZ4Z:[ M3[%MY5(U),.99_J&+3QZR<.%K;!]=)$/OK[;0.1?1:_:U+6:,L7:]2D(F6Z_Y^CJMC M.[QR7<4W1:/@( )X% 9 >&PO M=V]R:W-H965T]V"+%<\1#B4P.4MWI&L"0^Y8+ MG=+:F&X9!#JOH65Z)CL0N%-*U3*#IJH"W2E@A0.U/(C"'E%[0H^.VJ6IC'4&6=*R"+9B?W4:A%8PL1=."T(T4 M1$&9TLN+Y7INXUW KP8.^F1-K)*=E'?6N"Y2&MJ$@$-N+ /#WQ[6P+DEPC3^ M#)QT/-("3]=']J]..VK9,0UKR7\WA:E3^HF2 DK6VUD.X Q@[81_L_NASJ< )!G&A -@.@I8/X,(!X L1/J,W.RKIAA M6:+D@2@;C6QVX6KCT*BF$?86MT;A;H,XDZUZC1ZMR18JO!RCR7OR#00HQLFU M\*_$EOO-%1C6"QF[/CBEQ9SJD2>8CY-89MV MJ3N60TJQ*S6H/=#L]:N+1?AY2M]_(GND=CZJG9]CSW[T[0X4D25V583L. MQ[@=A\REZZTG M_A4.'S\K_M'XR77#5-4(33B42!G./F+K*C\-O&%DYQIJ)PVVIUO6.$!!V0#< M+Z4T1\,>,([D["]02P,$% @ &H-H5YD)AB4[@A]81$ 1Z]IDK&9 M%G&>7^LZ"R)(,;LB.63BS9K0%'/1I1N=Y11PJ$!IHEN&X>DICC/-GZJQ)?6G MI.!)G,&2(E:D*::_YY"0W4PSM?W 8[R)N!S0_6F.-[ "_I0OJ>CI-4L8IY"Q MF&2(PGJFW9C7"].6 !7Q(X8=:[21M/),R(OL? MGFB$500(!EQ18/+:P@"21 M3$+'KXI4J^>4P&9[S_Y5F1=FGC&#!4E^QB&/9MI80R&L<9'P1[*[@\J0*_D" MDC#UBW9EK.=J*"@8)VD%%@K2."N?^+5:B ; / 6P*H!U#'!. .P*H%9.+Y4I M6[>88W]*R0Y1&2W89$.MC4(+-W$FMW'%J7@;"QSWYP43(XRA%6S$[G"&/J$' MD3TKG !#E[? <9RP#V+T:76++B\^H L49^A[1 J&LY!-=2Y42"X]J&:,30ERR$L(W7A?K:@K6W,+=Z"5>07R';^(@LP[([]"S^'V[UR+'K M%;45GWV"3ZX>DZO7M30EU.F&RD_VFN4X@)DFODD&= N:__Z=Z1F?NWP-1-9R MZ=0NG3[V?IK53[_Q,\X9T.1!9R^6H=CDZ/]-*J-=((3&K:QM' MF=81YCIC=]*=:>-:V;A7V;WH4Y%J#P6GL3R4NA3V4KQU'P8B:[F=U&XGYV?; M9$B7 Y&U7)K&X4 TSL^W"MO,)->;V3BLS5YM2Z"JIIS=*QA3H1E72# 6DR'A9>M6C=;5^HVK4H_&YK.)5*7J@ M*:\ ]YANXHRA!-:"TK@:B;.2EE5UV>$D5X7I,^&BS%7-2-Q$@,H \7Y-"-]W MY 3UW<;_ U!+ P04 " :@VA7 =!L-U\# !I$ &0 'AL+W=OT8_RXR (E^%CD53 MLKQT79%D4&!QP4J@ZLZ&\0)+M>1;5Y0<<&J2BMP-/"]V"TRHLYB9O15?S%@E MRS:3>S$F]A#?)+N>)JY;8H*2F "L(H MXK"9.U?^Y;4?ZP03\97 3AQ<(RWECK'O>O$^G3N>9@0Y)%)#8/5V#]>0YQI) M\?C1@#KM9^K$P^L']+=&O!)SAP5$'8 MP^?ZW].# 3IA6^70X(4G\!Y5%!]4M*]<-5S4#ZZSZMEL ZRJ-6>32$?K[R&FYLX/1WT/UB,AG[,_?^4%%/4#3RVJ .TU'+ M=#3(]&,)7+&BV_91Z*,WB''NP5@"Z\B-6[FQ74O&-I5; NLH'[?*QW8M6N32GJAXZOO]-O4/F@C_?*/>JB"N MG/JADIRQQ]L)/Y#??C8C%%\ M[-B>H-'HA&'W78D_W);T&G8%W,Q%- &TXBRMDOX>8!C[[%.SA-:MQ+[K\4>6 M/6NU!;*%UE6_;X+\P4[C/]3'CUK/*'CDV9Z@*#CRK'LPM!7 MV:6%2AA%97U MH-/NMO/RE9D2C_:7>HXVP^ >IA[";S'?$BI0#AL%Z5V,5;%Y/=?6"\E*,QK> M,:D&37.9 4Z!ZP!U?\.8?%CH#VC_75C\!5!+ P04 " :@VA7)BVU'R0# M J#0 &0 'AL+W=OU0]N]G.R%M2HA S4L;V_<C+66// (0Z#E-"!\;D1#9A6GR(((4\W.: 9$C:\I2+&23;4R>,<"A!J6) MZ5B6;Z8X)L9DI/N6;#*BN4AB DN&>)ZFF/V;04*W8\,V7CINXTTD5(06FHI_@"FG#]B[9EK&6@(.>"IB58*DAC4OSCYW(A]@"2IQG@ ME #G$."] 7!+@%XYLU"F;2VPP),1HUO$5+1D4P]Z;31:NHF)VL:58'(TEC@Q MF>5<]G".5K"1NR,X^HJFX1\Y,83HNCL0I3M 5X$1$3=I:X1_=AX[(:D[]RJE_ M;,[Y77KMB*SFM5]Y[1^;5V>&S>#;OTVA%9S:MM[4Y1Z]C,*QGJJ3>P M#S*O(:KG#/O-F6?OG?)VJ[XE,%WRD0#0DM$P#T3S^=Q*\]$]Z8JM;MK9F7:. M3<&2H2N_';'5_>ZJ"[OU0'^77_?5:6I[UO P"5]'.>ZKSY^Y5W6FP#:Z&.CR7]02P,$% @ &H-H5T G M;6PQ!0 J1L !D !X;"]W;W)K&ULO5EM<^(V M$/XK&O>FDYNYQ)9L#*3 3"#7NF05*$,:0\) FB,%Z:MS@ZX5MI0,RBS]# M./#*-4I=>:+T.;VY"Z:&E3*""'R10GCRZP46$$4IDN3Q3PYJ%'.F ZO7)_1? M,^>E,T\>AP6-_@H#L9T:(P,%L/;VD7B@AR^0.S1(\7P:\>P3'7);RT#^G@L: MYX,E@SA,CM_>:QZ(R@")HQY \@&D.<#I&&#G ^S,T2.SS*U;3WBS":,'Q%)K MB99>9+')1DMOPB1]C2O!Y*^A'"=F\SV73SA'*]C(MR,XND0/X-/$#Z/0RR)- MU^@N\6D,Z GDNH'3W:/W"AP)BFZ"OR51"-#G^=WC[0VZN 7AA1'_*+&^KF[1 MQ8>/Z ,*$_2XI7ON)0&?F$)R3QF8?LYS?N1).GC:Z)XF8LO1YR2 H#[>E#X7 MCI.3XW.B!5S![@K9UB=$+&(K^"R^?SC1T+&+]V!G>'8'7COF82WF^9WHB+DJ MH,<)'?6$:7FXYCO/AZDA\Y\#>P%C]O-/V+5^446C)[!:;)PB-HX.?7;Q&^5R M,74'1.7]$7*80::U[&5VB?%X.)Z8+U6_VF8#!P\+HQK?0<%WH.5[EPB041 ( M7F6UY? ))2!4'(\P;F5R9^ Z#89M(]MR.QBZ!4-7R_ 6Y&OR\[4F$Q)Y,64B M_#=[H&+JMDB,1D/<8*HP<@:6FNFP8#K4,EU0MJ/,$X!\RH7R30];TV('VW:# MG,**.&.L9CV.:C0MGQEIG M5H+ZSY=I3PRD%W&Z=#O7P[C]JINK03O9&UW!5MG6+*TSLL?+#I[(%LH8)/XW M%,D: KPS%7.XJD>N.VI6"X750 HF]2+"E1Z,M63_V(%N]_E,_85GY[0ZO$IY0#6=M3S*W2.5Z^^I)F4*BO+&G4LX+)! M8WV'/CO;G._*MK:5)MO*[HSU[;DI5R_1(Q5>)(NX)O<479@,1\U>K3)SW$J5 MKU,NVS76]^MV@4#_H9LDC"7M+^!%8JLDK04].R%Z0JN'H-0!>/CN!4,K/:.*[*Z_G>Q5!1$KRB4.7@OC9CD_?M>L+ KTGK@<]=97VCU,)1:A>#WSD/2 MJ[#I"ZT>GU+8$*TP.#\/<[Q:ACEN8U&KC 8=;864(H/H1<9;LI"T%009M<2_ MPFI QAW_6DFI,XA>9RAS< DLV\Y,?$!+1H.]W\%E%T=IKE>-4-U^H>8;[9K#!JI9E9.?2(@6VRLR".?+I/Q/$8H'A:G#?=9*=S?+TXGAJ5,,=#K'N/;<*$HPC6$M*Z&LJ:QH[G0L<;07?9T46 MO !8:B!_7U,J3C?I!,7IW.Q_4$L#!!0 ( !J#:%>FDBSV>P, %$1 9 M >&PO=V]R:W-H965T^P3?,UD MQ_@WL060Z'M95&+J;*6L[UU7K+90$G'':JC4DS7C)9&JRS>NJ#F0O 65A>M[ M7NR6A%;.;-*.+?ALPAI9T H6'(FF+ G_\0@%VTT=[+P.?*:;K=0#[FQ2DPTL M07ZM%USUW)XEIR54@K(*<5A/G0=\/\>I!K01?U'8B:,VTE*>&?NF.Q_SJ>/I MC*" E=041'V]P!R*0C.I//[9DSK]G!IXW'YE_ZT5K\0\$P%S5OQ-<[F=.JF# MX#[ 5%FF_%"M%^HET7FT0.6C5"LG(/5AF4M.J^R??]0AP!<'@! MX.\!_O\%!'M T KM,FME/1%)9A/.=HCK:,6F&^W:M&BEAE9Z&Y>2JZ=4X>3L ML1%J1 BTA(W:'2G0>_0Q5PVZIN2Y /0@!*C1MT\@"2W$._7\Z_()O7WS#KU! MM$)?MJP1I,K%Q)4J'\WJKO9S/W9S^Q?F7D)]AP+O%^1[?F" S^WPWYOJ$MQ5 MJ] OA=\OA=_R!1?X.J4F&1TN-./TBW8O:K*"J:/>) '\!9S9SS_AV/O5)&HD MLH'$H)<8V-@M$CMTNC$0VD!OU*EJ1 'X 4L=[WU/JD@KKSW M1R,YU66-\1"U$E^[.6.Q#9?AJ-S -UIP#QQ+YDAL0YF'4@);CW&;3/_,8$GH MQ=Z)#4UA47KI]P\?"@!LKP",-EP ;R\$U0K0@K.\65W(W)C,ZLUBH?A"S4R>:PN(DO>#$0X6 [27"G/&: M*2^",3-6EJ,Q3:4>2@NL/5@M\E,SZX-:M8H/;.: M(2Y,@C0X\9I[=-_5?S9\(GQ#*X$*6"N@=Z=OY[R[OW<=R>KV"OS,I+I0M\TM MD!RX#E#/UXS)UXZ^5??_HLS^ U!+ P04 " :@VA7ROTA6RX# #P$@ M#0 'AL+W-T>6QEKTXS"F79#J6 MZ_PZ-V6P4&MI)F38A@)W^YQ.2#]^3P(G-U,IFY#[L[<_ULI3=R4GO MHF>O^_.K0_"L0\])Z)4?OD >5<9$XY=Y?LXQ)GVY+]T\?FJU6NXI1AYYR!W3 MT<)Z6:;C3,EN=2+B E:7YBQXH&)"9E3PN>; RFC.Q=:%!Q!8**%T8&Q9V$1] MB)2/#NZ['E1,K9-SJ725VV5P?^?UXP= TP.#7(C6X("XP'1<4&.8EM>V4SU< M!9] 0=V^VQ;6X5+3;7\P)!VANMDD&#:\,5NY*>FQ1W;F*:<-AGN>? />OZS\[QD MDFDJ=DW;VC_F67ZUXWK_^1N>JW\KAXZ])J/+X_=8[[3';C(^?I-1ZW/* ML9L<':7)L-Z_=PX)>T>$-AK 46Q"OL&13G1)@_F:"\-EW5OQ-&7RR4G!RALZ MM\?Y/7W[?,HRNA;FK@4GI&M_92E?YTG[U U,1/U4U_X"P^O'[3G0YN(R91N6 MSNJN7LZK9F ;-FM] >$0N:XN/X)Q'.9' ,/R8 XPCF-A>?ZG\8S0\3@,\S;R M(B.4,T(YCN5#9M4'R^/G)/;RCS1)HBB.L1F=S;P.9MB\Q3%\_6J8-V!@>2#3 M[\TUOMIXA3Q?!]B:/E7BKL
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
&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " : M@VA7P(AM=.D! !^)0 $P @ $]-0$ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 2 !( *\3 !7-P$ ! end XML 77 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 78 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 177 249 1 false 56 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.pahc.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 2 false false R3.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Statements 3 false false R4.htm 00300 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.pahc.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) Sheet http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals CONSOLIDATED BALANCE SHEETS (Parentheticals) Statements 5 false false R6.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) Statements 8 false false R9.htm 10101 - Disclosure - Description of Business Sheet http://www.pahc.com/role/DisclosureDescriptionOfBusiness Description of Business Notes 9 false false R10.htm 10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards Summary of Significant Accounting Policies and New Accounting Standards Notes 10 false false R11.htm 10301 - Disclosure - Statements of Operations-Additional Information Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation Statements of Operations-Additional Information Notes 11 false false R12.htm 10401 - Disclosure - Balance Sheets-Additional Information Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation Balance Sheets-Additional Information Notes 12 false false R13.htm 10501 - Disclosure - Debt Sheet http://www.pahc.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 10601 - Disclosure - Related Party Transactions Sheet http://www.pahc.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 10701 - Disclosure - Stock Incentive Plan Sheet http://www.pahc.com/role/DisclosureStockIncentivePlan Stock Incentive Plan Notes 15 false false R16.htm 10801 - Disclosure - Commitments and Contingencies Sheet http://www.pahc.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 10901 - Disclosure - Derivatives Sheet http://www.pahc.com/role/DisclosureDerivatives Derivatives Notes 17 false false R18.htm 11001 - Disclosure - Fair Value Measurements Sheet http://www.pahc.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 11101 - Disclosure - Business Segments Sheet http://www.pahc.com/role/DisclosureBusinessSegments Business Segments Notes 19 false false R20.htm 20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies Summary of Significant Accounting Policies and New Accounting Standards (Policies) Policies http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 20 false false R21.htm 30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables Summary of Significant Accounting Policies and New Accounting Standards (Tables) Tables http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 21 false false R22.htm 30303 - Disclosure - Statements of Operations-Additional Information (Tables) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables Statements of Operations-Additional Information (Tables) Tables http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation 22 false false R23.htm 30403 - Disclosure - Balance Sheets-Additional Information (Tables) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables Balance Sheets-Additional Information (Tables) Tables http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation 23 false false R24.htm 30503 - Disclosure - Debt (Tables) Sheet http://www.pahc.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.pahc.com/role/DisclosureDebt 24 false false R25.htm 30903 - Disclosure - Derivatives (Tables) Sheet http://www.pahc.com/role/DisclosureDerivativesTables Derivatives (Tables) Tables http://www.pahc.com/role/DisclosureDerivatives 25 false false R26.htm 31003 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pahc.com/role/DisclosureFairValueMeasurements 26 false false R27.htm 31103 - Disclosure - Business Segments (Tables) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsTables Business Segments (Tables) Tables http://www.pahc.com/role/DisclosureBusinessSegments 27 false false R28.htm 40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails Summary of Significant Accounting Policies and New Accounting Standards (Details) Details http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 28 false false R29.htm 40301 - Disclosure - Statements of Operations-Additional Information - Segments (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationSegmentsDetails Statements of Operations-Additional Information - Segments (Details) Details http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables 29 false false R30.htm 40302 - Disclosure - Statements of Operations-Additional Information - Net Sales by Product Type (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails Statements of Operations-Additional Information - Net Sales by Product Type (Details) Details 30 false false R31.htm 40303 - Disclosure - Statements of Operations-Additional Information - Net Sales by Region (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails Statements of Operations-Additional Information - Net Sales by Region (Details) Details 31 false false R32.htm 40304 - Disclosure - Statements of Operations-Additional Information - General Information (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationGeneralInformationDetails Statements of Operations-Additional Information - General Information (Details) Details 32 false false R33.htm 40305 - Disclosure - Statements of Operations-Additional Information - Interest Expense, Net (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails Statements of Operations-Additional Information - Interest Expense, Net (Details) Details 33 false false R34.htm 40306 - Disclosure - Statements of Operations-Additional Information - Depreciation and Amortization (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails Statements of Operations-Additional Information - Depreciation and Amortization (Details) Details 34 false false R35.htm 40307 - Disclosure - Statements of Operations-Additional Information - Annuity Purchase Agreement (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationAnnuityPurchaseAgreementDetails Statements of Operations-Additional Information - Annuity Purchase Agreement (Details) Details 35 false false R36.htm 40401 - Disclosure - Balance Sheets-Additional Information - Inventories (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails Balance Sheets-Additional Information - Inventories (Details) Details 36 false false R37.htm 40402 - Disclosure - Balance Sheets-Additional Information - Other Assets (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails Balance Sheets-Additional Information - Other Assets (Details) Details 37 false false R38.htm 40403 - Disclosure - Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details) Details 38 false false R39.htm 40404 - Disclosure - Balance Sheets-Additional Information - Other Liabilities (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails Balance Sheets-Additional Information - Other Liabilities (Details) Details 39 false false R40.htm 40405 - Disclosure - Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details) Details 40 false false R41.htm 40501 - Disclosure - Debt - General Information (Details) Sheet http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails Debt - General Information (Details) Details 41 false false R42.htm 40502 - Disclosure - Debt - Interest Rates - Stated Rates (Details) Sheet http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails Debt - Interest Rates - Stated Rates (Details) Details 42 false false R43.htm 40503 - Disclosure - Debt - Interest Rates - Weighted Average Rates (Details) Sheet http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails Debt - Interest Rates - Weighted Average Rates (Details) Details 43 false false R44.htm 40504 - Disclosure - Debt - Derivatives (Details) Sheet http://www.pahc.com/role/DisclosureDebtDerivativesDetails Debt - Derivatives (Details) Details 44 false false R45.htm 40505 - Disclosure - Debt - Reconciliation (Details) Sheet http://www.pahc.com/role/DisclosureDebtReconciliationDetails Debt - Reconciliation (Details) Details 45 false false R46.htm 40506 - Disclosure - Debt - Classification (Details) Sheet http://www.pahc.com/role/DisclosureDebtClassificationDetails Debt - Classification (Details) Details 46 false false R47.htm 40601 - Disclosure - Related Party Transactions (Details) Sheet http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.pahc.com/role/DisclosureRelatedPartyTransactions 47 false false R48.htm 40701 - Disclosure - Stock Incentive Plan - Restricted Stock Units (Details) Sheet http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails Stock Incentive Plan - Restricted Stock Units (Details) Details 48 false false R49.htm 40702 - Disclosure - Stock Incentive Plan - Stock-Based Compensation Expense (Details) Sheet http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails Stock Incentive Plan - Stock-Based Compensation Expense (Details) Details 49 false false R50.htm 40801 - Disclosure - Commitments and Contingencies - Environmental (Details) Sheet http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails Commitments and Contingencies - Environmental (Details) Details 50 false false R51.htm 40901 - Disclosure - Derivatives - General Information (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails Derivatives - General Information (Details) Details 51 false false R52.htm 40902 - Disclosure - Derivatives - Balance Sheet Location (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails Derivatives - Balance Sheet Location (Details) Details 52 false false R53.htm 40903 - Disclosure - Derivatives - Notional Amounts (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails Derivatives - Notional Amounts (Details) Details 53 false false R54.htm 40904 - Disclosure - Derivatives - Effects of Derivatives (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails Derivatives - Effects of Derivatives (Details) Details 54 false false R55.htm 40905 - Disclosure - Derivatives - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails Derivatives - Additional Information (Details) Details 55 false false R56.htm 41001 - Disclosure - Fair Value Measurements - Fair Value of Assets (Details) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails Fair Value Measurements - Fair Value of Assets (Details) Details 56 false false R57.htm 41002 - Disclosure - Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsAssetsMeasuredOnRecurringBasisUnobservableInputsDetails Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details) Details 57 false false R58.htm 41003 - Disclosure - Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsLiabilitiesMeasuredOnRecurringBasisUnobservableInputsDetails Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details) Details 58 false false R59.htm 41101 - Disclosure - Business Segments - General Information (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsGeneralInformationDetails Business Segments - General Information (Details) Details 59 false false R60.htm 41102 - Disclosure - Business Segments - Net Sales (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails Business Segments - Net Sales (Details) Details 60 false false R61.htm 41103 - Disclosure - Business Segments - Depreciation and Amortization (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails Business Segments - Depreciation and Amortization (Details) Details 61 false false R62.htm 41104 - Disclosure - Business Segments - Adjusted EBITDA (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails Business Segments - Adjusted EBITDA (Details) Details 62 false false R63.htm 41105 - Disclosure - Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details) Details 63 false false R64.htm 41106 - Disclosure - Business Segments - Identifiable Assets (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails Business Segments - Identifiable Assets (Details) Details 64 false false All Reports Book All Reports pahc-20230930.xsd pahc-20230930_cal.xml pahc-20230930_def.xml pahc-20230930_lab.xml pahc-20230930_pre.xml pahc-20230930x10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pahc-20230930x10q.htm": { "nsprefix": "pahc", "nsuri": "http://www.pahc.com/20230930", "dts": { "schema": { "local": [ "pahc-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "pahc-20230930_cal.xml" ] }, "definitionLink": { "local": [ "pahc-20230930_def.xml" ] }, "labelLink": { "local": [ "pahc-20230930_lab.xml" ] }, "presentationLink": { "local": [ "pahc-20230930_pre.xml" ] }, "inline": { "local": [ "pahc-20230930x10q.htm" ] } }, "keyStandard": 220, "keyCustom": 29, "axisStandard": 19, "axisCustom": 0, "memberStandard": 33, "memberCustom": 20, "hidden": { "total": 30, "http://www.pahc.com/20230930": 3, "http://fasb.org/us-gaap/2023": 23, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 177, "entityCount": 1, "segmentCount": 56, "elementCount": 432, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 537, "http://xbrl.sec.gov/dei/2023": 35 }, "report": { "R1": { "role": "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations", "longName": "00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:GrossProfit", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R3": { "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R4": { "role": "http://www.pahc.com/role/StatementConsolidatedBalanceSheets", "longName": "00300 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "longName": "00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_x8856lS5dUyQUA3aQ5uEoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_x8856lS5dUyQUA3aQ5uEoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity", "longName": "00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_DAu_fZZr1EmbTfAChYd8TQ", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_DAu_fZZr1EmbTfAChYd8TQ", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals", "longName": "00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "Unit_Divide_USD_shares_x8856lS5dUyQUA3aQ5uEoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "Unit_Divide_USD_shares_x8856lS5dUyQUA3aQ5uEoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.pahc.com/role/DisclosureDescriptionOfBusiness", "longName": "10101 - Disclosure - Description of Business", "shortName": "Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation", "longName": "10301 - Disclosure - Statements of Operations-Additional Information", "shortName": "Statements of Operations-Additional Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation", "longName": "10401 - Disclosure - Balance Sheets-Additional Information", "shortName": "Balance Sheets-Additional Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.pahc.com/role/DisclosureDebt", "longName": "10501 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.pahc.com/role/DisclosureRelatedPartyTransactions", "longName": "10601 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.pahc.com/role/DisclosureStockIncentivePlan", "longName": "10701 - Disclosure - Stock Incentive Plan", "shortName": "Stock Incentive Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.pahc.com/role/DisclosureCommitmentsAndContingencies", "longName": "10801 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.pahc.com/role/DisclosureDerivatives", "longName": "10901 - Disclosure - Derivatives", "shortName": "Derivatives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.pahc.com/role/DisclosureFairValueMeasurements", "longName": "11001 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.pahc.com/role/DisclosureBusinessSegments", "longName": "11101 - Disclosure - Business Segments", "shortName": "Business Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies)", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables", "longName": "30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables)", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables", "longName": "30303 - Disclosure - Statements of Operations-Additional Information (Tables)", "shortName": "Statements of Operations-Additional Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables", "longName": "30403 - Disclosure - Balance Sheets-Additional Information (Tables)", "shortName": "Balance Sheets-Additional Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.pahc.com/role/DisclosureDebtTables", "longName": "30503 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.pahc.com/role/DisclosureDerivativesTables", "longName": "30903 - Disclosure - Derivatives (Tables)", "shortName": "Derivatives (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsTables", "longName": "31003 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsTables", "longName": "31103 - Disclosure - Business Segments (Tables)", "shortName": "Business Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details)", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R29": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationSegmentsDetails", "longName": "40301 - Disclosure - Statements of Operations-Additional Information - Segments (Details)", "shortName": "Statements of Operations-Additional Information - Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_segment_hFaY3lnQrUahHc9V1_J3VA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:NumberOfReportableSegments", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails", "longName": "40302 - Disclosure - Statements of Operations-Additional Information - Net Sales by Product Type (Details)", "shortName": "Statements of Operations-Additional Information - Net Sales by Product Type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_srt_ProductOrServiceAxis_pahc_AnimalHealthMember_XITV43R-cUegPJ5W-Pvhtw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R31": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails", "longName": "40303 - Disclosure - Statements of Operations-Additional Information - Net Sales by Region (Details)", "shortName": "Statements of Operations-Additional Information - Net Sales by Region (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_srt_StatementGeographicalAxis_country_US_RFGiPFYSZUmDYPTHowsgQg", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R32": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationGeneralInformationDetails", "longName": "40304 - Disclosure - Statements of Operations-Additional Information - General Information (Details)", "shortName": "Statements of Operations-Additional Information - General Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "pahc:PaymentTermLowEndOfRange", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "pahc:PaymentTermLowEndOfRange", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails", "longName": "40305 - Disclosure - Statements of Operations-Additional Information - Interest Expense, Net (Details)", "shortName": "Statements of Operations-Additional Information - Interest Expense, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:AmortizationOfFinancingCosts", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:InterestExpenseOther", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfInterestExpenseNetTableTextBlock", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R34": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails", "longName": "40306 - Disclosure - Statements of Operations-Additional Information - Depreciation and Amortization (Details)", "shortName": "Statements of Operations-Additional Information - Depreciation and Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:Depreciation", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfDepreciationAndAmortizationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:Depreciation", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfDepreciationAndAmortizationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationAnnuityPurchaseAgreementDetails", "longName": "40307 - Disclosure - Statements of Operations-Additional Information - Annuity Purchase Agreement (Details)", "shortName": "Statements of Operations-Additional Information - Annuity Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_7_31_2023_xcAu8EhwdE2OsaA-zsU4Cg", "name": "pahc:DefinedBenefitPlanSettlementAnnuityPurchaseAgreementBenefitObligationAnnuityPurchasePrice", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_7_31_2023_xcAu8EhwdE2OsaA-zsU4Cg", "name": "pahc:DefinedBenefitPlanSettlementAnnuityPurchaseAgreementBenefitObligationAnnuityPurchasePrice", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails", "longName": "40401 - Disclosure - Balance Sheets-Additional Information - Inventories (Details)", "shortName": "Balance Sheets-Additional Information - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails", "longName": "40402 - Disclosure - Balance Sheets-Additional Information - Other Assets (Details)", "shortName": "Balance Sheets-Additional Information - Other Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails", "longName": "40403 - Disclosure - Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Balance Sheets-Additional Information - Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "pahc:AccruedExpensesAndOtherLiabilitiesCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "pahc:AccruedExpensesAndOtherLiabilitiesCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails", "longName": "40404 - Disclosure - Balance Sheets-Additional Information - Other Liabilities (Details)", "shortName": "Balance Sheets-Additional Information - Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:OperatingLeaseLiabilityNoncurrent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:OperatingLeaseLiabilityNoncurrent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "longName": "40405 - Disclosure - Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details)", "shortName": "Balance Sheets-Additional Information - Accumulated Other Comprehensive Income (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5NLMwCo6v0W8Blp7tJkOzA", "name": "us-gaap:AociBeforeTaxAttributableToParent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R41": { "role": "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "longName": "40501 - Disclosure - Debt - General Information (Details)", "shortName": "Debt - General Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_CreditFacilitiesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_8HUYamcStkeNQ-4dPijkmw", "name": "pahc:DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisMaximum", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_CreditFacilitiesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_8HUYamcStkeNQ-4dPijkmw", "name": "pahc:DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisMaximum", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "longName": "40502 - Disclosure - Debt - Interest Rates - Stated Rates (Details)", "shortName": "Debt - Interest Rates - Stated Rates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_RevolverMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_OHrrlBYy40K6UmZ2EpbkzQ", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_RevolverMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_OHrrlBYy40K6UmZ2EpbkzQ", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "longName": "40503 - Disclosure - Debt - Interest Rates - Weighted Average Rates (Details)", "shortName": "Debt - Interest Rates - Weighted Average Rates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_RevolverMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_zMEuec1P0U6SYxYUa2OGjQ", "name": "us-gaap:LongTermDebtWeightedAverageInterestRateOverTime", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_DebtInstrumentAxis_pahc_RevolverMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_zMEuec1P0U6SYxYUa2OGjQ", "name": "us-gaap:LongTermDebtWeightedAverageInterestRateOverTime", "unitRef": "Unit_Standard_pure_y9T20zL2GUKAmdJz2A-oOw", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "longName": "40504 - Disclosure - Debt - Derivatives (Details)", "shortName": "Debt - Derivatives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_oPHch5y--kqa3kltplMtXQ", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "longName": "40505 - Disclosure - Debt - Reconciliation (Details)", "shortName": "Debt - Reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.pahc.com/role/DisclosureDebtClassificationDetails", "longName": "40506 - Disclosure - Debt - Classification (Details)", "shortName": "Debt - Classification (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R47": { "role": "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails", "longName": "40601 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_RelatedPartyTransactionAxis_pahc_CompensationAndBenefitForServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_PtOOtgqnC0GQP091LRrVGQ", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_RelatedPartyTransactionAxis_pahc_CompensationAndBenefitForServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_PtOOtgqnC0GQP091LRrVGQ", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "longName": "40701 - Disclosure - Stock Incentive Plan - Restricted Stock Units (Details)", "shortName": "Stock Incentive Plan - Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_7_31_2023_us-gaap_AwardDateAxis_pahc_July2023Member_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_bApLUhTPlUC44uWnyiUrIA", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Unit_Standard_shares_KBFkKC_eU0uI4C4ddOoqoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_7_31_2023_us-gaap_AwardDateAxis_pahc_July2023Member_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_bApLUhTPlUC44uWnyiUrIA", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Unit_Standard_shares_KBFkKC_eU0uI4C4ddOoqoQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails", "longName": "40702 - Disclosure - Stock Incentive Plan - Stock-Based Compensation Expense (Details)", "shortName": "Stock Incentive Plan - Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1uy7atfl4kO5kobEVzmGIA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1uy7atfl4kO5kobEVzmGIA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails", "longName": "40801 - Disclosure - Commitments and Contingencies - Environmental (Details)", "shortName": "Commitments and Contingencies - Environmental (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "pahc:NumberOfPotentiallyResponsibleParties", "unitRef": "Unit_Standard_item_rsaNEI3OpUmbKmdM5wcqpg", "xsiNil": "false", "lang": null, "decimals": "-1", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "pahc:NumberOfPotentiallyResponsibleParties", "unitRef": "Unit_Standard_item_rsaNEI3OpUmbKmdM5wcqpg", "xsiNil": "false", "lang": null, "decimals": "-1", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "longName": "40901 - Disclosure - Derivatives - General Information (Details)", "shortName": "Derivatives - General Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_oPHch5y--kqa3kltplMtXQ", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "longName": "40902 - Disclosure - Derivatives - Balance Sheet Location (Details)", "shortName": "Derivatives - Balance Sheet Location (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_6_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zLg4vKiRL0ahS-qgNRWpAQ", "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zLg4vKiRL0ahS-qgNRWpAQ", "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails", "longName": "40903 - Disclosure - Derivatives - Notional Amounts (Details)", "shortName": "Derivatives - Notional Amounts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_oPHch5y--kqa3kltplMtXQ", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "longName": "40904 - Disclosure - Derivatives - Effects of Derivatives (Details)", "shortName": "Derivatives - Effects of Derivatives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_W-iSLyPMk0yqulTnJtA0qQ", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R55": { "role": "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "longName": "40905 - Disclosure - Derivatives - Additional Information (Details)", "shortName": "Derivatives - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_SGdZxTVy306eUKmL-koTfQ", "name": "pahc:RealizedGainLossOnMaturedContractsRecordedAsInventory", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_SGdZxTVy306eUKmL-koTfQ", "name": "pahc:RealizedGainLossOnMaturedContractsRecordedAsInventory", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails", "longName": "41001 - Disclosure - Fair Value Measurements - Fair Value of Assets (Details)", "shortName": "Fair Value Measurements - Fair Value of Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:ShortTermInvestments", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_Ha6qik1R40-T8JbkUZ6bYA", "name": "us-gaap:ShortTermInvestments", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R57": { "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsAssetsMeasuredOnRecurringBasisUnobservableInputsDetails", "longName": "41002 - Disclosure - Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details)", "shortName": "Fair Value Measurements - Assets Measured On Recurring Basis, Unobservable Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsLiabilitiesMeasuredOnRecurringBasisUnobservableInputsDetails", "longName": "41003 - Disclosure - Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details)", "shortName": "Fair Value Measurements - Liabilities Measured on Recurring Basis, Unobservable Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsGeneralInformationDetails", "longName": "41101 - Disclosure - Business Segments - General Information (Details)", "shortName": "Business Segments - General Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_segment_hFaY3lnQrUahHc9V1_J3VA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:NumberOfReportableSegments", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R60": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "longName": "41102 - Disclosure - Business Segments - Net Sales (Details)", "shortName": "Business Segments - Net Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_us-gaap_StatementBusinessSegmentsAxis_pahc_AnimalHealthMember_3s5OjfEh20qblmu3sCW7Fw", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R61": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "longName": "41103 - Disclosure - Business Segments - Depreciation and Amortization (Details)", "shortName": "Business Segments - Depreciation and Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R62": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "longName": "41104 - Disclosure - Business Segments - Adjusted EBITDA (Details)", "shortName": "Business Segments - Adjusted EBITDA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_T1AE968hsUqIJwZ1kh6f8Q", "name": "pahc:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": null }, "R63": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "longName": "41105 - Disclosure - Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details)", "shortName": "Business Segments - Reconciliation of Income before Income Taxes to Adjusted EBITDA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023__3C3lpobiEO2QX_R-vJjWw", "name": "pahc:CorporateCosts", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } }, "R64": { "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "longName": "41106 - Disclosure - Business Segments - Identifiable Assets (Details)", "shortName": "Business Segments - Identifiable Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "As_Of_9_30_2023_MhKYOA42Q0W0c3Sew3wpKw", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_p9tZZVzbekGQQG15o5tLVA", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_ObJT4TBVeUOna1fsJQoqog", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "pahc-20230930x10q.htm", "unique": true } } }, "tag": { "us-gaap_LongTermLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermLineOfCredit", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Line of Credit, Noncurrent", "verboseLabel": "Revolving credit facility", "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r29", "r54", "r55" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Noncurrent Assets", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment", "terseLabel": "Debt instrument, periodic payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r29", "r91" ] }, "us-gaap_PensionExpenseReversalOfExpenseNoncash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionExpenseReversalOfExpenseNoncash", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": -1.0, "order": 5.0 }, "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationAnnuityPurchaseAgreementDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Pension Expense (Reversal of Expense), Noncash", "terseLabel": "Pension settlement cost", "documentation": "Amount of noncash expense (reversal of expense) for pension benefits. Excludes other postretirement benefits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Line of Credit", "terseLabel": "Outstanding borrowings", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r20", "r132", "r794" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r149", "r222", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r254", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r653", "r704", "r795" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_AociBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociBeforeTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "AOCI before Tax, Attributable to Parent", "terseLabel": "Accumulated other comprehensive loss, before tax", "documentation": "Amount before tax of increase (decrease) in accumulated equity from transactions and other events and circumstances from non-owner sources, attributable to parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners (distributions to owners)." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit [Member]", "terseLabel": "Line of Credit", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeOptionMember", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Option [Member]", "terseLabel": "Foreign Exchange Option", "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r71", "r81" ] }, "us-gaap_AociTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociTaxAttributableToParent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "AOCI Tax, Attributable to Parent", "negatedLabel": "Accumulated other comprehensive loss, tax", "documentation": "Amount of tax expense (benefit) allocated to accumulated other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermLinesOfCredit", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-term Lines of Credit", "negatedTerseLabel": "Revolving credit facility repayments", "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Fixed Interest Rate", "terseLabel": "Derivative, fixed interest rate (as a percent)", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Fair Value, Net", "totalLabel": "Total Fair Value", "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives." } } }, "auth_ref": [ "r425" ] }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireShortTermInvestments", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Short-term Investments", "negatedLabel": "Purchases of short-term investments", "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r113" ] }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Foreign currency derivatives and interest rate swap", "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments." } } }, "auth_ref": [ "r10" ] }, "pahc_DescriptionOfBusinessAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DescriptionOfBusinessAbstract", "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "auth_ref": [] }, "pahc_VaccinesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "VaccinesMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Vaccines [Member]", "label": "Vaccines [Member]", "terseLabel": "Vaccines" } } }, "auth_ref": [] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation" ], "lang": { "en-us": { "role": { "label": "Supplemental Balance Sheet Disclosures [Text Block]", "verboseLabel": "Balance Sheets-Additional Information", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r705" ] }, "pahc_NumberOfPotentiallyResponsibleParties": { "xbrltype": "integerItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "NumberOfPotentiallyResponsibleParties", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents number of parties.", "label": "Number of Potentially Responsible Parties", "verboseLabel": "Number of potentially responsible parties" } } }, "auth_ref": [] }, "pahc_MedicatedFeedAdditivesAndOthersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "MedicatedFeedAdditivesAndOthersMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Medicated Feed Additives and Others [Member]", "label": "Medicated Feed Additives and Others [Member]", "terseLabel": "MFAs and other" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r188", "r296", "r297", "r298", "r299", "r300", "r302", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r320", "r440", "r655", "r656", "r657", "r658", "r659", "r717" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r692" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r20", "r92", "r93", "r131", "r132", "r188", "r296", "r297", "r298", "r299", "r300", "r302", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r440", "r655", "r656", "r657", "r658", "r659", "r717" ] }, "pahc_MineralNutritionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "MineralNutritionMember", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents segment manufactures and markets trace minerals for the cattle, swine, poultry and pet food markets.", "label": "Mineral Nutrition [Member]", "terseLabel": "Mineral Nutrition" } } }, "auth_ref": [] }, "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "documentation": "Adjusted earnings before interest taxes depreciation and amortization.", "label": "Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "totalLabel": "Adjusted EBITDA - Total segments", "verboseLabel": "Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r57", "r58", "r83", "r84", "r86", "r90", "r123", "r124", "r188", "r296", "r297", "r298", "r299", "r300", "r302", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r320", "r440", "r655", "r656", "r657", "r658", "r659", "r717" ] }, "pahc_LongTermAndDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "LongTermAndDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Long Term And Deferred Income Taxes", "verboseLabel": "Long term and deferred income taxes" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r71", "r75" ] }, "pahc_RealizedGainLossOnMaturedContractsRecordedAsInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "RealizedGainLossOnMaturedContractsRecordedAsInventory", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "This is the amount of gain (loss) on matured contracts, that we record to Inventory.", "label": "Realized Gain Loss On Matured Contracts Recorded As Inventory", "verboseLabel": "Realized gains (losses) related to matured contracts recorded as a component of inventory" } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "(Income) expense recorded in consolidated statements of operations", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r775" ] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Debt Issuance Costs", "negatedLabel": "Debt issuance costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r40" ] }, "pahc_CompensationAndBenefitForServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "CompensationAndBenefitForServicesMember", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Compensation and Benefit for Services [Member]", "label": "Compensation and Benefit for Services [Member]", "terseLabel": "Compensation and Benefit for Services" } } }, "auth_ref": [] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherLongTermDebt", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Other Long-Term Debt", "negatedLabel": "Payments of long-term debt", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "pahc_AnimalHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AnimalHealthMember", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Animal Health [Member]", "label": "Animal Health [Member]", "terseLabel": "Animal Health" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails": { "parentTag": "us-gaap_DepreciationDepletionAndAmortization", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "verboseLabel": "Depreciation of property, plant and equipment", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r9", "r53" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Derivative Instruments [Table Text Block]", "verboseLabel": "Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r15", "r66", "r67", "r68", "r70", "r73", "r76", "r78", "r79" ] }, "us-gaap_DerivativeAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Noncurrent", "terseLabel": "Derivative instruments", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r166" ] }, "pahc_PerformanceProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "PerformanceProductsMember", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance Products [Member]", "label": "Performance Products [Member]", "terseLabel": "Performance Products" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "pahc_TermALoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "TermALoanMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Term A Loan [Member]", "label": "Term A Loan [Member]", "terseLabel": "Term A Loan" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r694" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Current", "terseLabel": "Other current assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r164", "r676" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesTables" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of effects of derivatives", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r72", "r76", "r409" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r647", "r668", "r675" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r409" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureDerivatives" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "Derivatives", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r129", "r410", "r417" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r15", "r72", "r76" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net (loss) income - diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r180", "r205", "r208", "r209", "r210", "r211", "r213", "r216" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r15", "r72", "r76", "r77", "r81", "r82", "r409" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r448", "r449", "r785" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r773", "r774" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateContractMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r638", "r647", "r668" ] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingParValuePerShare", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Net Income per Share and Weighted Average Shares" } } }, "auth_ref": [] }, "pahc_AverageCustomerCollectionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AverageCustomerCollectionPeriod", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Average Customer Collection Period", "label": "Average Customer Collection Period", "verboseLabel": "Average worldwide collection period for accounts receivable" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "pahc_LatinAmericaAndCanadaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "LatinAmericaAndCanadaMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "documentation": "Latin America and Canada [Member]", "label": "Latin America and Canada [Member]", "terseLabel": "Latin America and Canada" } } }, "auth_ref": [] }, "us-gaap_FairValueNetAssetLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetAssetLiabilityAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Net Asset (Liability) [Abstract]", "terseLabel": "Fair Value of Assets" } } }, "auth_ref": [] }, "pahc_NutritionalSpecialtiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "NutritionalSpecialtiesMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Nutritional Specialties [Member]", "label": "Nutritional Specialties [Member]", "terseLabel": "Nutritional Specialties" } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Schedule of other liabilities", "documentation": "Tabular disclosure of other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "EMEA [Member]", "terseLabel": "Europe, Middle East and Africa", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r801", "r802", "r803", "r804" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r421" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseOther", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": "us-gaap_InterestExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Other", "verboseLabel": "Other", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loans Payable, Current", "terseLabel": "Current portion of long-term debt", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r26" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r417" ] }, "pahc_ShareBasedPaymentArrangementExpenseExpectedYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedPaymentArrangementExpenseExpectedYearFour", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Expense, Expected, Year Four", "label": "Share-Based Payment Arrangement, Expense, Expected, Year Four", "terseLabel": "Share-based payment arrangement, expense, expected, year four" } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r776" ] }, "pahc_ShareBasedPaymentArrangementExpenseExpectedYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedPaymentArrangementExpenseExpectedYearTwo", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Expense, Expected, Year Two", "label": "Share-Based Payment Arrangement, Expense, Expected, Year Two", "terseLabel": "Share-based payment arrangement, expense, expected, year two" } } }, "auth_ref": [] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r15", "r66", "r67", "r68", "r70", "r73", "r76", "r78", "r79", "r82", "r417" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting percentage (as a percent)", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r744" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r182" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r182" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedLabel": "Provision for income taxes", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r7", "r12", "r128" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "INVESTING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided (used) by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r114", "r115", "r116" ] }, "us-gaap_LoansPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Loans Payable [Member]", "terseLabel": "Loans Payable", "documentation": "Borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [] }, "pahc_ShareBasedPaymentArrangementExpenseExpectedYearOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedPaymentArrangementExpenseExpectedYearOne", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Expense, Expected, Year One", "label": "Share-Based Payment Arrangement, Expense, Expected, Year One", "terseLabel": "Share-based payment arrangement, expense, expected, year one" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "pahc_ShareBasedPaymentArrangementExpenseExpectedYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedPaymentArrangementExpenseExpectedYearThree", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Expense, Expected, Year Three", "label": "Share-Based Payment Arrangement, Expense, Expected, Year Three", "terseLabel": "Share-based payment arrangement, expense, expected, year three" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value", "terseLabel": "Grant date fair value" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "verboseLabel": "Other", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r26", "r676" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 }, "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Other liabilities, total", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r693" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r146", "r159", "r160", "r161", "r185", "r206", "r207", "r214", "r216", "r219", "r220", "r258", "r282", "r285", "r286", "r287", "r293", "r294", "r324", "r325", "r326", "r327", "r328", "r426", "r514", "r515", "r516", "r517", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r550", "r572", "r596", "r619", "r620", "r621", "r622", "r623", "r698", "r716", "r724" ] }, "us-gaap_FairValueInputsLevel12And3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel12And3Member", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]", "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3)." } } }, "auth_ref": [ "r743" ] }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetRelatedDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Balance Sheets-Additional Information" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r146", "r159", "r160", "r161", "r185", "r206", "r207", "r214", "r216", "r219", "r220", "r258", "r282", "r285", "r286", "r287", "r293", "r294", "r324", "r325", "r326", "r327", "r328", "r426", "r514", "r515", "r516", "r517", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r550", "r572", "r596", "r619", "r620", "r621", "r622", "r623", "r698", "r716", "r724" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r27", "r152", "r185", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r402", "r406", "r407", "r426", "r676", "r738", "r786", "r787" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r17", "r239", "r240", "r241", "r242", "r248", "r727" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r693" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "verboseLabel": "Property, plant and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r476", "r482", "r676" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementRelatedDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementRelatedDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Statements of Operations-Additional Information" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivatives" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r693" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r38" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r693" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r188", "r227", "r238", "r239", "r240", "r241", "r242", "r244", "r248", "r282", "r283", "r284", "r285", "r287", "r288", "r290", "r292", "r293", "r738", "r739" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Stock Incentive Plan" } } }, "auth_ref": [] }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalFundsEffectiveSwapRateMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg." } } }, "auth_ref": [ "r776" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r188", "r227", "r238", "r239", "r240", "r241", "r242", "r244", "r248", "r282", "r283", "r284", "r285", "r287", "r288", "r290", "r292", "r293", "r738", "r739" ] }, "us-gaap_LongtermDebtCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtCurrentAndNoncurrentAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDebtClassificationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Current and Noncurrent [Abstract]", "terseLabel": "Long-term debt" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total", "totalLabel": "Comprehensive (loss) income", "verboseLabel": "Comprehensive (loss) income", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r35", "r171", "r173", "r178", "r473", "r486" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Taxes Payable, Current", "verboseLabel": "Income and other taxes", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r24" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r121", "r274", "r275", "r626", "r734" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r539", "r541", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r563", "r564", "r565", "r566", "r583", "r584", "r585", "r586", "r589", "r590", "r591", "r592", "r609", "r611", "r614", "r616", "r679", "r681" ] }, "us-gaap_LongTermDebtAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Unclassified [Abstract]", "terseLabel": "Long-Term Debt" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r95", "r324" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r71", "r73", "r81" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r96" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "verboseLabel": "Current operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r442" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r95", "r550" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r95", "r550", "r568", "r799", "r800" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "terseLabel": "Common Class B", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r799" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "verboseLabel": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r96" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "verboseLabel": "Accrued expenses and other liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r714" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r202", "r354", "r701", "r702", "r723" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r422", "r423", "r424" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Long-term operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r442" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r95", "r324" ] }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent [Abstract]", "terseLabel": "Derivatives" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of other assets", "documentation": "Tabular disclosure of noncurrent assets." } } }, "auth_ref": [ "r708" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r202", "r354", "r701", "r723" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "netLabel": "Net (loss) income", "totalLabel": "Net (loss) income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r107", "r116", "r137", "r150", "r169", "r172", "r176", "r185", "r192", "r194", "r195", "r196", "r197", "r200", "r201", "r212", "r225", "r239", "r245", "r248", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r420", "r426", "r485", "r571", "r594", "r595", "r651", "r689", "r738" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r96", "r550" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r443" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "verboseLabel": "Common stock, shares outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r96", "r550", "r568", "r799", "r800" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r443" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r443" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAssetsMeasuredOnRecurringBasisUnobservableInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]", "terseLabel": "Changes in the fair value of the Level 3 assets" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189", "r190", "r191", "r218", "r458", "r513", "r535", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r563", "r564", "r565", "r566", "r567", "r569", "r573", "r574", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r596", "r682" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets", "verboseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "terseLabel": "Operating Segments", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r238", "r239", "r240", "r241", "r242", "r248" ] }, "us-gaap_DepositsAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssets", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deposits Assets", "verboseLabel": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future." } } }, "auth_ref": [ "r708" ] }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation", "terseLabel": "U.S. pension plan", "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r352", "r670" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r109", "r185", "r225", "r239", "r245", "r248", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r426", "r651", "r738" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r696" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU operating lease assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r441" ] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Sales Commission, Current", "verboseLabel": "Commissions and rebates", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26", "r643" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r174", "r175", "r432", "r433", "r434", "r435", "r436", "r437" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r29" ] }, "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsGeneralInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]", "terseLabel": "Business Segments" } } }, "auth_ref": [] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.pahc.com/role/DisclosureDescriptionOfBusiness" ], "lang": { "en-us": { "role": { "label": "Nature of Operations [Text Block]", "verboseLabel": "Description of Business", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r142", "r144" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r41", "r153", "r641" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r309", "r345", "r350", "r423", "r454", "r656", "r657", "r668", "r669", "r670" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r25", "r185", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r402", "r406", "r407", "r426", "r548", "r650", "r691", "r738", "r786", "r787" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails": { "parentTag": "us-gaap_DepreciationDepletionAndAmortization", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r51", "r52" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r309", "r345", "r350", "r423", "r453", "r668", "r669", "r670" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r130", "r156", "r185", "r225", "r240", "r246", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r401", "r406", "r426", "r477", "r562", "r676", "r691", "r738", "r739", "r786" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": "us-gaap_InterestExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r108", "r317", "r439", "r715" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "verboseLabel": "Employee related", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest and Other Income", "negatedLabel": "Interest income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r693" ] }, "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Disclosure [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "verboseLabel": "Schedule of revenues disaggregated by major product category and geographic region", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r742" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r226", "r227", "r238", "r243", "r244", "r250", "r252", "r254", "r338", "r339", "r458" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r309", "r345", "r346", "r347", "r348", "r349", "r350", "r423", "r455", "r656", "r657", "r668", "r669", "r670" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net (loss) income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r150", "r169", "r172", "r181", "r185", "r192", "r200", "r201", "r225", "r239", "r245", "r248", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r400", "r403", "r404", "r420", "r426", "r475", "r484", "r523", "r571", "r594", "r595", "r651", "r673", "r674", "r690", "r712", "r738" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r374" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r695" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Grant date fair value (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossUnrealized", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedLabel": "Foreign currency losses, net", "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r116", "r570", "r689", "r779", "r780", "r798" ] }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "presentation": [ "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Long-term debt, weighted average interest rate, over time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r703", "r713" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r101", "r133", "r481", "r676", "r718", "r729", "r778" ] }, "us-gaap_OtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]", "verboseLabel": "Other assets" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r693" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Net sales", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r339", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Nonoperating, Net", "negatedTotalLabel": "Interest expense, net", "documentation": "The net amount of nonoperating interest income (expense)." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r351", "r448", "r449", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r543", "r544", "r545", "r546", "r547", "r567", "r569", "r601", "r785" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r69" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r339", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of shares", "verboseLabel": "Weighted average common shares outstanding" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent, Total", "verboseLabel": "Foreign currency translation adjustment", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r7", "r12", "r128" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r386", "r393" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "verboseLabel": "Basis spread on variable rate (as a percent)", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Disaggregated Revenue, Deferred Revenue and Customer Payment Terms", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r145", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r340" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Additional Disclosure [Abstract]", "terseLabel": "Stock Incentive Plan" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted average number of shares - diluted (in shares)", "verboseLabel": "diluted (in shares)", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r205", "r216" ] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility, expiration date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r23" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r693" ] }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMiscellaneousNoncurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets, Miscellaneous, Noncurrent", "verboseLabel": "Other", "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r151", "r165", "r185", "r258", "r282", "r283", "r285", "r286", "r287", "r289", "r291", "r293", "r294", "r401", "r406", "r426", "r676", "r738", "r739", "r786" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r174", "r175", "r432", "r433", "r434", "r435", "r436", "r437" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Intangibles, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r120", "r459" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "basic (in shares)", "verboseLabel": "Weighted average number of shares - basic (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r203", "r216" ] }, "us-gaap_OtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities [Abstract]", "verboseLabel": "Other liabilities" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation", "terseLabel": "Stock-based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Net, Total", "negatedLabel": "Interest expense, net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r138" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r252", "r253", "r536", "r537", "r538", "r603", "r605", "r608", "r618", "r625", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r640", "r662", "r681", "r742", "r795" ] }, "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationOperatingIncomeLossAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]", "terseLabel": "Adjusted EBITDA", "verboseLabel": "Reconciliation of income before income taxes to Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r168", "r175", "r176", "r405", "r648", "r710" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureDebtClassificationDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDebtClassificationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Current Maturities", "negatedLabel": "Less: current maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r157" ] }, "us-gaap_DerivativeMaturityDates": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeMaturityDates", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Maturity Date", "terseLabel": "Derivative, maturity date", "documentation": "Date derivative contract ends, in YYYY-MM-DD format." } } }, "auth_ref": [ "r540", "r541", "r609", "r610", "r612", "r613", "r615", "r681" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "New Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_CommonStockValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValueOutstanding", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Outstanding", "verboseLabel": "Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2023, and June 30, 2023; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2023, and June 30, 2023", "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares." } } }, "auth_ref": [ "r96", "r550" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Noncash Income (Expense)", "negatedLabel": "Other", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r116" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlan" ], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "verboseLabel": "Stock Incentive Plan", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r355", "r359", "r387", "r388", "r389", "r672" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold", "verboseLabel": "Consolidated statement of operations - total cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r110", "r458" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax, Portion Attributable to Parent, Total", "negatedLabel": "Expense (income) recorded in comprehensive (loss) income", "verboseLabel": "Change in fair value of derivative instruments", "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r167" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net (loss) income - basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r180", "r194", "r195", "r196", "r197", "r203", "r204", "r213", "r216", "r225", "r239", "r245", "r248", "r651" ] }, "us-gaap_SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationIncomeLossBeforeIncomeTaxesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Income (Loss) before Income Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationProfitLossAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Profit (Loss) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r431" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r250", "r458", "r500", "r501", "r502", "r503", "r504", "r505", "r639", "r661", "r677", "r704", "r736", "r737", "r742", "r795" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r114" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r276", "r277", "r280", "r281", "r344", "r353", "r382", "r383", "r384", "r456", "r457", "r506", "r540", "r541", "r602", "r604", "r606", "r607", "r617", "r636", "r637", "r652", "r660", "r671", "r678", "r681", "r732", "r740", "r789", "r790", "r791", "r792", "r793" ] }, "us-gaap_AOCIAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Abstract]", "terseLabel": "Accumulated other comprehensive loss" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r41", "r114", "r183" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByProductTypeDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r250", "r458", "r500", "r501", "r502", "r503", "r504", "r505", "r639", "r661", "r677", "r704", "r736", "r737", "r742", "r795" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r799" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities, net of business acquisition:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "auth_ref": [ "r276", "r277", "r280", "r281", "r353", "r457", "r506", "r540", "r541", "r602", "r604", "r606", "r607", "r617", "r636", "r637", "r652", "r660", "r671", "r678", "r740", "r788", "r789", "r790", "r791", "r792", "r793" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r276", "r277", "r280", "r281", "r344", "r353", "r382", "r383", "r384", "r456", "r457", "r506", "r540", "r541", "r602", "r604", "r606", "r607", "r617", "r636", "r637", "r652", "r660", "r671", "r678", "r681", "r732", "r740", "r789", "r790", "r791", "r792", "r793" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "basic (in dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r179", "r194", "r195", "r196", "r197", "r198", "r203", "r206", "r214", "r215", "r216", "r217", "r419", "r420", "r474", "r487", "r649" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r714" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureDebtClassificationDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDebtClassificationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, non-current", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r158" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r679", "r680", "r681", "r683", "r684", "r685", "r688", "r720", "r721", "r777", "r796", "r799" ] }, "us-gaap_PreferredStockValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValueOutstanding", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Outstanding", "verboseLabel": "Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding", "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders." } } }, "auth_ref": [ "r95", "r550" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders' equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r96", "r99", "r100", "r118", "r552", "r568", "r597", "r598", "r676", "r691", "r718", "r729", "r778", "r799" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Total", "totalLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r85", "r139", "r177", "r229", "r438", "r580", "r689", "r797" ] }, "us-gaap_StockTransactionsParentheticalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockTransactionsParentheticalDisclosuresAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals" ], "lang": { "en-us": { "role": { "label": "Stock Transactions, Parenthetical Disclosures [Abstract]", "terseLabel": "Dividends declared" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense [Abstract]", "verboseLabel": "Interest expense, net" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "diluted (in dollars per share)", "verboseLabel": "diluted (in dollars per share)", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r179", "r194", "r195", "r196", "r197", "r198", "r206", "r214", "r215", "r216", "r217", "r419", "r420", "r474", "r487", "r649" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies.", "verboseLabel": "Commitments and contingencies (Note 8)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r31", "r89", "r478", "r549" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "verboseLabel": "(Benefit) provision for income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r141", "r143", "r200", "r201", "r233", "r396", "r399", "r488" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureDebtReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.pahc.com/role/DisclosureDebtClassificationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureDebtClassificationDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt", "totalLabel": "Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r20", "r132", "r308", "r323", "r656", "r657", "r794" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "verboseLabel": "Retained earnings", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r98", "r125", "r480", "r510", "r512", "r518", "r551", "r676" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign currency losses, net", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r593" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 }, "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Accumulated other comprehensive loss", "verboseLabel": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r33", "r34", "r105", "r162", "r479", "r511", "r512" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt" } } }, "auth_ref": [] }, "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Accrued Liabilities and Other Liabilities, Current", "label": "Accrued Liabilities and Other Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities, total" } } }, "auth_ref": [] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, Work in Process, Net of Reserves", "verboseLabel": "Work-in-process", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r119", "r645" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r122", "r184", "r295", "r301", "r302", "r303", "r304", "r305", "r306", "r311", "r318", "r319", "r321" ] }, "pahc_CreditAgreement2022TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "CreditAgreement2022TermLoanMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "documentation": "Credit Agreement, 2022 Term Loan [Member]", "label": "Credit Agreement, 2022 Term Loan [Member]", "terseLabel": "2022 Term Loan" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r697" ] }, "pahc_RevolverMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "RevolverMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolver [Member]", "label": "Revolver [Member]", "terseLabel": "Revolver" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r390", "r391", "r392", "r524", "r720", "r721", "r722", "r777", "r799" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories, net", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "pahc_DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisMaximum", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, First Lien Net Leverage Ratio, Trailing Four-quarter Basis, Maximum", "label": "Debt Instrument, Covenants, First Lien Net Leverage Ratio, Trailing Four-quarter Basis, Maximum", "terseLabel": "Maximum First Lien Net Leverage Ratio" } } }, "auth_ref": [] }, "pahc_CorporateCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "CorporateCosts", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "documentation": "Corporate Cost consists of the cost of employees, marketing expenses, other corporate indirect costs.", "label": "Corporate Costs", "terseLabel": "Corporate costs" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, Finished Goods, Net of Reserves", "verboseLabel": "Finished goods", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r119", "r644" ] }, "pahc_DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentBasisSpreadOnVariableRateScenarioFourMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread on Variable Rate, Scenario Four [Member]", "label": "Debt Instrument, Basis Spread on Variable Rate, Scenario Four [Member]", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate, Scenario Four" } } }, "auth_ref": [] }, "pahc_PaymentTermLowEndOfRange": { "xbrltype": "durationItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "PaymentTermLowEndOfRange", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Payment Term, Low End of Range", "label": "Payment Term, Low End of Range", "terseLabel": "Payment term, minimum" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, Raw Materials, Net of Reserves", "verboseLabel": "Raw materials", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r119", "r646" ] }, "pahc_IncrementalTermLoan2023DueApril2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "IncrementalTermLoan2023DueApril2026Member", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental Term Loan, 2023, Due April 2026 [Member]", "label": "Incremental Term Loan, 2023, Due April 2026 [Member]", "terseLabel": "2023 Incremental Term Loan due April 2026" } } }, "auth_ref": [] }, "pahc_InterestRateSwapMarch2020Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "InterestRateSwapMarch2020Member", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, March 2020 [Member]", "label": "Interest Rate Swap, March 2020 [Member]", "terseLabel": "Interest Rate Swap, March 2020" } } }, "auth_ref": [] }, "pahc_CreditFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "CreditFacilitiesMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "documentation": "Credit Facilities [Member]", "label": "Credit Facilities [Member]", "terseLabel": "Credit Facilities" } } }, "auth_ref": [] }, "pahc_PaymentsForInsurancePremiumFinancingFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "PaymentsForInsurancePremiumFinancingFinancingActivities", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Payments for Insurance Premium Financing, Financing Activities", "label": "Payments for Insurance Premium Financing, Financing Activities", "negatedLabel": "Payments of insurance premium financing" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Net (loss) income per share" } } }, "auth_ref": [] }, "pahc_ScheduleOfDepreciationAndAmortizationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ScheduleOfDepreciationAndAmortizationTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of depreciation and amortization.", "label": "Schedule of Depreciation and Amortization [Table Text Block]", "terseLabel": "Schedule of depreciation and amortization" } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r32", "r147", "r174", "r175", "r176", "r189", "r190", "r191", "r193", "r199", "r201", "r218", "r259", "r260", "r329", "r390", "r391", "r392", "r397", "r398", "r411", "r412", "r413", "r414", "r415", "r416", "r418", "r432", "r433", "r434", "r435", "r436", "r437", "r444", "r507", "r508", "r509", "r524", "r596" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r186", "r187", "r448", "r449", "r450", "r451", "r543", "r544", "r545", "r546", "r547", "r567", "r569", "r601" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventory, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r163", "r642", "r676" ] }, "pahc_AccruedExpensesAndOtherLiabilitiesCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AccruedExpensesAndOtherLiabilitiesCurrentTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accrued expenses and other current liabilities.", "label": "Accrued Expenses and Other Liabilities, Current [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Accumulated Deficit)", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r147", "r189", "r190", "r191", "r193", "r199", "r201", "r259", "r260", "r390", "r391", "r392", "r397", "r398", "r411", "r413", "r414", "r416", "r418", "r507", "r509", "r524", "r799" ] }, "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Preferred stock" } } }, "auth_ref": [] }, "pahc_PaymentTermHighEndOfRange": { "xbrltype": "durationItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "PaymentTermHighEndOfRange", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Payment Term, High End of Range", "label": "Payment Term, High End of Range", "terseLabel": "Payment term, maximum" } } }, "auth_ref": [] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNetAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories, net" } } }, "auth_ref": [] }, "pahc_DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentBasisSpreadOnVariableRateScenarioThreeMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread on Variable Rate, Scenario Three [Member]", "label": "Debt Instrument, Basis Spread on Variable Rate, Scenario Three [Member]", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate, Scenario Three" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r5", "r13", "r34", "r710", "r711", "r712" ] }, "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Common stock" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest", "terseLabel": "(Loss) income before income taxes", "totalLabel": "(Loss) income before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r106", "r136", "r225", "r239", "r245", "r248", "r475", "r483", "r651" ] }, "pahc_DefinedBenefitPlanSettlementAnnuityPurchaseAgreementBenefitObligationAnnuityPurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DefinedBenefitPlanSettlementAnnuityPurchaseAgreementBenefitObligationAnnuityPurchasePrice", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationAnnuityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Settlement, Annuity Purchase Agreement, Benefit Obligation, Annuity Purchase Price", "label": "Defined Benefit Plan, Settlement, Annuity Purchase Agreement, Benefit Obligation, Annuity Purchase Price", "terseLabel": "Annuity purchase price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureDebtReconciliationDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Long-term debt, gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r20", "r132", "r322" ] }, "pahc_DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentBasisSpreadOnVariableRateScenarioTwoMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread on Variable Rate, Scenario Two [Member]", "label": "Debt Instrument, Basis Spread on Variable Rate, Scenario Two [Member]", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate, Scenario Two" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "auth_ref": [] }, "pahc_InterestRateSwapJuly2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "InterestRateSwapJuly2022Member", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, July 2022 [Member]", "label": "Interest Rate Swap, July 2022 [Member]", "terseLabel": "Interest Rate Swap, July 2022" } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Short-term Investments", "verboseLabel": "Short-term investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r134", "r135", "r709" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r3", "r13", "r34", "r175", "r176", "r433", "r434", "r435", "r436", "r437", "r710" ] }, "pahc_AccruedInsurancePremiumFinancingCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "AccruedInsurancePremiumFinancingCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Accrued Insurance Premium Financing, Current", "label": "Accrued Insurance Premium Financing, Current", "terseLabel": "Insurance premium financing" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred income taxes", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r394", "r395" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r147", "r174", "r175", "r176", "r189", "r190", "r191", "r193", "r199", "r201", "r218", "r259", "r260", "r329", "r390", "r391", "r392", "r397", "r398", "r411", "r412", "r413", "r414", "r415", "r416", "r418", "r432", "r433", "r434", "r435", "r436", "r437", "r444", "r507", "r508", "r509", "r524", "r596" ] }, "us-gaap_DerivativeAssetFairValueNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueNetAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral [Abstract]", "terseLabel": "Other assets" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "pahc_DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentBasisSpreadOnVariableRateScenarioOneMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread on Variable Rate, Scenario One [Member]", "label": "Debt Instrument, Basis Spread on Variable Rate, Scenario One [Member]", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate, Scenario One" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r13", "r34", "r412", "r415", "r444", "r507", "r508", "r710", "r711", "r712", "r720", "r721", "r722" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r23" ] }, "pahc_DebtInstrumentCovenantsInterestCoverageRatioTrailingFourQuarterBasisMinimum": { "xbrltype": "pureItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentCovenantsInterestCoverageRatioTrailingFourQuarterBasisMinimum", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, Interest Coverage Ratio, Trailing Four-quarter Basis, Minimum", "label": "Debt Instrument, Covenants, Interest Coverage Ratio, Trailing Four-quarter Basis, Minimum", "terseLabel": "Minimum interest coverage ratio" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net, Current", "verboseLabel": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r255", "r256" ] }, "pahc_DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisTestPeriodMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "DebtInstrumentCovenantsFirstLienNetLeverageRatioTrailingFourQuarterBasisTestPeriodMaximum", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, First Lien Net Leverage Ratio, Trailing Four-quarter Basis, Test Period, Maximum", "label": "Debt Instrument, Covenants, First Lien Net Leverage Ratio, Trailing Four-quarter Basis, Test Period, Maximum", "terseLabel": "Maximum First Lien Net Leverage Ratio, Test Period" } } }, "auth_ref": [] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingImmediatelyVestInFullChangeInControlSharesOfStockCeaseToTradeOnNationallyRecognizedExchangePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingImmediatelyVestInFullChangeInControlSharesOfStockCeaseToTradeOnNationallyRecognizedExchangePercentage", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Immediately Vest in Full, Change in Control, Shares of Stock Cease to Trade on Nationally Recognized Exchange, Percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Immediately Vest in Full, Change in Control, Shares of Stock Cease to Trade on Nationally Recognized Exchange, Percentage", "terseLabel": "Vesting, immediately vest in full, change in control, shares of stock cease to trade on nationally recognized exchange, percentage (as a percent)" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r140", "r770", "r771", "r772" ] }, "us-gaap_LongTermLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermLoansPayable", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loans Payable, Noncurrent", "terseLabel": "Long-term debt", "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r29" ] }, "us-gaap_NotionalAmountOfDerivativesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotionalAmountOfDerivativesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Notional Disclosures [Abstract]", "terseLabel": "Derivatives" } } }, "auth_ref": [] }, "pahc_July2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "July2023Member", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "July 2023 [Member]", "label": "July 2023 [Member]", "terseLabel": "July 2023" } } }, "auth_ref": [] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingImmediatelyVestInFullQualifyingTerminationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingImmediatelyVestInFullQualifyingTerminationPeriod", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Immediately Vest in Full, Qualifying Termination, Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Immediately Vest in Full, Qualifying Termination, Period", "terseLabel": "Vesting, immediately vest in full, qualifying termination, period" } } }, "auth_ref": [] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other Investments", "terseLabel": "Insurance investments", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r707" ] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDaySharePriceMaximum": { "xbrltype": "perShareItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDaySharePriceMaximum", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Share Price, Maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Share Price, Maximum", "terseLabel": "Vesting, achievement of arithmetic average of closing stock price per share for each trading day, share price, maximum (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net Income per Share and Weighted Average Shares", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r42", "r43" ] }, "pahc_ScheduleOfInterestExpenseNetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ScheduleOfInterestExpenseNetTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest expense, net.", "label": "Schedule of Interest Expense, Net [Table Text Block]", "terseLabel": "Schedule of interest expense, net" } } }, "auth_ref": [] }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForEnvironmentalLossContingencies", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails" ], "lang": { "en-us": { "role": { "label": "Accrual for Environmental Loss Contingencies", "terseLabel": "Accrual for environmental loss contingencies", "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies." } } }, "auth_ref": [ "r279", "r654", "r699", "r700", "r733", "r735" ] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDaySharePriceMinimum": { "xbrltype": "perShareItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDaySharePriceMinimum", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Share Price, Minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Share Price, Minimum", "terseLabel": "Vesting, achievement of arithmetic average of closing stock price per share for each trading day, share price, minimum (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Aggregate available credit facilities", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r23" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r97" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "verboseLabel": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22", "r676" ] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDayPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDayPeriod", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Period", "terseLabel": "Vesting, achievement of arithmetic average of closing stock price per share for each trading day, period" } } }, "auth_ref": [] }, "pahc_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDayVestingPercentageMinimum": { "xbrltype": "percentItemType", "nsuri": "http://www.pahc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingAchievementOfArithmeticAverageOfClosingStockPricePerShareForEachTradingDayVestingPercentageMinimum", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Vesting Percentage, Minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting, Achievement of Arithmetic Average of Closing Stock Price Per Share for Each Trading Day, Vesting Percentage, Minimum", "terseLabel": "Vesting, achievement of arithmetic average of closing stock price per share for each trading day, vesting percentage, minimum (as a percent)" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r309", "r345", "r346", "r347", "r348", "r349", "r350", "r453", "r454", "r455", "r656", "r657", "r668", "r669", "r670" ] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Base Rate [Member]", "terseLabel": "Base Rate", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments", "verboseLabel": "Maturities of short-term investments", "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r36", "r113" ] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared (in dollars per share)", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r125" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r309", "r345", "r346", "r347", "r348", "r349", "r350", "r423", "r453", "r454", "r455", "r656", "r657", "r668", "r669", "r670" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegments" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Business Segments", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r237", "r242", "r246", "r247", "r248", "r249", "r250", "r251", "r254" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liability, Defined Benefit Plan, Noncurrent", "terseLabel": "International retirement plans", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r94", "r341", "r342", "r343", "r670" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r189", "r190", "r191", "r218", "r458", "r513", "r535", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r563", "r564", "r565", "r566", "r567", "r569", "r573", "r574", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r596", "r682" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies and New Accounting Standards" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAssetReconcilingItemLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAssetReconcilingItemLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Asset Reconciling Item [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "terseLabel": "Unrecognized net pension gains", "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r4", "r105", "r127" ] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Assets from Segment to Consolidated [Table]", "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax", "terseLabel": "Pension settlement recognition", "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r6", "r105", "r127" ] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Schedule of identifiable assets", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r116" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "verboseLabel": "Schedule of information regarding reportable segments", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r44", "r45", "r46", "r50" ] }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Supplemental retirement benefits, deferred compensation and other", "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent." } } }, "auth_ref": [ "r59", "r60", "r94", "r126" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Operating (loss) income", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r225", "r239", "r245", "r248", "r651" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationRevenueAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]", "terseLabel": "Net sales" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r44", "r45", "r46", "r50" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r638", "r686", "r687" ] }, "us-gaap_AccruedInsuranceCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedInsuranceCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Insurance, Current", "terseLabel": "Insurance-related", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r47", "r49" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Secured Debt [Member]", "terseLabel": "Secured Debt", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureDebtReconciliationDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedLabel": "Unamortized debt issuance costs", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r85", "r741" ] }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Other Long-Term Debt", "terseLabel": "Proceeds from long-term debt", "documentation": "Amount of cash inflow from issuance of long-term debt classified as other." } } }, "auth_ref": [ "r37" ] }, "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent." } } }, "auth_ref": [ "r408" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative." } } }, "auth_ref": [ "r775" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "verboseLabel": "Schedule of long term debt", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r29", "r57", "r58", "r83", "r84", "r86", "r90", "r123", "r124", "r656", "r658", "r719" ] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "parentTag": "pahc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Professional Fees, Current", "verboseLabel": "Professional fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_AccrualForEnvironmentalLossContingenciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForEnvironmentalLossContingenciesAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails" ], "lang": { "en-us": { "role": { "label": "Accrual for Environmental Loss Contingencies [Abstract]", "terseLabel": "Environmental" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Equity method investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r235", "r257", "r706", "r728" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value of assets and liabilities measured on a recurring basis", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r422", "r423" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "verboseLabel": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r111" ] }, "us-gaap_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesEnvironmentalDetails" ], "lang": { "en-us": { "role": { "label": "Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Environmental Loss Contingency, Statement of Financial Position", "documentation": "Indicates line item in statement of financial position that includes accrual for environmental loss contingency." } } }, "auth_ref": [ "r278", "r654" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net (loss) income to net cash provided (used) by operating activities:" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNoncurrentNet", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Noncurrent, Net", "terseLabel": "Debt issuance costs", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r85" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Business Segments" } } }, "auth_ref": [] }, "us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Immediate Family Member of Management or Principal Owner [Member]", "terseLabel": "Immediate Family Member of Management or Principal Owner", "documentation": "Family member whom a principal owner or a member of management might control or influence, or by whom they might be controlled or influenced, because of the family relationship." } } }, "auth_ref": [ "r783", "r784" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "auth_ref": [ "r801", "r802", "r803", "r804" ] }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities, Noncurrent", "verboseLabel": "Other long-term liabilities", "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventories", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r21", "r102", "r103", "r104" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "verboseLabel": "Stock-based compensation expense", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r61", "r62", "r357" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentageAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage [Abstract]", "terseLabel": "Debt" } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails": { "parentTag": "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "weight": -1.0, "order": 3.0 }, "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "totalLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r230" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Long-term Lines of Credit", "terseLabel": "Revolving credit facility borrowings", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r37" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r84", "r86", "r296", "r440", "r656", "r657" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r154", "r261", "r472", "r653", "r676", "r730", "r731" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Dividends, Common Stock, Cash", "negatedLabel": "Dividends declared", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r125" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsGeneralInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r726" ] }, "us-gaap_DerivativeGainLossOnDerivativeNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNetAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Gain (Loss) on Derivative, Net [Abstract]", "terseLabel": "Derivatives" } } }, "auth_ref": [] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r71", "r81" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortizationAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDepreciationAndAmortizationDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization [Abstract]", "verboseLabel": "Depreciation and amortization" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeNetAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Fair Value, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAssetsMeasuredOnRecurringBasisUnobservableInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfers between levels, assets", "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Frequency of Periodic Payment", "terseLabel": "Debt instrument, frequency of periodic payment", "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual)." } } }, "auth_ref": [ "r29", "r91" ] }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalFinancialInformationDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation" ], "lang": { "en-us": { "role": { "label": "Additional Financial Information Disclosure [Text Block]", "verboseLabel": "Additional Information", "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r87", "r88", "r575", "r576", "r579" ] }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral", "terseLabel": "Other assets", "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r16", "r18", "r19", "r80" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r445", "r446", "r447", "r449", "r452", "r519", "r520", "r521", "r577", "r578", "r579", "r599", "r600" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of accumulated other comprehensive loss", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r34", "r781", "r782" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Equity Award [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Other comprehensive income", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r7", "r12", "r128", "r170", "r173" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transactions", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r575", "r576", "r579" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stock Incentive Plan", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r356", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r356", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsLiabilitiesMeasuredOnRecurringBasisUnobservableInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers between levels, liabilities", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r351", "r448", "r449", "r543", "r544", "r545", "r546", "r547", "r567", "r569", "r601" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsLiabilitiesMeasuredOnRecurringBasisUnobservableInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]", "terseLabel": "Changes in the fair value of the Level 3 liabilities" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of net income per share and weighted average shares", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r725" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebtExcludingAmortization", "crdr": "debit", "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails": { "parentTag": "us-gaap_InterestExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest expense, excluding amortization", "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs." } } }, "auth_ref": [ "r112", "r316", "r658", "r659" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r15" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherAssetsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other assets", "totalLabel": "Other assets, total", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r155" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r63", "r64", "r65", "r147", "r148", "r175", "r189", "r190", "r191", "r193", "r199", "r259", "r260", "r329", "r390", "r391", "r392", "r397", "r398", "r411", "r412", "r413", "r414", "r415", "r416", "r418", "r432", "r433", "r437", "r444", "r508", "r509", "r522", "r552", "r568", "r597", "r598", "r624", "r690", "r718", "r729", "r778", "r799" ] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r56" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.pahc.com/role/DisclosureDebtDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesBalanceSheetLocationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesNotionalAmountsDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r72", "r74", "r76", "r77", "r539", "r541", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r563", "r564", "r565", "r566", "r583", "r584", "r585", "r586", "r589", "r590", "r591", "r592", "r609", "r611", "r614", "r616", "r647", "r679", "r681" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Interest rate (as a percent)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r28", "r297" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Amounts of Transaction", "verboseLabel": "Aggregate compensation and benefits", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r88", "r448" ] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies and New Accounting Standards", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r117" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.pahc.com/role/DisclosureStockIncentivePlanRestrictedStockUnitsDetails", "http://www.pahc.com/role/DisclosureStockIncentivePlanStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationNetSalesByRegionDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "auth_ref": [ "r252", "r253", "r536", "r537", "r538", "r603", "r605", "r608", "r618", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r640", "r662", "r681", "r742", "r795" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsAdjustedEbitdaDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsDepreciationAndAmortizationDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsIdentifiableAssetsDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsNetSalesDetails", "http://www.pahc.com/role/DisclosureBusinessSegmentsReconciliationOfIncomeBeforeIncomeTaxesToAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r222", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r254", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r272", "r273", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r653", "r704", "r795" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsFairValueOfAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r422", "r423", "r424" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.pahc.com/role/DisclosureDebtGeneralInformationDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesStatedRatesDetails", "http://www.pahc.com/role/DisclosureDebtInterestRatesWeightedAverageRatesDetails", "http://www.pahc.com/role/DisclosureDebtReconciliationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationInterestExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r29", "r188", "r296", "r297", "r298", "r299", "r300", "r302", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r440", "r655", "r656", "r657", "r658", "r659", "r717" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-9" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r639": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r641": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r644": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r649": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r650": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-16" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r692": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r693": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r694": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r696": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r698": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r699": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r700": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r701": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r702": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//210/tableOfContent" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-7" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 83 0001558370-23-018287-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-23-018287-xbrl.zip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
53C50%X@AHR1%!0%$ M*ZU5 )KMP'?(:&\-\HX2'5"Z#$$VU4@ #*926&Y4J$234Q *;L99! M0 8E*_Y#,RH?E+)*82'U1L-\4V MY8S\3#J",4@<:Z% 5,.UC$O4IOT^0Y MC'WU*DH%[H">*$20*LL!+*S&2)DQJDVU1BKQP'3G-LER+_K_PIUV_2T'=D!O MI.Q+M:8!":LS$E:,&L-Q$$&:?3U-?=PRQ9Y"0YJ/@0K%)2Q6=>+"L_G+Q%LO M;]=ZL.],8&;_L/3T473[E,3J7'P;!.8#JU@M/_+A\]D_M)R!UL=F8(C! 60V M[K&_3XFZ??CX^!#FTL, ;1"8#ZYBM?S@A\]G_^!R!EH?G#VC);@?/KY[_!:5 M6///]]=AEH?QYM9+?_6B/;[%Z?V3EZJG?"4\Y*QO$*(Y\2N @>9^+3>JZ;] M(M._ER*&1_=N$<.<4X4>4H^>V[U_VSXF,A$/GL.HB)3)4B4:#V=7 'G"?T(C2G"3DLT"RA8T8U210XJ$)"' NFK"<]\W*\ M2=(WI8P'4-#%/2V&V_4]%0A@B<\!#[HJGQ25L/.KP/W6BZ+3?1;&.%/[C ,H M2!60,MQ4@08(D I(>%"I -%)2Q$B4^.Z7GW\!F?>[E7N">E9"IPV*(>G0B' MU3PR6+ R'C4SZOJ="H>6@WKEA#*_YEQL<;HA$]A/:?*2/YTEVYT7J^<1!32D MWF@%:*J-%!1(:S2\J)2F1$$)(K0P+VK)M>? Z\##/?B_X3>ZGZZ(H:%&@SS,!ZM3&F@)M_DTS+ M2'O#K%COSOZ])6]O?><*!E$@V*9!].S4%E=]WQ0-.8W0<.V## *(/804 MH""-A+2\M#2&0Z,*?)*>GGW4YPX_XWB/+\DG.4MBQM%?POSI;)_EA.'TXM6/ M]G3EM,PR3/XO>/!>%0/2BQ*!BP6QZR:HXF4B4[S$^E9^@$Y;1O._+M!9[%"?R4)EEV MFR;K4!7T-2#@S%S"J&C7PF,00VZ]OZ4F# )QD(G-5+@A8!"S.SVS\_0$QU%$ MMP9Q3&PI(A:Y#+9AS)J(T!WCB]<=CK/#M'A79,!NX9W$:[0.M\*$Z2/>@35) M&2)#7J "G4UR30*HH ^5XPCZ$80U&L*BCD%X$AQQ>>Q>,,7HM=)J[1*"PEG M71K&15.2@('8C9*/ENY4D*C(#;RCP-\"SRM]^'\74<91R#"@DV$DP,59SKDO MC)*7^!<:W"T20%HA=DC21-4CO MXQI5J,+K+U",@:.ORR3%X2;F6][^&VOE24OUDO@G+XRI@9_B-8%1)_8Z48 S MG!Z"BK;4 1W$O#KSUU+.@@(J22"!!J)$BBEH@1X9I0DS=O8&.)[8?BDVG:YP MYH!IUG-LF9(,XSV945=5TH'+QN&(A#B[>"5Q99(&8>RE;ZP_^PVQ#)K,3%@H M6CH@[:;%1&^$WD*:="#;VU"3O YP*VM">53;8=S?U#L)_+6H?F_IB0IX]FJZ MN2"\G-]20(*&QOM1R0!P.G7^H2W&E$?CY?@5?^64/O *XYA&9,99@ A:1)>G M.,;J7*X2&MK[*@5H>\X6**#74_"B\EBTO6@!C]X5&!.OV2V26-U$J?BFV>'G MD-ZNC8A-.&029(%ES%,=P,"IOY194>D; ""J+N% NJ7=G):7>9Z&C_N<7BN* M\H1VD-"=Z1II19#K%-U6$+N4U#P3WK@\SV)_%UX:DWDU*UN,G(?1GJS3#+5E M1BPX&[442+1: PJ('5OQU*Y*+;#JQB\+5&#:E*'-$RCW$ZUE-XA$D2@;M[G- M&!9TZF6A;REZ >N.M328U]D( W3",@1.K.R!P3MF CH9'NDS]"Z,44#60%Z: MU8JO#DCJ"8QSI:PEP+LUF$F<6L M_X+#S1.=D(G4WJ9H4;E:M\[G&F+$[F3@'$%?D44/T94&B.OHQV1+?4LRJ*!3 MM"=EM\>W3F([&(*./0Q>,0QQ-0S,D"=.P%IXI:D$]?GI>RXE2J8X=C^EZ]+% MZ!UIN.^TE#%])P).NRM=_-S15[FP/!A#['K9P(T4/D(:]6.J/"XZ0?:20_JD M8DXT=:+I3<4YOV02V,(SJ4BXY)OT/(X420'GN4<676/+XCK)<3_64?HNDLUS M=J,\#+5:\TV,91S07ETI?L)Q%CX7V_2&55]G*H"G.?H)W#C6T8T$S/F./CRV MSS^(1^4:Z.56HBO'W"6RW6 B_(/W:M!=*TS(L[/6@C4/T1K1@$[36O(E.<,I M4;^RH)7N$Q$5)506BFUM=](0 X9@=7._NKXZ7SY'_X*L+C M^_[?HA3[21J0V)F$SGYCY&_LWZ2UI&T7!A?KWJ# MFPZ9'=T(8Q*R_(,QO%K?TL=LH&Z2N/B#WC:;XCQ,67[@EHA/+Y]KSET]9LBQ M7NR>XQU_6&WC^''>ZI2#'5NL?A'^.HQ)/%J,Z,.E;B;W(O MC-C?\Q[!M4U'@ UQ00%E]8C1&'\3AQ3;7=]8#P.#:HY H0QT(+(;G/\2>ULZ M>_P#!U6XGX8960F>[U-ZUR=K*CW$84[*C9M>=(8/8.M:)V3%.7\[N:SC.6'! MTZ+BO8B_N&CC?B3^=_XA_R4N?# A0QLHH%WAI3>$IJ,9!"JJ/DS_T&/LC13= M=(Z6 V'KX SDG'-25OSV<3062V"G\[/]!N;6T0/$.DG+S;3QLH/65-UT"1T& MQ-8M6)!TSC58\]S'/8@;T"!>PKH!X(0CU-R6<>&@LV:OO?ONO*-E(!W+/UPK M^YBFW&.6=+31V(:*[=;.YCS2S%WV2'-C:(JJ M1B4>="FC@3%]_6*%C$IL9ZH7Z84D>690O$,@.!63LRLJ4Q,"1&UD++0O^F) M[M0&=F :?#JPX_7^_N+A'C@(]+(G6OY,_G/Q]WWX[$6T&F:9GWEI2HNRZ(Z% MZGH"2US P+"+<(T0T081)EBTYZP=<1 DOO%&_R&@+Y"7HY("8B3 +6@407WZ M#URC P=63V3M^(#3[57\C'F5@ZK!FQP4,'#2L-X(E"1P,(&1DI%V($1!3\CT MLT4",+@!]),@M)!@GK#-]Y,]X>(.^YB8'UF DO50X:M+4H@"&=!:B- (\ M#3Q,N&=DJ!V;%"BHQBGN)BCPP.UCB%"I()0#G="?"QVVV:U MV>*V?@[4U_:0 4DSVP*$Z3-XBVQK?D-3V_YYTG;=1ACGZ?D>7+.H 2(\"I]4V MHHA*KH,'T7DS0[*Z%X:R8 6%O)2[0ILAJ+)8&PR2:E=)A6NIP .9RS .@-Z"]AI)*P?@QX)_@!BXT+P8MG,+>!-U[>OEV[> P/0@[1^YSWY3)7?__#I/5-G^@ME*-WCH#E'L060\)-3+3"!*?=0)D[5F&?@>UNE$2Z#"BXLMAX=>9S$GF#KY66963Y]@"8]ZJ8U8KRAY>+788Q7Z[,4!Z%ZD2@#A5PEJEEO+A/;<$#K1!4CDH5BN:RBP.RN M" 8^WX:#30+%7IX[_)Q$S_2 M9^R@IS#P"YGQ!'!M<6(.3QU9CAC6(= +$//*PYT%AW:EX09NQ&<[4:S9@7F*VVU&+#F8A#DT%P4X&#FHN5'JEU)C!C* M@O?#6(BWSCIA,+U$RKA(.Z^\$.F_OO_N_?OW']".!$7LTM7_@3Z]?[]XS_^' MSNC%2VA97C_K[?.G)*7]CQ?HX_O%IT__MOCO__;?RJ=AEM&<,$L%UPS1WB+W M1,,PN\KVTWN*^?'3@H']KWV,JY_HFP]>?*IX\8<__&'Q_M-8+X8^#877F$2L M01=/84*"/!%E(T[S3)0. ^A4E)DER0FB LEAQS%0,!OW\>$/E1%+C#=.]$8+ M7'<2!*SYG1?=>F%P%9]YNY"$X(*[554=6" "UJ-8B]6H33%BP=2I6++5WK.L M$!'%I#<#%K@+),[XX$;:6T(*?D*O@.0(L+9TAW./7C]QX:4Q,>QLZ?O[[3ZB M?=KIQ12^=1:7J?>^]!G<4:7/I'TU:==M,$= MD0.BSM0H_/"@A6) 9("03== _YK>4;'R5LVK$7B MVQ]90S#,$)S9K),>-S+O]RC0G-C6TXK4Y*C8N2:+L"OR M3V53; F@ _K08ENJ$Q44K%X]9#IF$,RR% M71Y?. \SGX3%>_+(C-W)X,&W9[.56Z9N9T%S1H MYELYPODE@;H[%Z1,-S:9-B\^MQ,@XJQ2YJ@")M8M3IFDB*,7]D<(<*L$3_$,EK*UD_HNC%&01)&79O5NJCL53-R1 M+*N=7/.XM#&)L%%K+VMO)LPIQ[Y MT\=6-C"B#&322_,CEJ*/G[)1JJ:/*NJJ2)2@.>2K[RN06O!L^JVMM M(0=R5$T1.Z:I;)%=,?4NR2H[3 <,MV,RIV6?;F>M1I+U*')735DMTU;39" M93AS)+EZ&HVE/&XG6&2"=3W1Z52:Q5(@D^U )UNL>+*V(I=G3992\F)(J>A0'"L/O-*7+W2]2$$IXK]Q185M#L5 M$+7MRV9+F>F9*J;#)2GT^(;>46HHC+]%%4%44W3IMI31QF%U>W&W?+BZ^0DM MSQZN?F47J$"'7LDZS.GA*N5,60. WAI\P.;!'<'%4Z@;@1NOEZK_P2E#\F>T M9P'#;7&AR.')(]J7+XES\O:(@EW%.2:,0[<_M)+U'3UI]RTQ;2HR='^*O^TS MWO;J(;G#5-7""!,FZU.%#\DX$]DTKX+L@3'=T#6[9HS_'J ^&U,)(NG,4;V* M^HKJ9:CE:NCC(YYZX<8TK<8T/G1I]#']T:?CNBO']=V>O/A;.KQ)-:A>]?(? M8?W@.=X1@4)V5POY=X3I/Y9QL-S2Z>_"M- I]Z)":@W4QPG.GF6!4P8,Y5RWXCVRJ%A,FS:EAI9U@I\,DC MA48B.+ M=).![D,4,O@V,LP4;/)M$AZC/WBOK!T#^2^_)T!RBXM&%*$IT4.U_%XI(ALC"%_*NXH EZ%ADJ6KFXHXBP!G29I#CG^)4^Q%FL*L;B3@#*N/J**1=<$',;CN#+8TM""! M2AI((((HE2JM7).:R!9_X +'>$.K('76.*+*.\,*A&I#HK03\+FIESBP%D#8)+-EAL\Q_Z^PPU%T M.S=L3W8A &&\2*NK+7TL.2 'I7DJ!;4L(F7D'&I1V\P4*?/9&_ M:-5R+&ZLD4"PN,FJ<3-AS+LW/^ZS,,89 ?#_O@\S=CD \ Y<>QR6OI_LXSR[ MPSX.GS4M'>U073):M6AZ>6%0 MYD*+<+@\7;YDLZWU<-@1<\FTNHBOMSD;2HX8HSVKME9:4*RR)'6#!4[-0=,= M, AS.RKQ)'PK,O@="+KF WV&!*CB7:@Z8X%=V:Z@X%3VNCP M9AL^X]0Y5N&YFSY@^ B50X%Y-,S'@5^I%EE([]@!9,78=2%P# >.969OC^WX M >/Q#A8#'WT81>0N!X^2<;KET[*&J&LD.%[#:K8MP MC6(W&T286C=[SMH%8 4N/>5:8".&?I(3?"00 $\E#1*3\//DT> V6:.LEB^T MD&^NUAP^QD%V293ULY?O4^8Z6+Z:2TT"^S,OBC+:$YBPG]M9XU"JH$U QAB0 M@\XA0TA"M1L9SK.DMQFGBNB8HYKN @F4V3J0T>8-M6=T"EUZNTTQ/C4E9_W% MH3,D Q'L:-6;- M;XM4L6R=ZHQ]#I.>@3M0P&2_U!Z\5C^.--*P])'C::/QTD5N)G^[B!-%P9\CP4 MDZVJN0Y\,)E7?R%5YE5G5]V9 MMLH6=ZLU6[:6@M+V=Q9N1XOMQA1F(:!J(M.@@D]G1MX,DUK5VI!8'<_(,'.D M-%CO0X?FMJ&B1I6?"72"S3ZSV1J< <>-&'OF.'8.A^T8 M.KY3.-X.H9N;_-U$;I[P(B)74YDS&_T7ZS7V<]I5UF<=^NZ(0UK%5'3ZOXN_ M[\-G+\*LFUB6IZ%/W!5]L(R#Y@\"I&)$)WD3G,%/.'"B9YC@-2 N9#(Y6H;' MW\0[.O-W(?HR1*9T2F#!'9% 9X'J5_"'M$#^\#8#X;BF\S-!)S?@QENT27.RP&(MX00 M45+4/XJW7"#.$))T[!"O4&YZ:\X9@@618#EW(/2X;<_8/;#$MN>^& MIQC_HW62H_N\XW-ATWJD:;W*CMG]1:Q-ZTPU.E+'@+P<8=K[9XTXJ'J+ET%+&"^3\=\ M(V,G X3)N:DY,6H,^L+!@57FUJ.]A#_C[2-.%5(V02 W5-NL-K=/Z^= FZ6' M#$BV1EF/Z2\<"/C;"_N<6@60P &N_%1,-U9SAT P*S0Y%^V@6M@/-ZO&/#GP M/KS#:O,R"-@%5EYTZX7!55RTS-!JM@$'3LNMA!$U7HL HOT6'+4[ZE8XB"*= MA'%]5YL;=M%'J@-1H,\?Y"3JP,&%E]*E>J:U#Q4PY(D#'?O-HP8R2* S!FI6 M)(<+.# JH5U1_8%2O%OZ_GZ[CVA!%CK'Z] /<_4=I_-,&35'[(P$#>TDX%T219=)^N*E@6+ .E-QZ08+ M*X'U%U9H23AR/X4%C[;74<@SO90<*NA!6_#LXD-GMP^%JW;D;Y.4ALZBPWU( MZ(5629R3L21<;*YB,IXX4V_*C$,<,E\^YO T$^MC4 ;*P(_'NF1CJ&TB8EE, M\896'-!\"2K?XL#>]J3#=>I%]'"0$SO8H(+.XBUE9T[H'KMB0-3@38[I\( MGX\D\@GH$H:L7]A)VCM:A)*%.;['Z7/H8UX5>(?]9!,S*K]ZT5YUR>3TKX5, M(<\SI,TL]+3O!$IDSR&4)!=>O9;U-&^FQE&=3UX@]O83]GHDOI\6[A4T M\:9JLK-! &IG9"5&U;1("SVKD=BR(^F05>'04NP2"[A)!KV7BO:/Y%>_DOE& M82TR0,"F%TJV&\TM6E P32P4;+0/W#% UAVF D5?'O!KCD[)Y__-@8[UMJ(X MJ>Q+WT_V<EV3.#C.44T'E838^:L;_"(^N\_)CUX: &O>J9>%V6I]2T:S['2WC -!GO:P M4+-G5J\8R&$DX;1WC*$0]7L(/1 +&,ZP9,N&D*06(A)EYF R&:=FEPE&YJOP M'KP6J3J.=8=9V9)]JJL#/FC13SVSG Q":IK6[-$A:ZV[B=BLOK;# M!:K'[L*<['X/BL[O%B@)H!=" 94D9IQP+.JV!TE+[-?;;%*^!8T*8C2[M<9I M6O_"+[TNQ2^Z:B+:<1YZ-50YCZ*WH!<)3J3V3B:+[4''A?-#'866GRFR) )\ MSJ@3E[JS1Q4A<;H1]E'<"B/N\: M,N0BL8MXS>6@#2;0 MPL^>-555'F+8;D9^]_O=+F)QJA>)L@I"FN:2;B0 ]^-[B-K8BN^ #[,+WYE! MR=*[)H$:ZMO<>7=IRAA![",P5'I72RV18;)0 0,6UFK9;Y352B%ABFHUK$@O MTW%)14QN6PGMBI)HG;$"U $U,2Y!Z:5+KH;?W46!3ERQD.S62_,WL0#+X!_- M:)")*CN1F@DJ/0Y08LJ&*4E"BA_P97B-6D W5XW:BX)X"6GKF#NA.J:6] MVU-KJ+-^?4JAH0^=E1*LULUJ>L8ON_ZPKK8!MC.)K'W(90 M!#H,-YQE16WZ%?D"<4Z;3=R2IT>B^J>BF,9UP5"J1Z#\^@'II?URDFZKOXYG MV=99.;4EZ\;)+%3.#8QR\P17=7V>4]/A-"/DGH>@Y?(A/XRVC .Z81K&&QS3 MTAGK7%)'&K!'.CH+>WBVPYH V"&/CAQ*3WL4-/@VMTCE"-35-']U)>*XPFIG MIVX4W%59DV?5ZJRSBZ[I18?.-Z?ALY>SWFW$Y>Q+27_&P:9QZ66'?8L!%"'S MUH,'HIG;[DT.*/\]D%])8KFD>'PJ;MYW&4+RJ)3N[85^II4>!,V ;440#U<&#&*"9H98>413$ M<-!G[%&,+?SEAS(Y3+.& <TS#Y2+#!1A>ILF-Q?1L>,JKP%HVR\PT[COID,RH@%>%N?G4"->_OT M*# W^-GPU+[+K[S31.CVQ#'1E^*_+EE1/R'IM>C%[1"[4DRVS/X+#C=/=.]R M2=[M;3!_!-W@![\(I^;3)";_]'D@QL6UL[CN9 "; _44N=$ZJ",-F,9"O9B4 M*'2CZ4&3D-,&/,T .-+UX=Y_PL$^PJOUH9^B?3+\91R^)L'UN3=%(/V MI088EPX;@$:LVH\43/PZA-=V3%M0HX4VLNF9T6335T&5!+KLI@=WSNE/-R Q MFBK/JJG\I9S*O6(JSQR8RH6& ZSO8-%@P,K\+7%!Z^WLA3NHJC,C0M7. MV7*F:RY1M- KVTG,;9YV)7"]!17-,>5X&0H:K34>W]#6^UN2HEV:!'L_1\2X M\"9)WYBI;G"R2;W=$_%B!&'HV4I%S]7:!967IUSP7NAD,:"UO\[80-U8NPM8 MM6:U1YW,"H/$9SN%3/^&?0&%FA*@?>2E5#.%RM6P(%9VQE_0&>6[:>U1YG'& MD5$TQ9($NB@EH\M>9T*#\066?LII77]@_W9Q:=T( /N M7#J++/$RUC1<<#<=F;7T.X% E4V"GD 7WO\,%5JTR_-#445JSCJD,4= ^[%= M25%59!STN<)K!ACE#L% 06*""A#N& M.8&X84$ O&BZEHG=8+W,,IQG]*['0C!K\S.ANV!^=B+*S4^/"VQ^-LQI]9%? M7\XI+%!-PV4C'"QTPH3V&(4IPO2E[Z=['!0K"EJ"REB^#KW',&(5J#8SW3!2 M0.'Z0-&KD+TG';BP?1##EJ&[Q]]1+C-Y@397YM)LH_I]4+'\N"-14"MS"5QF M[K4$B@X&#Q.,A>C#NND";*S!9*Y=M2"]5:AOCPX7:W0548PU;'%!8HUNS+54 MEENJ$%<(!-RQU9&$;<<8SIA@'3T1E[3?[EE_ 28N[3N0XB?B1-C!&;JA>9UD M=I8YF*H+BX-! R)?,_0B";R4&,"SUA $NL6\W:!&" 2_SGC/&BG1>%PG;U_4".ZX ),8LFM7(4%;,AZMK2J>)W$FQ-B$EO$ MNH.*9T$=+!T81>2(B(R8R %X%U%1(,E1UB[6ID=WP^9L1%19G@X7W/[,S!FV MK:2GL1VWP(%"9\(-:\D^SV@=+2VH#>H3V AO=U'R1J;)/$%;+Z:U=5LO_0WG M* VSW]@*.,"4$)M+O0SY7O:$UE'R@LB+-N[$X-+1^LD+8QI 7,75G5VK=77[ MR"U.60=X8F$#_4"?]SCK,/H/6@?/TOTE+KJ@OE)8=HM8(/J"(XCCIQTR^5;*,@Z$?$=QZ#I8Q7>89D.(*V8W;'9,"XSR#A>< MSXB#)7<\([P V.F,)H'6INK& (MBVY+-^V):L7P78BU!B[&COJ3I2<\$G M]1H N??I1 K8S_3@56L1[9/[ L4%/4%00CB] AM[6$+AED9ZFB)ER[&4D6?# MD#G1!("X0V(SQ'$5YT>X\Z3WLI8R)V=)G"51&-!5H5'&L"%HWIK1 MCQ;0%1I#F)5<+2&28WL7?'ID=Q*73B!/D$C4O8ABY%%I^(2 H(?KD$D\0OW4 M"!T*\GKG9?GLA1&+AQ+:K3:)62/TIR0BBZ^L..9I:-DT@!YDSX*!@]!L7M"3 M&% 7@T'C,5_S"!P:<&"0$+C!Y6I]0=8,^5MV5Z4. MRO:!'?NG=J3I8E/,#H-AUR[3@J!CC32M.3:WV%R(/39ICR)&^%\S5).N6E6Z M$YY/,32.=>:\V6\?<4J;N1S*H?*/&@3 *=HH1F,N5D+#3+H&=MIS"T/@[8): MY@.]I.TOC',9:UW'(X7X>A0W&V_)3$0'[UR;K9[=M=332W_MRM)5JOT'J?/H8^7K^&AHU6#S:\])I:IQJA@9M42/1,MS2A 66JL@"91 M!X&'4PE:15"PDITG6R\\/+MJ@ 55#C7S!QK2!H12$Q4G=KK",89IB^I(>AQN MO>AG[$7YTV=,Y\8#(9104 ?)E0S79\1;((#'OQ6\M,\S,T#$(=$7#COQDD2F MM.YS;3A9W8OU*4SK,PY"VE4RN,0X6 9!R*H\RZ/>F=K:+!&!#+"36)5-6F'! MF6D']EJ*5.$BBHPJ[+HC009MSU^'>'K#'R3CY5)HE#"%,[C9YVE(M<^+[G>T M\UK$JS=5/D /#V3Z-D)4%J\#AC-T,U>2E$&%@@0<:)L^.DGTYCN>.%.8[Z^> M[]-$JMI@#R& 3%3.:&64S<=P9BCCH_5]2R!H2W.16;TQ=>)XDMB7$$Z]J+)0 M3;"K@(2*;K6,U^&L% PP?M7P(ZEGW1$FV.97D?FFIV;W:\_/V26A-!#BYV7,-IR\AE:)RDB(1+MEI]'>(&R%_)D@7;)/LJ+WOD[G!.PI"(!U6ZLTY 4 MP*B"=L*,AXDPA5T+!Q[+S);:M#7 0-9M9+\R<"4DG(T;6&JG$FMX5") 3Z5' M)(/>-,<0Q,GMQFOB1JYRO%7MR)O1G-MV;(EDL?58X;BT_7C 5)4XH]:48H?_DH8:DHD/IA?!=ILT>]=_SKKQSU\;>M+_G)S]7!QCNX? ME@\7]T"3F9G).*1;)LR539)AN2;39[SQFO%EFNJN/.'OW+]R0):N^--[1) MM]?)RT4E^@N1,D&T8A]O]=F+C_#G(H.>RQ M8(<"=5C 3I3ZY( >'O 8@0UC[6"K:+]3HJ$:#W%$J/,%1RF.INWB"%*])&D4 MO(0!1GXMUHYALK(;SV=)QXRV7<7A,SU2"+R!W+A<0WM,508)N$VL9KRQ,]P& M@]D,5O$Q[,J6*?;(>FN/9#=5!^B*[ASNHZJA'- :P5U1EK8(:I6I81U0G$-F3.JS0!1CTF.K9RD.POS2\ZLVZ*J-+Q4D4$2J M9[P*1.5@(P$:8SP>4FQ:Q6AP!\Y DG3U/M M;X$$:I@6XAS8J 8#VER-K*D4IT)<((K*LB>((KMAR$N*8I+0=NU MJ998!>U*R-820!VQ7<,6#.MX,8?[U^Y4!W<6!%;AKV(B$L[RB]<=CC-LZ%RI MA(93>(, HL(K0$$47LM+2T]*:%2 S];TT>*FEIZ28 Z^0#%VRP2H35Z\^M&> MW@NSW-)>EO^0!2K=T9TQ$J.(&JM1XKI@1@;FC':U8,G&!:IH()$(\-0REJR5 MY>%*2L]&2@AC9+U/[,:C '7&R!JL:PR*P;E@/ (C%H:RTG:: 9I\="+H&890 M;CN9'%)I"VUV09&M=?B!MK<'[J#?D??">;NAQV5S*GX%@$' 0V!XK9:S+U/N M)B2HCLM84:M+U>.LN%]B(F7_@?,?TT.Q.+!1]VYBA'KF9U5ZSG%AKC=)G.QP M2@]?;&ZP:=FL1X4W"!O19.:APP,U%C-C:ITK+V0IL+]=()$ ^4NS;AW3FAYL M9Y APKJS&C^GS7U\?L-29= M<.\BS&K%V#$@@8Q+2:YQI&4BNK/6%EFSD-L5XS%9";@Y6&B"4PIMH[G)&NWH MR;TT?UN@'8'CL27^^S[% ,P5==TYU%9B%U10008Q.L(-=#<6"8H X7; !D3%^)WW\MDCE!$A:*??#*?/6+6( ML$%TP :,8DDM0HD%:Q\&MG360E!1A(E*YMB6"(Z;TER3] M[2J^31,?9]UL28?I@#&9!9-:DQH-UIQ,?.GLB>*B,$8%ML,6U5E*BG 2QB<[ MCN*(45V&<9@]X>"G) FZ&94.TP&C,@LF-2HU&JQ1F?C2&56)BQBRPS;56Y6OZ"J2A%%%-$)BSG':YRF.. 5E0_>*[=X=8&O#@%T MT] @QL%.H0(::GM0RXXL#\T0RL)=@E),(%/6ZG:IN.HK$*]^1[GW.LGM4=TJ M!I,L)'.?KJ[J$ BT:E#"[D'=H !53G88D%6B\> 9JF"LBL?M&?:@>">KE.R MG+4/U$5V#3#@L%["LLR41!S M7#1[\^M4HE&P9JT0"7@4$LQ9:! @MZ!T'+EG9#@=X^)^#.-Q=UVV#H(:##&PW5I=BK-?<4H1?= MTO1 F,07KSF.,WH@ZCK,>FU)=*'NZ.9%]P&RWN:P)^W>ADA7WOMLG2Q0]1:Z MNUZ]!Y4O0E_J5Z&+F$1\*2OIA2ZR='_DH,/B1FQ?.U&[L1&^M-WB8= +G%F+ MCC!,FK7K .HNK'4'L]]I;7RTGLGM40/N5N#[Z1X'UZ'W6-QO4';#$G_2%R)U MI '8RZ"/L(W6!ET(P'0ZZ,YA^\0/IX$$#*%YF_BK0]508PI>=*#B4B=,ZL*: M4503 ]Y]*<[CWN&(];FK^3K3)@@L\ !W9&R%:NS-F)!@=FGLN%*>LSY).:)H M;PMTYDAJ8*ATJ)#.I21!*<2;WH!,2*XLZ57BJ%?JAQ@.+,#E+)E7AQ6>.R;3 M2[#B::LRT9EIJ)@R[[V(F'ZRW8991F):O049<,#C0[TPDGA0C@ 9_^DX4H8] M# G56.[83A^I:C@>QZ7XD/-BRZQ*60S(8$;C$$FE-Q(I))QE:!@7S4$"!F(# M2CY:"L(@40'JCK+;"U"4Y-=+>P=JV0M3K8H\K>:#-C3X1* 20#(#'()"NGXY M+TJ?7X'/I/[F3J"=Q*C 3L98A"N:N!VR=)OB;;C?%NGO>"/7\&ZH0 W6.HI6 MM4NSQ(-K?M:)0;-UH (?501FLA>9Q7]5 NH;A V3LI9N5TBW+A$=*(FS3G,K MH8&+W^Q2V@I0N#(WZP1O:X_(G1"QAR NIZ='+F(;0M[5E/>896S]:3N81A^_ M'*N=<#_:,[-IX;S&28DEV9 \^$%C7]VZ7!&3_&NDWAS0N; [61[RHJ,$'WQ WGO,@Y: M[4=:;0*M,(#R/W:"5&D?/3A&+]GU07L:GWAKHD(H*+O"Y-XK;Y:TH/%* MX^=2J]Z0E^=I^+C/:8H>Y0E]ROX9A&L"C\F@9^@ES)_0W_9IF 6AG_-=J!CG M5$N_ TH:]1HGBH0H%B)H2-(."+!?XD"IF.^@NR>!>SV!;FGXS6Y%9,$""9?S M%.=A6C3'#^@/F)6@"5WQV44F0AABG,%'?PO]W.W[_!9DMA#%ZK :D^T*,8-OK/OY )\39-_H;]O *IK_&XBB]>:1?HU9K"\J.Z:FC% M1YKQ_2Y=6C;Q(.LO/IOHY8YE%W'QL+*BG %69.FS>(Y*S2 M93CE^7P=&OC!-MB1_^6[^^_0KAAH>A&OP]&?Y/[)T6(^>]J.1GI=!\/.#6/G1T5)_2XB\ *5;8A :W-]CQJ M%9J2*527=6E=($H-47*(T5L@3A%]X32AYS# (7#&IA]2LD2.^&W=P=_VO-^Y MK2EKD9VP8 OQ%(:KP82V5R-K6AV]3%(<;N*B"M1_0S4-M#PHGG#67N<> F?L M59(JZVZW5D20E!QB]* 7DJNS*]'D'A)N<*:VGT8T M0-6U%*FAJ@8<&-6T8JJMB@1-.:W,= +$/+'TE$TPLZ(Y9\/,(F)>P :5^.$I M7I-8EEZM*9%0-2!F/$"3LA6J85,F)!BCLN-*;E6/#)'6<"^Z!BHSF55?Z2SL M:E&*GWNO\#;6W;HLWP-5>L4.2BA8%\U#!@=B%VI&-$?R*/ "47 2I1$$X(7!H0SG MR=8+567D*F!W=*;)ODYK.*03>B.R8JDY' 5:=\CJ=K4^2W$0ZK.?,D! G5&R MW="7%A2,KBC8D%2CQI@687!05Q*+/=F']HE>7#::U.NU!!#2%ZK8;OK!0R@@ M'RAG0^+_:.:X@'1&K7MQ#ZO5=_@YB9YI>S^JYM INP('3=2MA1+77 M(H!8@ 5'+76J<$HW7V*Y8ABC"@4\"^"N-N4 "!S,;*!EI M>U0&ZF"DTU\$6#V_Q_X^I?N^CWHEE\#!:;B2:5&]6T @NJW@HGW$G<.Q99XK M2MV']RD:"[$V)C26DFJH' 2H=9""U:I7T,%SN.9 4D;:=P&P!C>(PLVDE#); M2B1[8;EQD5F\S MG3B>PEZN8C\MNLU0RZ1F28'.]WBY2\.(_/L/:E/J@ QD99W%JPS0&A/.-CNR M*+L\IL3G[=THA06B-!:(4$&,#/W[#]"6_?6)JO<+0^6EP$@J- H:TL*NR'[U MTI#F"^^\7+=_VP:#6X^I6!:78X#OZ MQ";GTY'YHV&!(,]J($B]L MQ:G$EEN# ^L_3KT,&QW"(1"M/44\!NW/>'!(YCOK \455]ZNG6DX5M_ M]E[#[7ZK_-H'SV&^MY3)\HLW'L[^S25O;WWU @9Z#\RJ'G1*,@8\Q=BMU86E5T%6=YRC;^R,(SS.YW*?:"52QF;$M>5K$\ M;!E("VBO=JCPU=9M7T)P.[G#.)9<(O%(ETTEO05B%!$GB9(8-;+Z"U3I-B$, MO=/[SS<4^IU@A\;# 8_W\)*,YO$$6L?A\5K"]_5X%:&C\7@''(^GUH3PD7F\ MKV H1O5X4XZ'"QZ/$!LORFM0.Q*OUQZ WGZO)G4\GN^0YQ$5G)(^-N_W=0S' MN!YPXC%QP M>DA$>S0F*Q([#![;%[^L":TI'XP$/61Y/NRGE(_-_7\5@C.K] MIAT1Z-MTQ:&X]'S,[ZQ7;,.KP2'OJM6+T+Q:5@X+=!.LCAFSEE$,Q%' ;U;M M),ERLTE97SFT2\/8#W=>A#R]' #&<(N)B0:A?^NQZ[:M1&_AN&(6"F'4MG& MX("!2#DR6TF)A@H\ITRE@TRA(-.NE&EGD EB#DGQW_?T,HK5NH\%Z=!=,2:S MB)HY1XGK@(F9F+.8DTH*[&)PETVOGZRB%:Y%6=TRR6NA5US5.(A7H9PF:9J\ MT+9"WHX\R=\4H]6-A!LM"&U%534G-.&#MRVT8]#4T+"DLD!E(55%")64H%L M#1>ZE.VQDLTWR09FFW>85GP0'H=8IXZ(6_9I%M=DH6H*SMBHB45[*ZTH'8>= M=A:\7@]ZSUX8L4R)SP=AS6F"W]9]GN1<'U$:KF0=:>5F3O*SD7&!1F^PSHT&W932+U&[1J,8!;-=H8DK1]S 3 MI@L!<^%&5G"X:,4DD-28+F4ZE!L''ZP6H#IT5S(=9A'5F0XUK@.9#A-S _=X MIK6\9YP^)EUR'9VEY<)EE7#/I7 I.WSO92OAB$V&12327 MDHSP"B?*Q48;*D41V6#ZKI26C22(V;ZK%RT0>Q6B[T+D9:A\&V*O(YZ@>"$K M+CKY.W\ECU:K?+\3E6B_C]W PK6I!K#<.-$.ELO^^@%G167%#)Y;\K(C]^'* MX1O=F[?>=/Q^72'2;%Z*OK\HO/A:W/T_WY#.,PO8CJO5?- 8IADGAZN8B$/> M3'\PSWMAW'$ZZ$?>K0E@R!"97'X?VLXY^?Y"=/)!Y6M0^1Z[L)._SRT?_ON( M]7+1(PY;\12%Y1#YY1"E@\/SD7.%I=3L3 WMF!3<\JT#PNWRD4!YOEUML!TA M5W*-7<16YR)MJ#B0J[1GT^P *JLO3DLQ-@R>=X44[:QO@AW*K, MLC,5R$O7>PG3 MGM6'!DSZEU)ZKY ^%,VZD#[723_3))N&SQYM0?Y JVF4/NT "G*ZE#+Q60J$O# [XEJ&:GWH&NPNSWS3WE.E17- 3M2ARI6G# VN0BB&= M.M4X3MQO5G-VEL1LV?% WJ:]Z4R/XH)BJ461*U8;'EBQ5 SI%*O$<>1>-'&& M+EG37@RC0X!3*K,8HDJIH4$4RL2.>H7#;CVI-S@\Q M'#%SN2!**V^"NV/D,KZLU(8B4JWYZ)J)'XU$W0Q\N%BN++7K'$#V$UFI72=9 M=OKV,PXV]"9<'#'5S9["7]B'=#6:UK)C-#6:05)IP:=1!,5"L+-! U ML^:KI78E)CH/,S]*Z.W$F3O5B_WE$B!=\;1-88P.XQ#)NPP-Y7 MQHQ&9Q:HL@LG^E0-$"0N!7&C?7W)V&7XB@,QU6*47(+A@DDH!9%;10L/WOY/@WS-]JKQQRP'T"[8"U2 >26 MT@ %MA()+UJ-*N%=Z/K47XIM*05\:R>Q)M>P\I"#NE$SKEM;R.# J[\-479= MY,Q+O'^)_4;VS),NS&ZRV M"04TI#EH!6A:@A04R @TO"A.ZF79GL(B!KR@73DF,H$?./\QZ](?Z(V@BQB_ MQ&3AG.;A/\B,%K"V@*5(/D5T)RRRF/Q<"8-,X0]XV&/ETB?VY4GN1;91C8+? M!TH#7D/S@LNS/3&[.%_&P0W1E^(/H)N+6,F$4<0/PI8/H&PI1++Q(!>G&+'' N&JR*,# YXP&'];&4.1D=+<' MS147=1 &9]F/J#3@K5F$V96^MEH+845@-U2_S;Y*^VM(< ,X9,5H Q>O?K1G MUQ#-9@U]4D8=Y.)+Y#B)3PH,6(NX]Y]PL(_P:LU*[G!PZZ7YVT/JQ1F9QV@% MWNE;XXGFR']/6G#V-$AXT=QZ$0*QQ@&GP[>.Q$ MXP([^36%[ET(P.EX=S%%Q;;'!M'FKNRU5+BAEPM$3[4[4;(@ M)&Q=>MLP*OA?K3][L;?!=(-GE=ZF8>R'.R]:O<0XU;AL$8%:DC14;2J,X4E'ER+BDX,MD\X M"MALCZ_ 1VLR6Y84H'M6?#TBZIM8S""GDS/3M>$TJQG-N?FI)9+%%'4->NC5 MCJDN$]6UQ8'8>58;8\OFIAGQBM!LM19^ZQCR2BDX9UPZ06T6&A)TETQ.S9^] MABZ*(Y 970,+OX-?K#!;O0.+ &\*C<*_=)&;8 M)X\4'34"2/$E=+M8!"Q>A-B;W-@ZYD*3%VBR9PV!<]&2"M*SLXN][ M>IJW\+6.['%G>1KZ)(R[SQ/_MU]B$G+=W?]BV.[6XD"N,2R$::XJ- A ZP@C M1Y*50XF#&!)B6.@=P69)=OMU)E%NLR0+;MV9E=LNE%BO-JQG<"?"(D\NXIO<1HFP=@CW?GU1^B >@[Q*&ZJX[N/RYGU M$FY\E[= 10I+X 0Q5E!.>$$%,[37$F4'A3'B#!VK>QQGW!D0&O.,OIM1/T/NWLEG?H]#;*+KOK@MNE M_Q3B9W[V9+U,P_QIB_/07S[CE BP6I]%24; 6&Q[FX8^)L/ "%XFZ87G/SVD M'NV*<.Z]%03K8?H5 A$"(256\0YIL%*L0"2H/^ M_KV_RN^M3R0?[4>OOIC7_&)>_<6\^HOYQ1?+V!?;L2]&8AN^3F-?#-,OEA=? M+*!?[+D5%"W0EO/T3Q4=21-ECO+X3Q_YM%-N3C+X>U33'(GCG-/FR/H=0;CR M^X?\FN(0[=>+U]^A#.2C' M.7_Q9PSV]RS*[U_XGRI>L?W,TXE3Q3W^.;W[_P/UE\H_W,<\B+! 7AOY=B%/,@:S_%9\YF4PH3]A,2;QVC&JY4"T8*B6;KWASLNCH]^_N M]'>?-F:"_/C5EPN%+_=7\\LMEU9?C<91??KF\_')Q_>72^LOA MZLL=5<6Q] /]>>]%X9I>\$UO,@NYP-/5S'3GX6N*:RP&>]H01PEGW/*==_,+[*E$V$>/SV.;.WS^, MRU/J5%^'CU! 1VA-1^A9.T)?5;.2OV!ZG!<'Q2Z*<:9UD+^OO]V)]4>"Z(=B M9.ZK;IAB*;U3$T+)<[7![-(,<2P?4#IG3+%U.^)4(O:F?DA6C[D7QC\E29 M MXZ"\'&KY2 ;.\W/C9^E&S 4GW4=\N4?M0@G8_75G5=O]J?)!-=D%.@\S6ORP M3VE_W8(6<(_=B^TN2MXP+D14>)/R%IE: )/^CT 7SA1&&Q31*@83!3&0D;CN M;BO+( CY_E5'LYEGVIUL7)QK![F,&%T*7_5"U_;)$!>W9W$J_1RML* M$Z;#=P?6NIMF@0YL@<-DI&96R-BX&0T;9!ME%Z ,P^M!+;BE_Z&W,?PG]M)5 M;,C>VU,!S[IW%5B2+;/Q M7C6W(]HP)7HD'NQ(Y1_7BQD'H8\?TP["?)[LDHSM"&/$R1R''Q-%[NO&*(VC M\6(UL^,9,:5Y'#[L.*4?U8,9AZ"' UOKAF">1+/OIWLOHJ>0X^[3_PX6[9+XBQ\C/"ME^:$29G[LD0$"B\A4[?04/<+4?"3SL86DN"%I M1"7UK22=I[A++=[;/9E;BAY!EV'L$6Z]Z#;)0KYW3GP,.AE6;T+EJ]"7^F5(>!OT&N ( MA@[65U5UY-DY3L-GCU:_9:<>$9!6UV&<7]/7$C9/WVH UIF#K)@>"&.G;S_C M8$,;E^$LW/!#O0\>&3C%%YGRA7!>;/IA%%W:=&\#\6]3B].RV/H428:$5RY0 M\5+$WHK*UR[H29<:#I6O1O3=Z M[$W ].0FJ,)&\;'Y3:HK94O5/$':: +!VH=LQEJ^AJJLBQH CH1TC*6S?9K2V@=+#9&" RN*1H26 MODA@X=1&R8Q">PIX:RV:)X ;010'[."&*%LW4U!A %N#7I"60K^B-=)BM%JO298[&HLVFZ+@'N1.Y6Q_<>%1R>>4R&) MU-$PP9;;9!_G-TG./\=RXX5QEM=?I)\/LR3M@A4/'YH.4X\5718TD6SK=CJ$D-.;%L)+3.;0J0'2MFF_>G, MUB,T,OV)^ !:_595X]SAB.V#9$_A[O3M*O:3+:Z*X60U/36QNS#[35=%-B<# M+ECS7,,L]PI3OQW8N\PCGBYT$#A8(,H#>D>Y^-:-XC+M2-FG ?7(CEJ996)0 MA^F>=MNG"C6:Z6#:L)1O%??+&AKQ75!22R'E>FI !E95*^ZTT9ZHH4F,Q$>6 M"<2YUUA#979F':40I.\ .&ULO8S,3>,:;%036=(/7+:8-7(.!MF20L1W/)K[ MMNS-P:YK30,<%!>^9DD4T@L4 I25 1^[^#79%>>!G#,]X403EVV5TMZ\*7ZB MAYEH*$!_['+,<.1WN&32(PR6WOP'O, 15S%8 ENW>I^'C/J>+XX?DUF.U M-?HH?X;W0A=!SC"H[6K*"5\*6)8YN52JHDB9ORMM_,S+GM!EE+P@]M8##^"M MZ5[3'?8C+\O"=5B=7>0;382Y!>*Y'D* M,T3^CU@%\M@.*YW--\S*HW+YM>7D6<,31G]!;]3+T4NY@*$[S]6;H!I+C3DL M)2WN[UB#A56,"GK5*=D,E131,JL' +;YU"3#P#;;N49@HA,IW:+ [+.W=*-> MTWH9\MB=*TE<1(FA<8CF[4#!"YV7<7 =>H]A%-*^6I^Q1Z]O"E8Q&:=]FM)I M( YNDC@M_SSULC"S:C@QG+X#_27&&B1I.XFAQ&&[1XS#O:99Q )51) 7!T@D MX\9.7346IV_5/W\.R9(R]9_>KO$S45CU@61;9 >LP$H\J8IK,6'UUX(UC7*B M"H?KYO)7)XXS5R(5ELBRJ&TYM2><.])P0#^[""M54QL"L-IJSV%'I77BS'0E MT56\V^<9,\,/'\G4\4G?\,2(YH!R&D22ZJ,"!U8%M4QIYW&.N4 ,%WU8H(], M_SXYJ$, ]F^@>H#@:FW0,2UR+2/H&(Q8Q")Q-Z(4J!'#$)@:D M@ZX--THU,@N-*4P<6<\<9[5%D=(T$*@ M?.9#KQW;3726N.SVRSMB^6\HJ,MWV!08QH0'G.4H]7*,LA=OY\BL)R3)_Q+F M3[_$R6.&TV>Z4\BC:KK['_MD,%A]R5TC:F"#]9!Z<;8F(VP^QS3Y6QV8;Z<= M4--6S(BO=&;S9G29M&&"\&+T0MZ,Q%<7*V'4?+FXZ\[>OR@[;50\.':X"V:8 MSU@G](P>7J'U8VLZZL]EX$)_*?,++K3?F&B(YOT@7Z%'G-$3?DT>$-;S?9WN M3E4C6X*@1YR_8!RCB/HU,A).^37+;!$3O350S7&R#?LF>:4#'F["H1R2JNSR MOJ/(7'87:+Q$9N'>VC[QP"4Z&.3--[K6$5Y4<^*(.QPT-52YNME"/<4;'7"& MTPWD^"&?]'5''/9IY)DA]*O>_E6&?UW&5AT".N/X[OTG'.PCO%K?XPUK!H9W M]+1BO+F*UTFZ+=J&%0]UQU=Z48)S5 ,$%QU0#S(@CJ4WGRVE+BG1N;P 1Q4Q M)%!CMY&6$$Z<.JEZ#YSNLS#&659PEVD.FQAP !781IB&JNH08)32S%%;_0H0 M)PZ-%,QH#X4
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Ļ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®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end